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Despite recent advances in tumour cell biology, the prognosis for patients suffering
from malignant glioma remains poor. Although primary glioma rarely metastasises
outside the central nervous system (primary being defined as the mass of tumour
cells at the original site of the neoplastic event) median survival of adults is less than
1 year after diagnosis.The efficacy of existing therapeutic interventions is limited by
poor penetration of chemotherapeutic drugs across the blood brain barrier, the
inherent radioresistance of glioma tissue and the infiltrating nature of the tumour.
Further progress is likely to be achieved through analysis of the complex biology of
these tumours and the development of novel therapeutic strategies. The purpose of
this study was to investigate the therapeutic potential of the n-6 essential fatty acids
arachidonic acid and gamma-linolenic acid, which may inhibit tumour proliferation
by acting as substrates for the production of potentially cytotoxic reactive oxygen
intermediates and stimulating apoptotic cell death, both alone and in conjunction
with radiation.
Experiments were undertaken to investigate the effects of exogenous arachidonic
acid and gamma-linolenic acid on cellular peroxidation, proliferation, viability and
apoptosis. These investigations were carried out on single cell suspensions of
morphologically heterogeneous fresh human glioma tissue and associated normal
brain, human phagocytes and the rat C6 glioma cell line. It was shown that oxidative
activity was impaired in human glioma tissue. Addition of 4-40pM arachidonic acid
and gamma-linolenic acid induced a concentration dependant increase in tumour
reactive oxygen intermediate production and apoptotic activity. Although the
kinetics of reactive oxygen intermediate formation in the presence of arachidonic
acid and gamma-linolenic acid followed an exponential function in both normal and
tumour cell preparations, tumour cells showed a significantly higher sensitivity to
exogenous essential fatty acid stimulus. The kinetics of this stimulation were grade
dependent, with high grade tumours responding in a more rapid and sustained
manner in comparison with lower grade tumours. The morphological heterogeneity
of the human glioma preparations was confirmed with immunohistochemical
analysis and flow cytometry using monoclonal and polyclonal anti-Glial Acidic
Fibrillary Protein (GFAP). GFAP positive cells responded to exogenous arachidonic
acid and gamma-linolenic acid with increased reactive oxygen intermediate
production, indicating a high sensitivity of glioma cells to essential fatty acid
stimulus. Reactive oxygen intermediate production was also investigated in
phagocyte preparations of patients undergoing pulmonary resection for lung cancer.
It was found that reactive oxygen intermediate generation was stimulated in patient
and control phagocytes by exogenous 1 -40(iM arachidonic acid and gamma-linolenic
acid both pre and post-operatively. Increased reactive oxygen intermediate formation
was detected in the cell population identified as leukocytes in preparations of human
primary glioma, although this response was less than that of associated tumour. It
was also found that surgery was associated with an increase in phagocyte reactive
oxygen intermediate at 2 and 7 days post-operatively in lung cancer patients. The
interactive effects of arachidonic acid, gamma-linolenic acid and therapeutic
radiation were demonstrated in the rat C6 glioma cell line. The rate of reactive
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oxygen intermediate production in response to exogenous arachidonic acid and
gamma-linolenic acid increased within the first hour, and elevated oxidative activity
was detected for up to three hours. However, a different pattern of reactive oxygen
intermediate generation was observed in response to radiation alone. Similarly, an
early apoptotic response was observed following exogenous arachidonic acid and
gamma-linolenic acid stimulation. In comparison, radiation induced stimulation of
apoptosis occurred over the 12 hour period of incubation and was maximal between
6 and 8 hours post-irradiation. An enhanced radiation response was observed when
the stimulation of apoptosis induced by essential fatty acid stimulus alone was low,
suggesting that essential fatty acids and radiation may interact to potentiate reactive
oxygen intermediate generation and apoptosis.
In conclusion, this study has provided evidence that glioma tissue has low basal
oxidative activity in comparison with associated normal brain, and that addition of
exogenous arachidonic acid and gamma-linolenic acid stimulates peroxidative and
apoptotic activity in glioma tissue a grade dependant manner. Studies on the cellular
heterogeneity of human glioma samples indicate that the stimulation of reactive
oxygen intermediate production by exogenous arachidonic acid and gamma-linolenic
acid occurs in GFAP positive cells. This indicates high sensitivity ofhuman glioma
to exogenous essential fatty acid stimulus. Phagocyte populations from lung cancer
and malignant glioma patients also respond with increased reactive oxygen
intermediate production to exogenous arachidonic acid and gamma-linolenic acid,
although the magnitude of this increase is less than that observed for tumour cells. In
addition, there is evidence ofpotentiation of the oxidative and apoptotic response of
the rat C6 cell line to exogenous arachidonic acid and gamma-linolenic acid in the
presence of therapeutically relevant doses of radiation. These results are consistent




The Role of Essential Fatty Acids in Cell Proliferation and Death:
Relation to Reactive Oxygen Species Formation and Human
Primary Glioma
1.1 Introduction
Gliomas are the most common group of intrinsic brain neoplasms in children and
middle aged adults (Prados and Levin, 2000). These tumours are currently classified
according to presumed cellular origin and histological features associated with
increasing malignancy, generally using the WHO system or the system of Daumas-
Duport et al (1988). The WHO classification defines these tumours on the basis of
cellularity, nuclear and cellular pleomorphism, mitoses, endothelial proliferation and
necrosis, with glioblastoma, the highest grade tumour in this system, generally
possessing high degrees of each of these characteristics (Berens and Giese, 1999).
Anaplastic astrocytomas do not generally contain regions of endothelial proliferation
or necrosis, are less cellular and pleomorphic and contain fewer mitoses.
Astrocytomas are characterised by moderate cellularity and minimal pleomorphic
change, with only occasional mitoses. The Daumas-Duport system grades tumours of
glial origin on the presence or absence of four major criteria: nuclear atypia, mitoses,
endothelial proliferation and necrosis. Grade one neoplasms have none of these
features, grade two have one, grade three have two and grade four have at least three
(Daumas-Duport, 1988).
Although there have been significant technical advances in surgical and radiation
treatments for brain tumours in recent years, the impact of these developments on
clinical outcome has been disappointing (Berens and Giese, 1999 and Neider et al,
2000). This poor prognosis is due in part to the progression of low grade tumours
towards more malignant phenotypes and the poor clinical response ofmalignant
gliomas to existing treatment options (Darling, 1990). Surgery is limited by tumour
invasion into surrounding normal brain (Turazzi and Licata, 2000), radiotherapy by
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the inherent radioresistance ofmalignant glioma and poor normal tissue tolerance
(Mansur et al, 2000) and chemotherapy by the poor penetration of chemotherapeutic
drugs across the blood brain barrier (Brandes and Pasetto, 2000 and Olivi et al,
2000). Improvements in patient survival are therefore likely to arise from novel
therapeutic interventions which increase tumour cytotoxicity, either alone or in
conjunction with conventional treatment options (Neider et al, 2000, Brandes and
Pasetto, 2000 and Darling, 1990).
A number of investigations have indicated that essential fatty acids may have clinical
relevance in the treatment ofhuman maligant glioma. Essential fatty acids are highly
unsaturated lipids which cannot be synthesised de novo and must be acquired from
the diet or other external sources (Burr and Burr, 1929 and Burr and Burr, 1930).
They are generally classified into two groups - omega-3 (n-3) and omega-6 (n-6), the
number in brackets indicating the position of the first double bond from the methyl
terminus of the hydrocarbon chain (Burr and Burr, 1929 and Burr and Burr, 1930).
Omega-3 and omega-6 essential fatty acids are not metabolically interconvertible,
and they often have different structural, physiological and biochemical functions in
vivo (Kinsella, 1988 and Simopoulos, 1991). The empirical structure of a typical fatty
acid molecule is shown in Figure 1.1a and the molecular configuration of the C20
essential fatty acid arachidonic acid is shown in Figure 1.1b. Typical naturally
occurring sources of essential fatty acids are shown in Table 1.1, and processes
involved in their metabolism are shown in Figure 1.2.
Although there is limited information on the activity of essential fatty acids in human
glioma cells, in vitro investigations have indicated that essential fatty acids are
associated with loss of glioma cell viability in established cell lines, possibly through
potentiation of cellular oxidative activity (Das, 1990a, Das, 1990b, Traynelis et al,
1995 and Hrelia et al, 1996). These studies concur with other data which indicate that
essential fatty acids inhibit the growth of transformed cells by acting as substrates for
the production ofpotentially cytotoxic reactive oxygen species and lipid peroxides
(Cornwell and Morisaki, 1984 and Gonzalez, 1992). Breast (Cheeseman et al, 1984)
2
and hepatic tumour tissues (Bartoli and Galeotti, 1979) have low levels of
peroxidative activity, possibly due to dietary deficiency and/or lack ofmetabolic
conversion of essential fatty acid precursors (Bartoli and Galeotti, 1979, Cornwell
and Morisaki, 1984 and Vatten et al, 1993). This may result in loss of cellular
oxidative activity and hence dysregulation ofmolecular pathways involved in cell
proliferation and death (Cheng and Levy, 1979, Galeotti et al, 1984 and Galeotti et al,
1986). The processes involved in the initiation of lipid peroxidation are shown in
Figure 1.3.
In addition to mediating direct tumour cytotoxicity, essential fatty acids may augment
the therapeutic response to conventional cancer therapy. As there is evidence that
radiotherapy and chemotherapy may induce tumour cell death, in part at least,
through stimulation of lipid peroxidation (Ewing and Jones, 1987, Ma et al, 1991 and
Alaoui et al, 1992), provision of exogenous essential fatty acids may provide pro-
oxidative substrate upon which radiation can act (Yamanaka et al, 1978, Oberley and
Buettner, 1979 and Yamaguchi, 1994).The relevance of this hypothesis to glioma
therapy has been demonstrated in vitro, where essential fatty acids increased the
radiosensitivity of rat astrocytoma cell lines while exhibiting minimal toxicity to
normal rat astrocytes (Vartak et al, 1997 and Vartak et al, 1998).
While the mode of glioma cell death resulting from essential fatty acid
administration, either alone or in conjunction with radiation, has not yet been fully
characterised, preliminary evidence indicates that this action may be due to
stimulation of a morphologically stereotyped and genetically regulated process
termed apoptosis (Nakatsu et al, 1996 and Zhu et al, 1996) rather than a pathological
form of cell death termed necrosis which occurs in response to tissue insults
including hypoxia and membrane disruptants (Kerr et al, 1972, Wyllie, 1974, Wyllie
et al, 1980 and Bellamy et al, 1995). These preliminary studies therefore suggest that
essential fatty acids may be involved in tumour-specific molecular pathways
mediating programmed cell death and radiosensitivity.
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Figure 1.1a. Typical Structure of a fatty acid molecule. Fatty acid carbon atoms are
numbered from the carboxyl terminus. Carbon atoms 2 and 3 are referred to as a and
P respectively, and the methyl carbon atom at the end of the chain is called go or 8.
The structure of a fatty acid molecule is usually symbolised by the x:y n-z notation
where x represents the total number of carbon atoms in the hydrocarbon chain, y, the
total number of double bonds and z, the position of the first double bond from the
methyl terminus.
Figure 1.1b. Energy optimised configuration of the C20 essential fatty acid
arachidonic acid as determined by the Oxford Molecular Program optimised over 400
cycles. Green: carbon, white: hydrogen, yellow: aliphatic double bond, red: oxygen
atoms of carboxyl tenninus. Molecular modelling was performed by I. Dawson and
A. Leaver (Department of Pharmacology).
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Table 1.1. Characteristics and Sources of the Principal Naturally
Occurring Fatty Acids
family name structure maior source
saturated palmitic acid 16:0 dairy produce and red meat
stearic acid 18:0 dairy produce and red meat
unsaturated oleic acid 18:1 n-9 various vegetable oils
including olive oil
linoleic acid 18:2 n-6 dairy produce, offal, human
milk and vegetable seed oils
e.g. sunflower, safflower corn
and olive oils
y-linolenic acid 18:3 n-6 various seeds including
evening primrose, borage and
blackcurrant
a-linolenic acid 18:3 n-3 green vegetables, soya and
linseed oil




20:5 n-6 fish, fish oil and shellfish
docosahexaenoic 22:6 n-3 fish, fish oil and shellfish
acid
Figure 1.2. Overview of the metabolic pathways traditionally
believed to be involved in the metabolism of the n-3, n-6 and n-9
series essential fattv acids.















































*these metabolic conversions proceed slowly in subjects consuming typical western
diets. This is because high concentration of 18:2 n-6 fatty acid precursor in cell
membrane phospholipids enables successful competition for active sites on
desaturase and elongase enzymes. Additional pathways for essential fatty acid
metabolism involving the transfer of 24 carbon fatty acids from the endoplasmic
reticulum to peroxisomes are discussed in Section 1.4.
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Figure 1.3. Processes involved in the initiation of lipid peroxidation (from Krmsky et
al, 1992).
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1.2 The Role of Essential Fatty Acids and Oxidative Metabolism in
Tumour Proliferation and Death in vivo and in vitro
The role of essential fatty acids in tumour cytotoxicity was suggested through
epidemiological studies which investigated the involvement of dietary lipid in
tumour pathogenesis. The relatively low incidence of certain forms of cancer among
populations whose diets contained little or no saturated fat, e.g. the Eskimos and
Japanese, implied there was an inverse association between polyunsaturated fatty
acid consumption and the occurrence ofmalignant disease (Armstrong and Doll,
1975 and Pritchard et al, 1989). Additionally, epidemiological studies indicated that
the probability ofmigrant Eskimo and Japanese populations developing breast and
colon cancer was not significantly different from native western populations. This
suggested that environmental rather than genetic factors were important determinants
of the pathogenesis of these diseases (Armstrong and Doll, 1975).
Although these epidemiological and dietary studies demonstrated a positive link
between saturated fat consumption and cancer of the colon (Committee on Diet and
Health, 1989 and Willet et al, 1990), the involvement of saturated dietary lipid in the
pathogenesis of breast tumours is less well established (Willet et al, 1992). Little or
no association between total fat intake and breast cancer has been observed in most
epidemiological studies (Goodwin and Boyd, 1987 and Willet et al, 1992), although a
pooled analysis of twelve case controlled investigations suggested a weak but
statistically significant positive association between saturated fatty acid intake and
the incidence of breast cancer (Howe, 1992).
The limited nature of the evidence supporting the involvement of saturated fatty acids
in breast tumour pathogenesis lead to the proposal that the type of fat consumed may
be more important than the dietary ratio of unsaturates:saturates, and that essential
fatty acids may mediate certain anti-tumour activities (Pritchard et al, 1989 and
Horrobin, 1990a). Evidence supporting this hypothesis has been acquired from in
vivo investigations. Low levels of alpha-linolenic acid in adipose breast tissue are
associated with increased risk ofbreast cancer (Klein et al, 2000), and dietary studies
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have demonstrated that administration of the essential fatty acids eicosapentaenoic
acid and docosahexaenoic acid to rats was associated with a reduction in the
development of breast tumours and metastasis (Pritchard et al, 1989 and Rose et al,
1995). However, additional studies are required to further characterise the role of
unsaturated lipids in mammary tumour pathogenesis.
The anti-tumour activities of essential fatty acids in vivo have been demonstrated in
other malignancies. Omega-3 and omega-6 fatty acids inhibited the proliferation of
spontaneously occurring tumours (Tinsley et al, 1981), solid tumour allografts
(Hillyard and Abraham, 1979) and tumours induced chemically (Chan et al, 1977 and
Nicholson et al, 1990) or by irradiation (Hillyard and Abraham, 1979 and Silverman
et al, 1980). Additionally, arachidonic acid, gamma-linolenic acid, docosahexaenoic
acid and eicosapentaenoic acid inhibited tumour growth in vitro in over one hundred
transformed cell lines (Roos and Choppin, 1984, Burns and Spector, 1987, Horrobin,
1990a, Stubbs et al, 1992, DeBranvo et al, 1994, deKock et al, 1994, Finstad et al,
1994, Fujiwara et al, 1986, Meijer et al, 1987, deAntueno et al, 1988 and Cantrill et
al, 1997). The majority of these cell types responded to gamma-linolenic acid,
eicosapentaenoic acid and docosahexaenoic acid with either a retardation of cell
growth or an induction of cell death.
Although the cytotoxic activities of n-3 and n-6 essential fatty acids have been
demonstrated in a large number of in vitro and in vivo investigations, there is
inconsistency regarding the relative potencies of arachidonic acid, gamma-linolenic
acid, docosahexaenoic acid and eicosapentaenoic acid. This may be due to varying
concentrations of intracellular mediators known to influence lipid peroxidation, for
example anti-oxidants and bivalent cations. Additionally, the activities of the n-9
fatty acid oleic acid and the n-6 essential fatty acid linoleic acid in tumour tissue have
not been well characterised. Most studies indicated that oleic acid had little effect on
tumour cytotoxicity (Horrobin, 1990a, Motaung et al, 1999 and Menendez et al,
2001). This suggested fatty acid-specific modulation of pathways involved in the
inhibition of cell proliferation and/or the stimulation of cell death. However, a recent
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study indicated that oleic acid increased tumour proliferative activity in mouse
murine mammary gland adenocarcinoma and salivary gland tumours, and increased
the incidence and multiplicity ofmetasteses. Linoleic acid had little effect in this
investigation (Actis et al, 1999 and Munoz et al, 1999), although other studies
suggested that linoleic acid increased proliferative activity in breast, colon, prostate
and pancreatic tumour cells (Rose et al, 1991, Gonzalez, 1993, Rose et al, 1993,
Appel et al, 1994, Welsch et al, 1995 and Godley et al, 1996).
Although the molecular-genetic pathways involved in linoleic acid and oleic acid-
mediated stimulation of tumour proliferation have not been well characterised, a
recent report indicates that linoleic acid-mediated stimulation of tumour cell growth
occurs through potentiation of phospholipase C and protein kinase C activity (Park et
al, 2000). Other studies suggest that rather than possessing direct tumourigenic
activity, increasing the availability ofnon-essential fatty acids to tumour cells may
augment deficiency of long chain highly unsaturated membrane lipids, and that this
may constitute a pro-tumourigenic condition (Monis and Eynard, 1981, Eynard et al,
1997a, Eynard et al, 1997b, Eynard, 1998, Actis et al, 1999 and Munoz et al, 1999).
Omega-6 essential fatty acid deficiencymay be potentiated through lack ofmetabolic
conversion of linoleic acid, as delta-6 desaturase activity is known to be impaired in
transformed tissue (Dunbar and Bailey, 1976).
A number of studies have indicated that essential fatty acid deficiency may increase
the risk of tumour development by reducing cellular oxidative activity. Essential fatty
acid deficiency resulting from loss of elongation and desaturation products in
cultured human keratinocytes attenuated toxicity due to lipid peroxidation (Wey et al,
1993), and supplementation of porcine endothelial cells with polyunsaturated fatty
acids increased lipid peroxidation and toxicity (Hart et al, 1991). In comparison,
endothelial cells supplemented with saturated and monounsaturated fatty acids had
less peroxidative activity and toxicity than the unsupplemented controls (Hart et al,
1991). Inhibition of tumour proliferation in the breast (Pritchard et al, 1989) and
glioma cell lines (Das, 1995) by gamma-linolenic acid and in the pancreas by
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eicosapentaenoic acid (Zhang and Go, 1996) is associated with accumulation of the
products of lipid peroxidation. Tumour cell cytotoxicity is increased by the addition
of Fe2+ and Cu2+, which stimulate lipid peroxidation (Cantrill et al, 1997 and Sziraki
et al, 1999). This effect was inhibited by antioxidants up to five days after essential
fatty acid administration (Begin et al, 1988, Cantrill et al, 1997, Vartak et al, 1997
and Vartak et al, 1998).
Gamma-linolenic acid mediated inhibition of cell proliferation in the GHP-212
neuroblastoma cell line was also associated with stimulation of cellular oxidative
activity (Hrelia et al, 1996). Although gamma-linolenic acid was metabolised to
dihomo-gamma-linolenic acid and arachidonic acid in these cells, the highest
cytotoxic effect was observed when gamma-linolenic acid was not converted to its
metabolites. This suggests that gamma-linolenic acid toxicity to these tumour cells is
not dependent on its metabolites but is due to gamma-linolenic acid itself (Hrelia et
al, 1996).
1.3 The Role of Essential Fatty Acids and Oxidative Metabolism in
Glioma Proliferation and Death in vivo and in vitro
(a) The cytotoxic activities of essential fatty acids in malignant
glioma
The majority of studies investigating the cytotoxic activities of essential fatty acids in
malignant glioma cells have been carried out in vitro. Gamma-linolenic acid,
eicosapentaenoic acid and docosahexaenoic acid reduced clonogenic survival in rat
36B10 astrocytoma cells (Vartak et al, 1997 and 1998), peroxidised low density
lipoprotein inhibited proliferative activity in human glioma cell lines (Kikuchi et al,
1997) and cA-unsaturated fatty acids inhibited proliferation and stimulated cell death
in a variety of glioma cell lines (Das et al, 1990a). Although information on the
cytotoxic activity of essential fatty acids in malignant glioma in vivo is limited, there
is evidence that polyunsaturated fatty acid (PUFA) administration was associated
with the rejection of transformed microglial tumour cells in rats (Frei et al, 1994).
Furthermore, an intracerebral infusion study indicated that gamma-linolenic acid is
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not cytotoxic to normal rat brain (Das et al, 1995).
Although intercranial infusions of gamma-linolenic acid have shown efficacy in
inhibiting glioma proliferation (Frei et al, 1994), little is known about the dose
response characteristics of glioma cells to essential fatty acid therapy in vivo.
However, a recent study used a spheroid model to address this important
pharmacological issue (Bell et al, 1999). Spheroids derived from a variety of glioma
cell lines were grown in collagen gel and exposed to a range of concentrations of
gamma-linolenic acid (0-1mM) for five days. Low concentrations of gamma-
linolenic acid (less than 100uM) increased both apoptosis and proliferation, with a
net increase in spheroid growth and invasion. In contrast, high concentrations of
gamma-linolenic acid (greater than 1 OOpM) reduced spheroid growth. Although the
proliferative activity of low dose gamma-linolenic acid may be a hazard in the
clinical treatmentmalignant glioma, its low toxicity against normal cells means
higher doses could be used to reduce tumour size.
The cytotoxicity of gamma-linolenic acid in vivo has also been investigated in a small
clinical trial (Das et al, 1995). Fifteen patients were selected on the basis of
histological and radiological evidence ofmalignant glioma, and following surgical
resection the subjects were given lOmg of gamma-linolenic acid orally each day for
ten consecutive days. After gamma-linolenic acid therapy was completed, the patients
received a CT scan followed by monthly clinical examinations. Administration of
gamma-linolenic acid induced glioma regression and improved patient survival, with
80% of the subjects being alive two years after surgery. However, only fifteen
patients were assessed in this study, and no control groups were included.
Additionally, plasma concentrations of gamma-linolenic acid were not measured,
although other studies in rats indicate that essential fatty acids are easily absorbed
and readily cross the blood brain barrier when administered at equivalent
concentrations (Dhopeshwarkar and Mead, 1973, Spector, 1998, Punchard et al, 2000
and Tso et al, 2002). Further studies are therefore required to characterise the
response ofmalignant glioma to essential fatty acid therapy in vivo.
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Essential fatty acid-mediated cytotoxicity in glioma cells may be associated with
modulation of cellular oxidative activity. Inhibition of tumour proliferation in glioma
cell lines was associated with stimulation of lipid peroxidation (Das et al, 1990a and
Das et al, 1990b), cis-parinaric acid, an 18C PUFA was cytotoxic to human and rat
cell lines via an oxidative pathway (Traynelis et al, 1995) and polyethylene-stabilised
glucose oxidase, an enzyme capable of producing reactive oxygen species, induced
significant growth delay in subcutaneous rat 9L gliomas (Ben-Yoseph and Ross,
1994). Oxidative stress induced through glutathione depletion has also been
associated with C6 glioma cell death (Mawatari et al, 1996). This effect was inhibited
by serotonin, which reduced lipid peroxidation (Shinagawa, 1994). However, it has
been reported that the lipid peroxidation inhibitors U78517F and U74006F had no
significant effect on tumour growth or viability (Megyesi et al, 1990 and Del Maestro
et al, 1991).
Analysis of basal cellular oxidation in human brain tumour tissue and glioma cell
lines has provided additional evidence that reactive oxygen species are implicated in
the control of cell division and death. An in vitro study indicated that lipid
peroxidation was higher in low grade astrocytoma cell lines in comparison with those
derived from more malignant lesions (Louw et al, 1997), and the PUFA content of
glioma cells was 50% of that observed in normal astrocytes (Preuss et al, 2000).
Additionally, when cellular oxidative activity was investigated ex vivo in human
glioma and meningioma tissue, basal oxidation was consistently lower in tumour
cells in comparison with associated normal brain (Levcheko and Demchuk, 1991).
However, no statistically significant differences in basal oxidative activity were
detected between gliomas of different grades in this study (Levcheko and Demchuk,
1991).
In C6 glioma cells, arachidonic acid-induced loss of cell viability was associated with
cell swelling, which occurred due to H20 influx resulting from increased sodium
permeability (Chan and Fishman, 1982, Staub et al, 1994a and Staub et al, 1994b).
This effect was reduced following the administration of SOD, and virtually abolished
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by the aminosteroid U-74389F, which is an antagonist of lipid peroxidation (Staub et
al, 1994b). It has also been shown that the hydroxyl radical is associated with
stimulation of lipid peroxidation and membrane blebbing in C6 glioma cells
(Goldberg et al, 1991). As membrane blebbing is a morphological characteristic
associated with apoptosis (Kerr et al, 1972 and Wyllie et al, 1980), this observation
suggests that lipid peroxidation may induce tumour cell cytotoxicity by modulating
molecular pathways which mediate programmed cell death.
Other studies suggest that the activity of anti-oxidant enzymes is a determinant of
cell proliferation rather than reactive oxygen species formation. The sensitivity of the
glioblastoma cell lines A-172 and U-87 MG to docosahexaenoic acid and
eicosapentaenoic acid was not related to intracellular content of the products of lipid
peroxidation, but rather cellular anti-oxidant activity (Schonberg et al, 1997). An in
vitro study also indicated that the malignant progression of low grade astrocytoma
was associated with increased expression of intracellular glutathione (Louw et al,
1997). It has also been observed that while gamma-linolenic acid upregulated the
antioxidant enzyme CAT in normal astrocytes, it had no significant effect in glioma
cells. This suggests that the cytotoxic effect of gamma-linolenic acid in malignant
glioma may be due, in part at least, to its inability to upregulate CAT (Preuss et al,
2000).
Preliminary evidence indicates that essential fatty acid administration is not
associated with significant toxicity to non-neoplastic brain tissue. Although cis-
parinaric acid was cytotoxic to human and rat glioma cell lines, this CI8 PUFA did
not cause significant toxicity to foetal rat astrocytes (Traynelis et al, 1995). Similarly,
while gamma-linolenic acid, docosahexaenoic acid and eicosapentaenoic acid
administration was associated with cytotoxicity and radiosensitisation in the rat
36B10 astrocytoma cell line, these essential fatty acids were not toxic to normal rat
astrocytes (Vartak et al, 1998). It has been postulated that this selective cytotoxicity
is associated with increased oxidative stress in glioma cells (Vartak et al, 1999). This
may be due to the inability of gamma-linolenic acid to upregulate glioma cell CAT,
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and selective uptake of essential fatty acids by glioma cells (Preuss et al, 2000).
Docosahexaenoate, palmitate and arachidonate preferentially penetrate cerebrally
implanted tumours once they have gained access to the brain (Naraia et al, 1993), and
although the PUFA content of glioma cells was significantly lower than that of
normal astrocytes, both cell types contained similar levels ofPUFAs following a 24
hour supplementation with gamma-linolenic acid (Preuss et al, 2000).
(b) Additional evidence supporting a potential clinical role for
essential fatty acids in glioma therapy
Immunological, biochemical and neuropathological studies have indicated that
essential fatty acids possess biological actions which may augment their cytotoxic
potential in vivo. Both n-3 and n-6 essential fatty acids readily cross the blood brain
barrier (Abumrad et al, 1981, DeGrella and Light, 1985 and Spector, 1988), where in
addition to mediating direct cytotoxicity they may inhibit glioma invasion (Jiang et
al, 1995a, Jiang et al, 1995b, Jiang et al, 1995c, Jiang, 1996 and Mareel et al, 1996)
and blood vessel formation (Ito et al, 1993, Byres et al, 1995 and Cai et al, 1999),
both ofwhich are associated with malignant progression (Louis, 1997). Additionally,
pathogenesis of glial tumours is associated with local immunosuppression (Roszman
et al, 1991 and Tada and deTribolet, 1993). Essential fatty acids including
arachidonic acid and gamma-linolenic acid have specific activities on macrophages
and T-cells including NADPH activation and stimulation of the respiratory burst
(Flenderson and Chappell, 1992, Henderson et al, 1993, Aebischer et al, 1993,
Sumimoto et al, 1994 and Sawai et al, 1993) (Chapter 3).
Octadecenoic, myristic and oleic acid enter the brain via a saturable,
probenecid/phoretin sensitive mechanism (Abumrad et al, 1981 and Spector, 1988),
which may be located in cerebral capillaries (Spector, 1988). This uptake is
dependent on the ratio of fatty acid:plasma protein in the periphery and the CNS.
Linoleic acid also readily gains access to the CNS, and there is evidence that this
transfer is largely probenecid insensitive (Spector, 1988). The lack of interaction
between linoleic acid and the probenecid sensitive carrier may be due to the presence
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of two double bonds on the hydrocarbon chain which alter its shape and solubility. It
has been proposed that linoleic acid and certain other essential fatty acid preparations
enter the CNS by diffusion (Abumrad et al, 1981). As there is little or no net
extraction of linoleic acid from the blood during a passage through the brain
(Pardridge and Mietus, 1980) and phoretin can inhibit both the influx and efflux of
fatty acids from the isolated adipocyte (Ambumrad et al, 1981) it has been suggested
that there is a specialised exchange mechanism for fatty acids at the blood brain
barrier.
Studies on cerebral microvasculature indicate that arachidonic acid increases
membrane permeability in a dose dependant manner. This effect was inhibited by co¬
administration of the anti-oxidants superoxide dismutase and catalase, and by the
iron chelator desferoxamine, suggesting a role for reactive oxygen species in the
regulation of the blood brain barrier (Easton and Fraser, 1998). Although the integrity
of the blood brain barrier is compromised during the pathological progression from
grade I astrocytoma to grade IV glioblastoma, the poor penetration of chemotherapy
agents into the brain remains a barrier to cure (Brandes and Pasetto, 2000 and Olivi et
al, 2000). This activity may therefore have therapeutic relevance.
The development of intratumoural microvascluture is involved in the progression of
low grade astrocytoma to high grade glioblastoma (Louis, 1997). Inhibitors of
arachidonic acid metabolism inhibit angiogenesis in human microvascular
endothelial cells in vitro (Ito et al, 1993). Gamma-linolenic acid inhibits vessel
formation in vitro (Cai et al, 1999), possibly by reducing vascular endothelial cell
motility (Jiang et al, 1997) and modifying the expression of cell adhesion molecules
(Jiang et al, 1995a, Jiang et al, 1995b, Jiang et al, 1995c and Byers et al, 1995). This
action may be due, in part at least, to the formation ofmetabolites (Ito et al, 1993).
However, arachidonic acid may stimulate angiogenesis by stimulating the production
of tumour necrosis factor (TNF) (Sakata et al, 1987, Chaudhri and Clark, 1989 and
Carman-Krzan and Wise, 1993). TNF initiates vascular endothelial cell growth in
human malignant glioma by increasing expression of the vascular endothelial growth
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factor gene (Ryuto et al, 1996). The potentiation ofTNF production by arachidonic
acid and reactive oxygen species may therefore contribute to vessel formation in
vitro.
1.4 Current Opinions on the Biochemistry of Essential Fatty Acid-
Mediated Tumour Cytotoxicity
(a) Essential fatty acids and apoptosis
Although there is evidence that essential fatty acids are associated with tumour
cytotoxicity (Section 1.2), relatively few studies have analysed the molecular
pathways mediating these cell death responses. However, preliminary evidence
suggests that stimulation of apoptosis is the principal cause of essential fatty acid-
mediated cytotoxicity. Gamma-linolenic acid stimulates apoptosis in human cervical
carcinoma (deKock et al, 1996), arachidonic acid, gamma-linolenic acid,
docosahexaenoic acid and eicosapentaenoic acid stimulate apoptosis in Hep2 human
larynx tumour cells (Colquhoun et al, 1998), arachidonic acid stimulated apoptosis in
GH3 cells (Yasuda et al, 1999) and eicosapentaenoic acid stimulates apoptosis in
pancreatic tumour tissue (Lai et al, 1996). There is also evidence that linoleic acid
induces apoptosis in endothelial cell cultures (Meerarani et al, 2000), although
linoleic acid and oleic acid had little effect on cell death in Hep2 human larynx
tumour cells (Colquhoun et al, 1998).
The stimulation of apoptosis by essential fatty acids may be due to potentiation of
reactive oxygen production. In vitro evidence has indicated that the pro-apoptotic
activity of conjugated eicosapentaenoic acid and docosahexaenoic acid in various
transformed cell lines involved potentiation of lipid peroxidation, and it has been
proposed that the increase in apoptotic activity observed in human glioma cell lines
following addition of selenium is attributable to stimulation of cellular oxidative
activity (Nakatsu et al, 1996 and Zhu et al, 1996). Hydrogen peroxide, a reactive
oxygen species formed during the oxidation of highly unsaturated membrane lipids,
has also been shown to stimulate apoptosis in GH3 and hepatoma cell lines (Yasuda
et al, 1999 and Li et al, 2000), and the induction of apoptosis in human
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retinoblastoma Y79 cells involved oxidative stress (Vento et al, 2000). Additionally,
time-dependent episodes of increased apoptotic activity have been observed in
dopamine secreting neurons and human colon carcinoma cell lines. This may
correlate with peaks of oxidative activity in these cells (Shirvan et al, 1997). It has
also been proposed that gamma-linolenic acid may stimulate apoptosis in vivo by
disrupting integrin association with matrix proteins (Frisch et al, 1994 and Frisch et
al, 1996), as an association between cell-matrix adhesion and cell cycle progression
has been characterised (Assoian and Zhu, 1997).
The anti-apoptotic activity of various anti-oxidant enzymes provides additional
evidence for a role of reactive oxygen species in the potentiation of programmed cell
death. Alpha-tochopherol suppressed the pro-apoptotic activity of conjugated
eicosapentaenoic acid and docosahexaenoic acid in cultured human tumour cells
(Igarashi and Miyazawa, 2000), arachidonic acid-induced apoptosis in HepG2-
MV2E1-9 cells was inhibited by the iron chelator desferioixamine (Chen et al, 1998)
and depletion of cellular glutathione was associated with increased toxicity of
arachidonic acid in HepG2-MV2El-9 cells (Chen et al, 1998). Glutathione depletion
has also been implicated in the initiation of apoptosis in rat C6 glioma cells (Higuchi
and Matsukawa, 1999). However, the observation that vitamin E prevented
eicosapentaenoic acid-induced apoptosis in Raji cells but not Ramose cells lead to
the proposal that the cytotoxic activity of essential fatty acids in vitro is dependant on
the cell type used, and that lipid peroxidation may not be the only pathway mediating
essential fatty acid-induced stimulation of tumour cell death (Finstad et al, 1998 and
Das, 1999).
Preliminary results indicate that unsaturated fatty acids may inhibit apoptosis in non-
transformed cells. Addition of docosahexaenoic acid prevented the formation of
apoptotic nuclei and increased cell survival in rat retinal cells stimulated into
apoptosis through serum deprivation (Rotstein et al, 1997). It has also been
demonstrated that cfs-oleic acid prevented the loss of cardiomyocyte viability
induced by the saturated fatty acid 16:0 (deVries et al, 1997). This implies essential
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fatty acids may have a protective effect on tumour-associated normal brain tissue.
(b) Essential fatty acids and oncogene expression
Essential fatty acids modify the activity of genes implicated in tumour proliferation
and death (Tebbey and Buttke, 1993, Clarke and Jump, 1994 and Sen and Packer,
1996). Linoleic acid regulated the expression ofHER-2/neu levels in MCF-7 cells
(Tiwari et al, 1991), eicosapentaenoic acid up-regulated expression of the tumour
supressor gene nm23-Hl (Jiang et al, 1997), the activity of c-myc was regulated by
linoleic acid (Earashi et al, 1996) and n-3 fatty acids induced apoptosis during colon
carcinogenesis by reducing activation of the ras oncogene (Chapkin et al, 1997).
There is also evidence that expression of the pro-apoptotic oncogene Fas is increased
following stimulation of lipid peroxidation (Haider et al, 1995), and that jun activity
is sensitive to redox regulation in vitro (Abate et al, 1990).
Other putative molecular targets of essential fatty acids and their metabolites include
the anti-apoptotic oncogene bcl2. The observation that bcl2 protein possessed anti¬
oxidant activity lead to the proposal that i) activation of this oncogene inhibited
apoptosis by reducing the expression or action of reactive oxygen species (Buttke and
Sandstrom, 1995, Epperly et al, 1994, Sarafian and Bredessen, 1994 and Steinman,
1995), and ii) that essential fatty acid-mediated stimulation of cellular oxidative
activity may represent a mechanism to subvert bcl2-mediated inhibition of tumour
cell death (Das et al, 1999). Although other reports suggest reactive oxygen species
are not required for the initiation of programmed cell death (Hug et al, 1994, Muschel
et al, 1995 and Jacobson, 1996), there is evidence that bcl2 is not capable of
inhibiting apoptosis induced by lipid hydroperoxides (Sandstrom et al, 1995). It has
also been proposed that essential fatty acids may inactivate bcl2 protein through
phosphorylation (Haider et al, 1995 and Das, 1999), although additional studies are
required to confirm this hypothesis.
There was no evidence of a correlation between bcl2 expression and the presence or
degree ofmalignancy in reactive and neoplastic astrocytes (Krishna et al, 1995).
19
However, expression ofwild type p53 was associated with expression of bcl2 in an
immunohistochemical study of a series ofhuman gliomas (Alderson et al, 1995).
This may represent a mechanism to subvert p53 mediated apoptosis (Alderson et al,
1995). Recent evidence suggests that the induction of apoptosis by p53 involves the
activity of reactive oxygen species (Polyak et al, 1997). In addition, docosahexaenoic
acid-mediated inhibition ofmammary tumour proliferation has been associated with
up-regulation of p53 gene transcription (Tillotson et al, 1993).
1.5 Essential Fatty Acids and Conventional Cancer Therapy
Essential fatty acids may potentiate cytotoxic responses to chemotherapy and
radiotherapy. Radiotherapy and certain chemotherapy drugs stimulate the generation
of reactive oxygen species (Barber and Wilbur, 1959, Yamanaka et al, 1979, Sodhi
and Gupta, 1986, Kanofsky, 1986, Dennis and Shibamoto, 1990, Yamaguchi et al,
1994 and Bordoni et al, 1999), which may be involved in modulating cell
proliferation and/or apoptosis (George et al, 1983, Schlager et al, 1983, Ramu et al,
1984, Ewing and Jones, 1987, Ma et al, 1991 and Alaoui et al, 1992). It has been
proposed that exogenous essential fatty acids may potentiate radiation-induced
reactive oxygen species formation, and hence tumour cell cytotoxicity, by providing
substrates for lipid peroxidation upon which radiation can act (Yamamoto et al, 1985,
Porter, 1986 and Krinsky, 1992).
Vincristine-resistant human cervical carcinoma cell lines contain low levels of alpha-
linolenic acid, gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic
acid in comparison to vincristine sensitive cells (Das et al, 1998), and pre-incubation
of vincristine resistant cells with sub-optimal doses of these essential fatty acids
increased the cytotoxic action ofvincristine (Das et al, 1998). In addition, gamma-
linolenic acid, eicosapentaenoic acid and docosahexaenoic acid increased the
radiation sensitivity ofmalignant astrocytoma cell lines (Vartak et al, 1997 and
Vartak et al, 1998). This effect was blocked by antioxidants and was not observed in
response to oleic acid (Vartak et al, 1997).
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There is also evidence that gamma-linolenic acid potentiates chemosensitivity to
placitaxel. In human breast cancer cells, placitaxel-mediated inhibition of cell
proliferation was significantly greater following exposure to gamma-linolenic acid in
comparison with the non-peroxidisible fatty acid oleic acid (Menendez et al, 2001).
However, as gamma-linolenic acid-induced chemosensitivity was only partially
abolished by the lipid peroxidation inhibitor vitamin E, the influence of oxidative
metabolism on placitaxel cytotoxicity may be limited (Menendez et al, 2001).
In addition to potentiating therapeutic response, it has been postulated that essential
fatty acids reduce the occurrence ofpathological side effects associated with
conventional cancer therapy (Horrobin, 1991). It has been proposed that these
pathological side effects occur, in part at least, due to elevated free radical production
in non-malignant tissue (Freeman and Crapo, 1982, Slater, 1984a, Slater 1984b,
Galeotti et al, 1986, Halliwell and Gutteridge, 1986, Halliwell and Gutteridge, 1989
and Cadenas et al, 1989). This theory would predict that provision ofpolyunsaturated
fatty acids should potentiate radiation induced damage by making available
additional substrate for free radical formation. However, preliminary evidence
suggests that dietary gamma-linolenic acid inhibits radiation-induced damage to
porcine epidermis (Hopewell et al, 1993). In vivo studies have also demonstrated that
gamma-linolenic acid reduces central nervous system damage associated with
radiotherapy (Liebel and Sheline, 1991). It has therefore been proposed that
pathological side effects associated with exposure to radiation are not caused by free
radical activityper se, but rather by chain reaction-mediated loss of essential fatty
acids from cell membrane phospholipids (Horrobin, 1991).
Essential fatty acids may also reduce the occurrence of certain pathological side
effects associated with chemotherapy. Fatty acid metabolites associated with lung
inflammation and fibrosis, including hydroxyproline (a marker for collagen
synthesis) and the pro-inflammatory leukotriene LTB4, are reduced by dietary
gamma-linolenic acid (Ziboh et al, 1997). Additional in vitro evidence suggests that
both n-3 and n-6 fatty acids with two or more unsaturated sites containing 18-22
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carbon atoms in the hydrocarbon chain are potent antagonists at the LTB4 receptor
(Yagaloff et al, 1995).
Recent in vitro evidence also indicates that the cardiotoxicity of doxorubicin is
associated with the formation of conjugated dienes, impairment of fatty acid
desaturation and elongation and a reduction in cellular essential fatty acid content
(Bordoni et al, 1999). Additionally, at therapeutic concentrations doxorubicin
induces membrane peroxidation of the endoplasmic reticulum where fatty acid
metabolism occurs, further reducing the rate at which essential fatty acid
accumulation can occur (Bordoni et al, 1999). These observations are consistent with
the hypothesis that provision of exogenous essential fatty acids may protect against
certain side-effects of chemotherapy.
Essential fatty acids may inhibit the formation of radiation induced tumours
(Horrobin, 1990 and Horrobin, 1991). Protein kinase C is rapidly and transiently
activated following exposure to ionising radiation (Hallahan et al, 1991b, Woloschak
et al, 1990 and Uckun et al, 1993) resulting in increased expression of the proto-
oncogenes c-jun, Egr-1 and zif-268 (Hallahan et al, 1991a, Hallahan et al, 1991b and
Hallahan et al, 1992). Radiation induced transformation and proliferation can be
reduced by inhibitors ofprotein kinase C (Hallahan et al, 1991a, Hallahan et al,
1991b and Hallahan et al, 1992 and Umans and Kennedy, 1992). It has also been
demonstrated that protein kinase C inhibitors induce apoptosis in human malignant
glioma cell lines (Couldwell et al, 1994 and Ikemoto et al, 1995). There is evidence
that n-3 and n-6 essential fatty acid are able to inhibit activated protein kinase C
(Chen and Murakami, 1992, Holian and Nelson, 1992 and May et al, 1993).
1.6 Current investigations
(a) Hypotheses to be investigated
The purpose of this study was to investigate the pro-oxidative and cytotoxic activity
of arachidonic acid and gamma-linolenic acid in human glioma. Human malignant
glioma is a highly invasive tumour which is refractory to all currently available
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treatment options (Berens and Giese, 1999 and Neider et al, 2000). However, in vitro
evidence has indicated that essential fatty acid-mediated stimulation of glioma
oxidative activity is associated with tumour cytotoxicity, both alone and in
conjunction with radiation (Das, 1990a, Das, 1990b, Hrelia et al, 1996, Vartak et al,
1997 and Vartak et al, 1998).
These results are consistent with a potential clinical role for arachidonic acid and
gamma-linolenic acid in the clinical management of human malignant glioma.
However, the kinetics of reactive oxygen formation in fresh human tissue are not
well documented. Additionally, most of these investigations have been carried out on
established cell lines, and use of these cells is associated with experimental
limitations (see Section 1.6b). This study addressed these issues by investigating the
following primary hypotheses:-
1) Oxidative activity is impaired in human glioma tissue in comparison with tumour-
associated normal brain
2) Addition of exogenous essential fatty acids stimulates tumour reactive oxygen
species generation
3) Potentiation of tumour reactive oxygen species generation is associated with
tumour cytotoxicity, in part at least through stimulation of apoptosis
4) Stimulation of tumour oxidative and apoptotic activity by arachidonic acid and
gamma-linolenic acid is potentiated by simultaneous exposure to therapeutic doses
of radiation
(b) Choice of tissue
Fresh human glioma tissue was used for this analysis, after first establishing
appropriate experimental conditions using human lymphocyte preparations. Fresh
human glioma tissue was used because of limitations associated with established cell
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lines. Cell culture is associated with loss of phenotypic markers, and this increases
with passage frequency (Pilkington, 1992). Additionally, relatively homogeneous cell
lines do not contain cell populations often present in biopsy samples which may
influence tumour growth and proliferation, for example infiltrating immune cells
(Pilkington, 1992 and Thomas and Graham, 1995, Chapter 1).
The use of established cell lines may also explain, in part at least, the discrepancy
between the reported pro-oxidative and cytotoxic activities of arachidonic acid,
gamma-linolenic acid, docosahexaenoic acid and eicosapentaenoic acid. As the
growth inhibitory actions of essential fatty acids are dependent upon pre-existing
levels of agents known to modulate cellular oxidative activity, for example anti¬
oxidants and bivalent cations, it is possible that intracellular variations between these
factors are responsible for the differences in essential fatty acid activity which have
been observed. This suggests that studies carried out on fresh tissue may predict the
response of human malignant glioma to essential fatty acid therapy in vivo more
accurately than those performed on established cell lines, where the native tumour
phenotype is less well conserved.
As the human glioma samples received for analysis contained cell populations other
than transformed glial cells, it was possible to analyse individual glioma sub-
populations. Sub-population oxidative activity and essential fatty acid sensitivity
were correlated with expression of the glial cell marker glial fibrillary acidic protein
(GFAP). Additionally, the pro-apoptotic activities of arachidonic acid and gamma-
linolenic acid in GFAP-positive cell populations were investigated. GFAP is an
intermediate filament protein expressed in brain and spinal cord. It is present in
astrocytomas and ependymomas, but not tumours ofneural origin including
neuroblastoma and Schwannoma (Debus et al, 1983, Miettinen et al, 1984, Coakham
et al, 1985 Garson et al, 1985 and Royds et al, 1986). It can therefore be used as a
marker of tumours ofglial origin.
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Essential fatty acid-mediated radiosensitisation of glioma cells was also investigated.
Insufficient quantities of human tissue were available for this analysis. Additionally,
it was predicted that cellular heterogeneity would make tumour-specific responses
difficult to interpret. The rat C6 cell line was therefore used for this investigation.
The C6 cell line is a clonal line which was developed in randomly bred adult Wistar
rats from a glioblastoma induced through transplacental exposure to N-
nitrosomethylurea (Benda et al, 1963). It was selected because of its well
characterised astrocytic morphology, and its possession of glial markers such as
GFAP and S-100 protein (Benda et al, 1963, Pfeiffer et al, 1971, Cravioto et al, 1973,
Cravioto et al, 1974 and Weiss et al, 1976).
(C) Choice of reagents
In these studies, the activity of the essential fatty acid arachidonic acid and its n-6
precursor gamma-linolenic acid were examined. Arachidonic acid is an important
metabolic and structural polyunsaturated fatty acid in CNS phospholipids (Chan and
Fishman, 1980 and Chan and Fishman, 1982) which has been shown to induce the
transient formation of superoxide radicals and lipid peroxides in brain cortical slices
(Chan and Fishman, 1980). There is evidence that human malignant glioma has
deficits in the n-6 products of delta 6-desaturation including arachidonic acid and
gamma-linolenic acid (Martin et al, 1996).
The uptake of arachidonic acid into the brain is up to twenty times greater than that
of docosahexaenoic acid (Easton and Fraser, 1998) and arachidonic acid
preferentially penetrates intracerebrally implanted carcinosarcoma in vivo in
comparison with surrounding normal brain (Nariai et al, 1993). There is also
evidence that fatty acids from the n-6 series, including linoleic acid, arachidonic acid
and gamma-linolenic acid modulate leukocyte activity (Bromberg and Pick, 1984,
Poulos et al, 1991 and Braun et al, 1993). These cells are present in human glioma
tissue and are involved in modulating tumour oxidative activity and apoptosis
(Roszman et al, 1991 and Tada and deTribolet, 1993).
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Docosahexaenoic acid is also an important metabolic and structural component of the
brain. Docosahexaenoic acid was not chosen for analysis in these studies because of
its involvement in brain specific biochemical pathways not associated with tumour
metabolism (Uauy et al, 1996 and Kaplan and Greenwood, 1998). These include
cognitive development in neonates, photoreceptor function (Uauy et al, 1989, Uauy
and Hoffman, 1991, Carlson et al, 1994, Uauy et al, 1996 and Birch et al, 1998) and
sleep regulation (Warne et al, 1979). Additionally, high concentrations of
docosahexaenoic acid are localised in specific brain regions including the cerebral
and occipital cortex and retina (Greiner et al, 1997 and Martinez, 2001). As the
biopsy samples received for analysis had different cellular and anatomical origins,
this non-uniform distribution of docosahexaenoic acid would have made tumour
specific responses to docosahexaenoic acid difficult to analyse.
Gamma-linolenic acid, which is commercially available and currently licensed for
human therapeutic use, may have potentially therapeutic activities in human
malignant glioma. In vivo and in vitro studies have demonstrated that gamma-
linolenic acid induces tumour cell cytotoxicity in established brain tumour cell lines
(Das, 1990a, Das, 1990b and Hrelia et al, 1996), induces tumour regression and
improves patient survival in a small clinical trial of human glioma patients (Das et al,
1995). Gamma-linolenic acid also inhibits glioma motility and invasion in vivo
(Jiang, 1996). Western blot and immunohistochemical studies have demonstrated
that gamma-linolenic acid increases expression of the cell adhesion molecule E-
cadherin and the desmosonal adhesion complex in lung, colon, breast melanoma and
liver cancer cells (Jiang et al, 1995a, Jiang et al, 1995b and Jiang et al, 1997). This is
associated with increased cell aggregation in vitro. Studies in lung, colon, breast,
melanoma and liver cancer cells in vitro suggested arachidonic acid was not able to
induce alterations in E-cadherin expression (Jiang et al, 1995a and Jiang et al,
1995b). There is also evidence that gamma-linolenic acid is more effective than
eicosapentaenoic acid and docosahexaenoic acid in selectively increasing the
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sensitivity of the rat 36B10 astrocytoma cell line to radiation-induced tumour cell kill
(Vartak et al, 1997).
(d) Investigations undertaken
(i) Stimulation of tumour reactive oxygen species production by
essential fatty acids
This study examined the stimulation of reactive oxygen production by arachidonic
acid and gamma-linolenic acid in single cell preparations of explants ofhuman
glioma tissue obtained at biopsy. These cells were characterised in terms of their
basal oxidative activity i.e. reactive oxygen generation in the absence of exogenous
essential fatty acid stimulation, and sensitivity to exogenous essential fatty acid
stimulus. Differences between glioma tissue and tumour-associated normal brain
were analysed, and tumour oxidative activity was correlated with tumour grade and
cell membrane permeability. This analysis was carried out using novel statistical
parameters derived in association with the University of Edinburgh Department of
Statistics.
(ii) Investigation of glioma heterogeneity and its relation to
oxidative metabolism
As human glioma preparations are characterised by cellular heterogeneity (Louis,
1997) analysis of the oxidative responses of these tumours was complex. In order to
establish the experimental and dose response conditions required for the study of
human glioma preparations, the oxidative activity of relatively homogeneous fresh
human leukocyte preparations acquired from patients undergoing pulmonary
resection for bronchogenic carcinoma was investigated. These cells were
characterised in terms of their basal oxidative activity and sensitivity to exogenous
arachidonic acid and gamma-linolenic acid, both before and after surgery. This
analysis also provided information on the previously uncharacterised effects of
surgery on human leukocyte reactive oxygen production and facilitated identification
of a sub-population thought to represent leukocytes in human glioma preparations.
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Cell size and DNA content were used to identify additional cell types present in
human glioma. These sub-populations were characterised in terms of their basal
oxidative activity, sensitivity to exogenous n-6 essential fatty acids, cell membrane
integrity and GFAP expression. This study was used to confirm the cellular
heterogeneity associated with malignant progression, and provided additional
information on tumour-specific responses to exogenous arachidonic acid and gamma-
linolenic acid.
(iii) Investigation of the stimulation of glioma apoptosis by essential
fatty acids
It is recognised that dysregulation of apoptosis is implicated in the pathogenesis of
neoplasia. This has prompted the development ofnew therapeutic strategies which
may increase cellular apoptosis in tumour tissue (Bellamy et al, 1995). This study
investigated the hypothesis that exogenous arachidonic acid and gamma-linolenic
acid stimulate apoptosis in fresh explants of human glioma obtained at biopsy. The
biochemical pathways which mediate the cytotoxic responses to essential fatty acids
and their metabolites are incompletely understood and it is not known whether
apoptosis or necrosis are the principal causes of essential fatty acid-mediated
stimulation of cell death. This study examined the stimulation of apoptosis in fresh
human glioma tissue removed at biopsy in response to stimulation by exogenous
arachidonic acid and gamma-linolenic acid. This was correlated with basal apoptotic
activity observed in fresh human glioma tissue and paraffin-fixed sections, cell
membrane integrity and tumour grade. These studies also examined the kinetics of
apoptotic activity in fresh human glioma tissue and their relation to tumour grade.
The effect of arachidonic acid and gamma-linolenic acid on cell proliferation in the
rat C6 cells line was also examined and correlated with apoptotic activity.
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(iv) Investigation of the interaction between radiation and essential
fatty acids
It has been demonstrated that arachidonic acid and gamma-linolenic acid increase the
radiosensitivity of the rat 36B10 malignant astrocytoma cell line (Vartak et al, 1997
and Vartak et al, 1998). However, the kinetics of reactive oxygen species formation
in glioma cells following simultaneous exposure to essential fatty acids and radiation
has not been investigated. Additionally, the mode of cell death resulting from this
interaction has not been characterised. The purpose of this study was to address these
issues by investigating the interaction of arachidonic acid and gamma-linolenic acid
with radiation. The rat C6 glioma cell line was used to examine the effects of
arachidonic acid and gamma-linolenic acid on cellular oxidative activity, apoptosis
and cell membrane permeability in the presence or absence of a therapeutically
relevant dose of irradiation. These studies were carried out to investigate a potential
therapeutic role for arachidonic acid and gamma-linolenic acid as radiosensitisers.
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Summary of the Aims of theWork
The principal aims of this research were as follows:-
1) To establish the conditions required for analysis of glioma peroxidative activity by
investigating the oxidative responses of relatively homogenous phagocyte
preparations (Chapter 3).
2) To analyse basal oxidative activity and the kinetics of the response to exogenous
arachidonic acid and gamma-linolenic acid in more heterogeneous samples of
human glioma tissue, to establish any differences between tumour tissue and
normal brain and to correlateWHO tumour type and grade ofmalignancy with
peroxidative activity (Chapter 4).
3) To differentiate between the cell populations present in human glioma
preparations and to characterise them in terms of their basal oxidative activity,
sensitivity to arachidonic acid and gamma-linolenic acid and expression of the
glial cell marker GFAP (Chapter 5).
4) To investigate the effects of exogenous arachidonic acid and gamma-linolenic acid
on apoptosis and proliferation in human glioma explants and cell lines, and to
correlate apoptotic activity with tumour peroxidation and WHO tumour type and
grade ofmalignancy (Chapter 6).
5) To investigate the interaction between arachidonic acid, gamma-linolenic acid and






All investigations were carried out on lymphocyte preparations, human glioma tissue
or the rat C6 cell line. Fresh lymphocytes, obtained from patients undergoing
pulmonary resection, were used to investigate lymphocyte reactive oxygen species
generation in the presence and absence of exogenous arachidonic acid and gamma-
linolenic acid. This initial study was undertaken to help characterise experimental
and dose response conditions appropriate for subsequent analysis of glioma oxidative
activity. Human glioma tissue, obtained at the time of surgery, was either preserved
in paraffin for routine diagnostic procedures or digested into single cell suspensions
using collagenase. Single cell suspensions were used to investigate oxidative or
apoptotic activity, or were preserved in ethanol for analysis ofGFAP expression.
Experiments on the rat C6 cell line were conducted on adherent cells or on single cell
suspensions obtained through trypsinisation. Adherent cells were used for analysis of
apoptotic and proliferative activity. Single cell suspensions were used to investigate
oxidative and apoptotic activity in the presence and absence of exogenous
arachidonic acid and gamma-linolenic acid, sodium nitroprusside and radiation. Cell
viability, determined through analysis ofmembrane permeability to vital dyes, was
routinely measured following each analysis ofmetabolically active cells.
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Table 2.1. Overview of the Experimental Analysis Undertaken
tissue preparation experimental analysis
lymphocytes ortholyse purification oxidative activity
viability




paraffin fixation routine diagnosis
GFAP expression
C6 cell line adherent cells apoptotic activity
proliferative activity





2.2 Initial Preparation of Fresh Tissue
(a) Human Phagocytes
Peripheral blood lymphocytes were withdrawn between 8.00a.m. and 9.30a.m from
patients undergoing pulmonary lobectomy for peripheral pulmonary opacity
consistent with peripheral bronchogenic carcinoma. Additional blood samples were
taken post-operatively and 2 and 7 days after surgery. Blood withdrawn from healthy
donors at similar time intervals was used as a contemporary control. Lymphocytes
were purified using Ortholyse solution within 2 hours of venupuncture, and the cells
were resuspended at a density of 106 cells/ml in phosphate buffered saline.
(b) Human Glioma Tissue
Tumour samples obtained at the time of surgery were placed in Hams F-10 medium
containing 20mM HEPES buffer pH 7.5, 10% foetal calf serum (FCS), 200pg/ml
penicillin, 200pg/ml streptomycin, lOOpg/ml kanamycin and 2.5pg/ml amphoterecin
within 15 minutes of removal. Obvious non-tumour material was removed and the
remaining tissue chopped into l-2mm fragments with sterile disposable scalpels. The
tissue was resuspended in Hams F-10 medium containing 200 units/ml collagenase
(clostidopeptidone A; EC 3.4.24.3. Type 1 Lot 113H1019, Sigma, Poole, U.K.) for 4-
18 hours at 37°C, and agitated regularly to facilitate the formation of a single cell
suspension. Once tumour dissagregation was complete, the cells were centrifuged
and resuspended at a density of 106 cells/ml in collagenase-free Hams F-10 medium
containing 10% FCS.
(c) The Rat C6 Glioma Cell Line
C6 glioma cells, obtained initially from Porton Down Laboratories, Sussex, U.K.,
were grown from samples stored at -70°C in 10% dimethylsulphoxide in Hams F-10
medium containing 10% FCS. The frozen cells were thawed in a water bath at 37°C,
centrifuged with 10-12ml ofHams F-10 medium containing 10% FCS and 5%
penicillin and streptomycin, and grown in 15ml ofHams F-10 complete medium at
37°C and 5% C02 for 2-3 days or until confluent.
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Single cell suspensions of rat C6 glioma cells were obtained by briefly incubating
adherent C6 cells with 10ml trypsin diluted 1:10 with Hams F-10 solution containing
10% FCS. Excess solution was removed, and the cells were incubated at 37°C for 5
minutes. Trypsinisation was terminated by the addition of 10ml Hams F-10 solution
containing 10% FCS. The cells were centrifuged and resuspended at a density of 105
cells/ml for analysis of apoptotic activity, or 106 cells/ml for analysis of oxidative
activity.
2.3 Experimental Analysis of Oxidative Activity
Oxidative activity was investigated using flow cytometric analysis of the intracellular
accumulation 2',7'-dichlorofluorescein. 2',7'-dichlorofluorescein is fluorescent
oxidation product derived from the non-fluorescent precursors 2'7'-
dichlorofluorescin diacetate and 2'7'-dichlorofluorescin (Figure 2.1). As a result of
its high lipid solubility, 2'7'-dichlorofluorescin diacetate readily traverses cell
membranes, and is converted to 2'7'-dichlorofluorescin by non-specific intracellular
esterases. In the presence of intracellular peroxides and reactive oxygen species, 2'7'-
dichlorofluorescin is converted to 2'7'-dichlorofluorescein, whose green fluoresence
can be measured at 515-545nm. 2'7'-dichlorofluorescein-associated fluorescence is
therefore directly proportional to cellular oxidative activity.
2',7'-dichlorofluorescein was chosen for this analysis because of its rapid cellular
uptake and well characterised metabolism and stochiometry (Cathcart et al, 1983 and
Leaver et al, 1995). However, it has the disadvantage that certain tumour cells may
metabolise diacetete esters more slowly than non-transformed cells (Watson et al,
1978). Additionally, intracellular fluorescein degradation has been demonstrated, and
the probe slowly leaks from cells (Watson et al, 1978). Therefore the endogenous
leakage and degradation of the probe was corrected by expressing stimulated
metabolism as a ratio of the unstimulated rate. In order to correct for variations in
uptake, 2',7'-dichlorofluorescein fluorescence was expressed in terms of the change
in initial fluorescence.
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Figure 2.1. The intracellular oxidation of the fluorescent probe 2'7'-
dichlorofluorescein. The non-fluorescent substrate 2'7'-dichlorofluorescin
diacetate traverses the cell membrane and is converted to non-fluorescent 2'7'-
dichlorofluorescin by non-specific intracellular esterases. 2'7'-
dichlorofluorescin can then interact with peroxides and oxygen based free
radicals to form the fluorescent product 2'7'-dichlorofluorescein. 2'7'-




Purified leukocyte preparations were incubated with 5pM 2',7'-dichlorofluorescin
diacetate (Kodak, Harrow, U.K.) for 10 minutes at 37°C, and analysis of2',7'-
dichlorofluorescin oxidation was carried out using an Ortho flow cytometer with
Immunocount software and Orthocount calibration.
The kinetics of reactive oxygen intermediate production were analysed in duplicate
samples ofmononuclear and polymorphonuclear lymphocytes at 30 second intervals.
Oxidative activity was analysed for 7 minutes in the absence of exogenous
arachidonic acid or gamma-linolenic acid. The stimulated rate of reactive oxygen
intermediate generation was then measured following the addition of arachidonic
acid (sodium salt, Sigma) or gamma-linolenic acid (lithium salt, Scotia
Pharmaceuticals, Stirling, U.K.) for 13 minutes.
(b) Human Glioma Preparations
Cell suspensions of 106 cells/ml in Hams F-10 medium containing 10% FCS were
centrifuged and loaded with 2',7'-dichlorofluorescin by incubating with 5ml 5pM
2'7'-dichlorofluorescin diacetate (Kodak, Harrow, U.K.) for 10 minutes at 37°C. The
cells were washed and resuspended at approximately 106 cells/ml in collagenase free
medium containing 10% FCS. Flow cytometric determination of oxidative activity
was carried out by analysing 2'7'-dichlorofluorescin-associated fluorescence at 515-
545nm using LYSIS software on a FACScan flow cytometer.
Basal reactive oxygen intermediate formation was determined for up to 7 minutes.
The sample was then treated with 4-40pM arachidonic acid (sodium salt, Sigma) or
gamma-linolenic acid (lithium salt, Scotia Pharmaceuticals, Stirling, U.K.), and
intracellular 2',7'-dichlorofluorescin oxidation monitored as described above for up
to 3 hours. Basal and stimulated oxidative activity was assessed on 5 000 cells every
10 seconds. Statistical analysis of human glioma peroxidation is described in Section
2.4b.
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(c) Human Glioma Sub-Populations
Although macroscopically normal and necrotic tissue was removed prior to oxidative
analysis, the cellular composition of the tumours analysed was highly heterogeneous,
containing varying proportions of transformed glial cells at various stages of
differentiation, reactive astrocytes, vascular cells and normal brain (Darling, 1990
and Thomas and Graham, 1995, Chapter 1). To differentiate between these various
populations, up to 6 sub-populations within each tumour analysed was identified on
the basis of their laser scatter characteristics. The oxidative activity of these sub-
populations was calculated using flow cytometric analysis of stored data obtained
following the initial analysis ofwhole tumour reactive oxygen species formation.
2.4 Statistical Analysis of Reactive Oxygen Species Generation
(a) Human Phagocyte Preparations
Analysis of 2',7'-dichlorofluorescin-associated oxidation in monocyte and neutrophil
populations indicated a normal distribution of fluorescence. Analysis of variance was
therefore used to compare treatment groups (Ratkowsky, 1989).
(b) Human Glioma Preparations
The kinetics glioma reactive oxygen intermediate production did not fit any well
established linear model well. Nonlinear reaction kinetics were therefore required to
calculate the rate of 2',7'-dichlorofluorescin oxidation with time (Ratkowsky, 1989).
This was achieved using the exponential function:-
y = I + (3[l-exp(-Kt)] (Equation 1)
where y=the ratio of the stimulated/unstimulated reactive oxygen intermediate
formation, I=the intercept on the y axis i.e. the value of y at t=0, (3=the range of the
response between t0-°°, i.e. the total extent of stimulated oxidation at the x asymptote
and K=the rate of stimulated oxidation, i.e. the rate at which y changed from its initial
value I at t=0, to its final value at t=°°.
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The rate of 2',7'-dichlorofluorescin oxidation in the absence of essential fatty acid
stimulation was analysed using the equation:-
y = alog(-p)+ alog(log time+200sec) (Equation 2)
where y=mean cell fluorescence in unstimulated cells compared with cells
immediately after loading with 2',7'-dichlorofluorescin, i.e.(mean fluorescence at x
seconds)/(mean fluorescence at 0 seconds)xlOO. The y intercept I=alog(-p) indicates
probe metabolism per cell at 200 seconds and a is the rate constant describing the
change in cell associated metabolism per second. All statistical analysis of human
glioma preparations was carried out on a Sun SPARC computer station using the
statistical analysis software program (SAS Institute Inc. N. Carolina, 1991).
(c) Human Glioma Sub-Populations
As a result of the relative heterogeneity and small population size of the human
glioma sub-populations, oxidative activity could be described using linear reaction
kinetics (Ratkowsky, 1989). Basal oxidative activity in human glioma sub-
populations was analysed using the equation:-
where ABF= mean basal 2',7'-dichlorofluorescein-associated fluorescence. The time
periods in seconds are shown as subscripts in parentheses. For each determination of
mean basal fluorescence over a 200 second interval, 10 values ofmean 2',7'-
dichlorofluorescein- associated fluorescence were used.
The rate of increase of cellular oxidation in human glioma sub-populations following
the addition of exogenous arachidonic acid or gamma-linolenic acid was analysed
using the equation:-
ABF(0-200) ~ ABF(200-400) X100 (Equation 1)
F(0-200) ~AF(2OO-4OO) /AF(O_2OO) x 100 (Equation 2)
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where AF=the mean % increase in 2',7'-dichlorofluorescein-associated fluorescence
over the time periods shown in parentheses. Arachidonic acid or gamma-linolenic
acid was added at time t=0.
2.5 Analysis of GFAP Expression
Flow cytometric analysis ofGFAP staining intensity was carried out on human
glioma cells which had been fixed in 100% ethanol and stored at -20°C for 2-8
weeks. Glioma sections were used for the positive control and the primary antibody
was omitted for the negative control. The ethanol preserving process did not alter the
characteristic laser scatter profile which was observed in samples of the fresh tissue.
(a) Monoclonal GFAP staining
Monoclonal rabbit anti-cow GFAP (protein concentration 14.0 g/L, Dako) was
diluted 1:5, 1:10 and 1:20 and phycoerythrin was diluted 1:10, in phosphate buffered
saline (PBS) containing 20% FCS and 5% tween (Bio-Rad, Watford, U.K., CAS
9005-64-5, batch 126714A). Ethanol preserved cells were washed twice with 1ml
PBS and resuspended at a density of approximately 106 cells in 1ml PBS containing
20% FCS and 5% tween. lOOp.1 of antibody solution was added to each cell pellet and
incubated at room temperature for 30 minutes. The cells were centrifuged,
resuspended in 1:10 phycoerythrin and incubated at 4°C for 2 hours. GFAP labelled
cells were suspended in 1ml PBS containing FCS and tween, centrifuged and
resuspended in 1ml PBS for flow cytometry at 564-607nm using a Becton-Dickinson
FACScan flow cytometer and LYSIS software. Control samples were incubated with
the fluorochrome alone. This method was adapted from standard techniques applied
in flow cytometric immunohistochemistry (Ormerod, 1990 and Darzynkiewicz and
Crissman, 1990).
(b) polyclonal GFAP Staining
FITC-conjugated polyclonal swine anti-rabbit GFAP (protein concentration 0.5g/L,
Dako) was diluted 1:5, 1:10 and 1:20 in PBS containing 20% FCS and 5% tween.
lml aliquots of ethanol preserved cells containing 106 cells/ml were washed twice in
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lml PBS-FCS-tween solution and incubated with lOOgl of the antibody solutions at
4°C for 2 hours. GFAP labelled cells were suspended in lml PBS-FCS-tween
solution, centrifuged and resuspended in lml PBS for flow cytometry at 564-607nm
using a Becton-Dickinson FACScan flow cytometer and LYSIS software. Control
samples were incubated with the fluorochrome alone. This method was adapted from
standard techniques applied in flow cytometric immunohistochemistry (Ormerod,
1990 and Darzynkiewicz and Crissman, 1990).
2.6 Analysis of Cell viability
Loss of cell viability is associated with reduced cell membrane integrity and
increased permeability to vital dyes. In these studies, leukocyte and human glioma
cell viability was assessed by analysing the cellular uptake of ethidium homodimer
and propidium iodide respectively, both ofwhich are excluded from cells whose
membrane is intact. Ifmembrane integrity is compromised and these compounds gain
access into the cell, they bind with high affinity to nuclear DNA, and form a
fluorescent product which can be detected using flow cytometry at 564-607nm. The
fluorescence associated with ethidium homodimer and propidium iodide is therefore
inversely proportional to cell viability (Ormerod, 1990 and Darzynkiewicz and
Crissman, 1990).
Human glioma cell viability was also determined by analysing cellular uptake of the
hydrophilic dye trypan blue. Light microscopy was used to determine the proportion
of cells which were stained with this dye. Staining was associated with reduced cell
membrane integrity and hence loss of viability.
(a)Analysis of lymphocyte and human glioma cell viability
Lymphocyte and glioma cell viability was determined at the end of each analysis of
oxidative activity. Human glioma cells were suspended at a density of 106 cells/ml,
incubated with lmg/ml propidium iodide at 20°C for 10 minutes, and analysed with
LYSIS software on a FACScan flow cytometer. In lymphocyte preparations, viability
was determined by assessing cell permeability to ethidium homodimer.
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2.7 Analysis of Apoptosis
Apoptotic activity was determined flow cytometrically using the TUNEL assay.
During the process of apoptosis, Ca2+ activated endonucleases are responsible for the
induction of double strand breaks in chromosomal DNA (Arends et al, 1990). The
TUNEL assay uses the enzyme deoxyuridine-5'-triphosphate (dUTP) to label these
oligonucleotide fragments. Flow cytometric detection of dUTP binding, which is
proportional to cellular apoptotic activity, is made possible by the covalent addition
of the fluorescent tag fluorescein isothiocyanate (FITC) to dUTP. This reaction is
catalysed by the enzyme terminal deoxynucleotidly transferase (TdT) (Gorczyca et al,
1992, Gavrieli et al, 1992 and Gorczyca et al, 1993).The major advantage of this
method is its ability to reveal early DNA breaks during apoptosis (Vermes et al,
2000). However, since DNA strand breaks are not unique to apoptosis
(Darzynkiewicz et al, 1992), it is important that cell viability is determined
simultaneously.
(a) Analysis of Apoptotic Activity in Human Glioma Preparations
Collagenase dispersed human glioma cells were resuspended at a density of 106
cells/ml in Hams F-10 medium, and incubated in the presence or absence of 20-
30pM arachidonic acid or gamma-linolenic acid for up to 36 hours at 20°C. At
intervals of 0, 15, 30, 45 minutes and at hourly intervals for up to 36 hours, 1ml
aliquots ofhuman glioma cells were fixed in ethanol and stored at -20°C.
These ethanol preserved preparations were washed twice in TBS and resuspended in
40pi cacodylate terminal deoxynucleotidyl transferase reaction buffer (Promega,
Madison, U.S.A.) diluted 1:5 with distilled water. The cells were incubated at room
temperature for 10 minutes, centrifuged and resuspended in 25pl of reaction buffer
containing 19.5pl of distilled water, 5pi of terminal deoxynucleotidyl transferase
reaction buffer, 0.25pl of terminal deoxynucleotidyl transferase Co2+ (20 units/ml,
Promega, Madison, U.S.A.) and 0.25pl of fluorescein-12-2'-deoxyuridine-5'-
triphosphate (Fluorescein-12-dUTP), and incubated at 37°C for 2 hours. The reaction
was terminated by centrifuging the cells twice with TBS. The cells were left to stand
at room temperature for 15 minutes before analysing 2 000-10 000 cells on a
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FACScan flow cytometer using LYSIS software. This identified apoptotic cells on
the basis of dUTP/FITC-associated fluorescence and side scatter.
At the same time as glioma cells were fixed in ethanol, membrane integrity was
measured by analysing trypan blue permeability. Approximately 0.5x106 cells were
incubated with lOOpl trypan blue for 2 minutes at 20°C, and viewed on a modified
Fuchs Rosenthal haemocytometer (Webber Scientific International) at magnification
x40. Cell viability was expressed as the percentage ofnon-staining cells in a random
field containing 100-200 cells. Paired data sets comparing apoptotic activity and cell
viability were compared using Students t-test. Results were calculated as the mean ±
SEM of n determinations.
(b) Analysis of Apoptotic Activity in Rat C6 Glioma Cells
Pre-confluent C6 cells were incubated with Flams F-10 medium containing 10%
FCS, penicillin, streptomycin, glutamine and gamma-linolenic acid at concentrations
OpM, lpM, 5pM, 10pM, 20pM and 40pM. The medium bathing the cells was
harvested and replaced every 6 hours, and centrifuged at 2 500rpm. The resulting
pellet contained C6 cells which had detached from culture and was stored in ethanol
for subsequent assessment of apoptotic activity using the TUNEL method (Section
2.7).
After 7 days, adherent C6 cells were harvested using 10% trypsin digestion (Section
2.2c). The cells were resuspended at a density of 106 cells/ml, and their viability was
measured using flow cytometric analysis of propidium iodide uptake. The remaining
adherent cells were stored in ethanol for TUNEL analysis of apoptotic activity
(Section 2.7).
2.8 Analysis of Cell Proliferation
Cells proliferation was assessed using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) assay. Cells were incubated with MTT, which was
converted to formazan crystals by intracellular dehyrogenases. The formazan crystals
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were solubilised using dimethyl sulphoxide, and absorbance of the resulting solution
was measured at 540nm. As cell proliferation in each of the C6 populations analysed
was directly proportional to the activity of intracellular dehydrogenases, absorbance
at 540nm gave an indication of the overall rate of proliferative activity.
Confluent C6 cells were harvested using trypsin digestion (Section 2.2c) and
suspended in Hams F-10 medium containing OpM, lpM, 5pM, 20|iM and 40pM
gamma-linolenic acid (lithium salt, Scotia Pharmaceuticals, Stirling, U.K.) at a
density of 103 cells/1 OOjal ofmedium. lOOpl of each solution was added to seven 96
well plates, which were left overnight to allow the cells to adhere to the surface of the
well. 50pl ofMTT solution at a concentration 1.5mg perml of culture medium was
aliquoted into each test well and the cells were incubated at 37°C for 7 days. 150ul of
dimethylsulphoxide containing 0.5% FCS was added to each well, and the plates
were shaken at room temperature on an orbital shaker for 30 minutes. Absorbance
was measured at 540nm on a microplate reader (model 450; Bio-Rad Laboratories,
Hemel Hempstead, Hertfordshire, U.K.).
2.9 The Interaction of Glioma Cell Preparations with Sodium
Nitroprusside and Radiotherapy
(a) Sodium Nitroprusside
Single cell suspensions of human glioma tissue and the rat C6 cell line were
resuspended at a density of 106 cells/ml and incubated in the presence or absence of
arachidonic acid or gamma-linolenic acid and the nitric oxide donor sodium
nitroprusside (Sigma). Immediately, and at hourly intervals for 10 hours, 1ml aliquots
were withdrawn for analysis of peroxidative metabolism (Section 2.3), apoptosis
(Section 2.7) and viability (Section 2.6).
(b) Irradiation
Approximately six 250ml flasks of rat C6 glioma cells at different phases of growth
and development were harvested with trypsin to form a single cell suspension
(Section 2.2c). The cells were centrifuged and resuspended at a density of 106
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cells/ml in the presence or absence of exogenous arachidonic acid or gamma-
linolenic acid. Care was taken to exclude all air gaps, and the cells were irradiated
with a single dose of irradiation at 2Gy. Immediately, and at hourly intervals for 10
hours, 1ml aliquots were withdrawn for analysis of peroxidative metabolism,
apoptosis and viability using flow cytometry, and proliferation using the MTT assay.
2.10 Analysis ofParaffin Fixed Human Glioma Tissue
The WHO classification of each tumour analysed for peroxidative and apoptotic
activity was assessed using standard histopathological techniques (Liebovitz, 1990)
Paraffin-fixed tissue sections were stained with haematoxylin and eosin to determine
diagnostic indicators such as necrosis, vascularity, the presence ofmitotic bodies and
cellular differentiation. Where required, GFAP expression was also analysed in order
to confirm the glial origin of the tumour. The diagnosis was recorded in a definitive
histopathology report whose conclusions were confirmed by a second independent
observer. In addition, the expression of bcl2 and p53 was determined by
immunocytochemistry in a limited series of tumours.
(a) Pathological and Diagnostic analysis
Pathological and diagnostic analysis was carried out on each of the human glioma
samples analysed for oxidative activity. This was achieved using standard
histopathological and immunohistochemical techniques (Liebovitz, 1990). Tumour
diagnosis was determined following analysis of glioma sections stained with
haematoxylin and eosin. Where appropriate, GFAP expression was also investigated.
(i) Haematoxvlin and Eosin
Paraffin embedded tumours were cut into 5pm sections, floated onto poly-L-lysine
(PLL) coated microscope slides and allowed to dry at 80°C for at least 60 minutes.
The sections were rehydrated by sequential exposure to xylene, ethanol, picric acid
and hydrogen peroxide as shown in Table 2.1, and incubated with Meyer's
haematoxylin solution for 5 minutes. The sections were rinsed in tap water, placed in
lithium carbonate for 30 seconds and rinsed in tap water. The sections were
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dehydrated according to the protocol shown in Table 2.2 and fixed with clean
microscope slides.
(ii) Glial Fibrillary Acidic Protein
Paraffin embedded tumours were cut into 5pm sections, floated onto PLL coated
microscope slides and allowed to dry at 80°C for at least 60 minutes. The sections
were rehydrated by sequential exposure to xylene, ethanol, picric acid and hydrogen
peroxide as shown in Table 2.1, incubated with 3% aqueous hydrogen peroxide for
10 minutes and rinsed with tap water. The sections were incubated with 20% normal
swine serum for 10 minutes, followed by polyclonal GFAP (Dako) diluted 1:200 in
20% normal swine serum for 30 minutes. The sections were washed in TBS for 5
minutes, incubated with ABC reagent containing lOOpl streptavidin (Dako) for 30
minutes and rinsed in tap water, and incubated with 3,3-diaminobenzidine
tetrahydrochloride (DAB) solution for 5 minutes. After being rinsed in tap water, the
sections were incubated with lithium carbonate solution for 30 seconds, rinsed in tap
water and dehydrated according to the protocol shown in Table 2.2. The sections
were mounted on a clean microscope slide. A section of normal brain was used as a
positive control, and the primary antibody was omitted for the negative control.
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Reagent Time of Exposure
xylene 5 minutes
95% ethanol 3 minutes
70% ethanol 3 minutes
picric acid 15 minutes
hydrogen peroxide 5 minutes
Table 2.2. Rehydration procedure for paraffin embedded tumours used for
histopathological analysis of tissue ultrastructure (haematoxylin and eosin) and glial
fibrillary acidic protein (Section 2.10). The sections were exposed sequentially to the
reagents shown below for the time periods stated.
Reagent Time of Exposure
70% ethanol 2 minutes
74% ethanol 2 minutes
100% ethanol 2 minutes
100% ethanol 2 minutes
xylene 2 minutes
xylene 2 minutes
Table 2.3. Dehydration procedure for paraffin embedded tumours used for
histopathological analysis of tissue ultrastructure (haematoxylin and eosin) and glial
fibrillary acidic protein (Section 2.10). The sections were exposed sequentially to the
reagents shown below for the time periods stated.
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Chapter 3:
The Effects of Arachidonic Acid and Gamma-Linolenic Acid on
Monocyte and Neutrophil Reactive Oxygen Species Production
3.1 Introduction
The main purpose of this study was to use flow cytometry to i) investigate the effect
of exogenous arachidonic acid and gamma-linolenic acid on cellular reactive oxygen
species formation in human phagocytes and ii) investigate the phenotype of these
cells. This was undertaken using phagocyte preparations acquired from lung cancer
patients undergoing pulmonary resection. Initially, these cells were purified and their
forward and side scatter characteristics determined. Basal and stimulated reactive
oxygen species formation was then investigated by analysing phagocyte oxidative
activity in the presence and absence of exogenous arachidonic acid and gamma-
linolenic acid. Cell viability was assessed by measuring permeability to ethidium
homodimer. These parameters were analysed pre and post-operatively to evaluate the
effect of surgery and essential fatty acid sensitivity on phagocyte activation.
These studies were carried out primarily to assist in subsequent flow cytometric
analysis of human glioma cells. Although a number of studies have analysed glioma
cell lines using flow cytometry (Knott, 1990, Pellicciari et al, 1995, Yahanda et al,
1995, Li et al, 1997, Rooprai et al, 1999 and Ly et al, 2001) fresh human cells
acquired from biopsy samples have not been studied extensively using this technique.
Consequently, it was necessary to optimise experimental and dose response
conditions using cell types whose flow cytometric properties were better
characterised. Phagocyte preparations were chosen for this analysis because of their
well established laser scattering properties, relative homogeneity and ready
availability (Ormerod, 1990 and Darzynkiewicz and Crissman, 1990).
In addition to establishing appropriate conditions required for the analysis of human
glioma reactive oxygen species formation, the involvement of arachidonic acid and
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gamma-linolenic acid in phagocyte activity is of interest because essential fatty acid
mediated stimulation of leukocyte reactive oxygen species production may be
associated with tumour cytotoxicity (Cornwell and Morisaki, 1984 and Gonzalez,
1992). It is known that patients with primary intracranial tumours have altered
immune function, due, in part at least, to inhibition of T-cell function (Bullard et al,
1986). However, there is evidence that certain fatty acids, including arachidonic acid,
gamma-linolenic acid and docosahexaenoic acid potentiate superoxide formation in
human neutrophils and cell free extracts (Badwey et al, 1981 and Poulos et al, 1991).
This may be associated with generation of the cellular immune response against
malignant glioma (Holladay and Wood, 1993).
The generation of reactive oxygen species by lymphocytes which have infiltrated
tumour tissue involves activation ofNADPH oxidase (Badwey et al, 1981), and
specific roles for arachidonic acid have been identified at several molecular sites
associated with NADPH oxidation (Henderson and Chappell, 1992 and Henderson et
al, 1993). These include i) the interaction of the NADPH oxidase component rap 1A
with rap-GTPase activating protein (Mohazzab et al, 1994) ii) the activation of rap-
GTPase activating protein by arachidonic acid (Ligeti et al, 1993) resulting in iii) the
exposure of the p47-SH3 region crucial for oxidase assembly (Sumimoto et al, 1994)
and iv) the binding of cytochrome b protein p22 phox and the p67 phox protein
(Sumimoto et al, 1994). Additionally, arachidonic acid induces translocation of rac
p21s to the membrane and the activation ofNADPH oxidase (Sawai et al, 1993).
The involvement of arachidonic acid in physiological changes associated with
phagocyte activity are less well characterised. However, an arachidonic acid-specific
phospholipase A2, which is sensitive to nanomolar Ca2+ and responds to the
chemotactic peptide fMet-Leu-Phe and the g-protein agonist guanosine 5'[y-thio]-
triphosphate has been identified in neutrophils (Bauldry et al, 1996). Additionally,
recent evidence indicates that arachidonic acid is involved in phagocyte NADPH-
oxidase activation through induction of a conformational change to p47phox (Shiose
and Sumimoto, 2000). The release of arachidonic acid by cytoplasmic PLA2 has also
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been implicated in the activation of an NADPH-oxidase-associated H+ channel (Levy
et al, 2000). These specific activities of arachidonic acid on phagocyte activation may
contribute to tumour cytotoxicity in vivo.
In order to investigate the role of arachidonic acid and gamma-linolenic acid in
phagocyte oxidative activity, individual cell types, specifically lymphocytes,
monocytes and granulocytes, were identified using sub-population analysis. Reactive
oxygen species formation in each population was then investigated in the presence
and absence of exogenous arachidonic acid and gamma-linolenic acid, both before
and after surgery. These studies established suitable parameters for the investigation
of human glioma cell oxidative activity, while simultaneously providing information
on the previously uncharacterised effect of arachidonic acid and gamma-linolenic
acid in phagocyte activation.
3.2 Materials and Methods
Blood samples were withdrawn between 8.00 and 9.30a.m.from patients undergoing
pulmonary lobectomy for peripheral bronchogenic carcinoma (Section 2.2a). All
patients underwent bronchoscopy, media stenoscopy and computed axial tomography
of the thorax and upper abdomen. Routine haematological and biochemical profiles
were performed, and isotopic bone scans were carried out when indicated. All
patients had pulmonary function adequate for lobectomy and stable cardiac status.
Blood samples were taken pre-operatively, 2 and 7 days after surgery. Informed
consent and local ethical board permission was obtained for this study. Blood
withdrawn from healthy blood donors at the same time as patient blood samples were
collected were used as contemporary controls.
Leukocyte preparations were purified using ortho-lyse solution within 2 hours of
venepuncture. The cells were loaded with 2',7'-dichlorfluorescin (Section 2.3a),
and patient and control phagocytes were analysed using an Ortho flow cytometer
with Immunocount software and Orthocount calibration. Oxidative activity was
determined in duplicate mononuclear and polymorphonuclear phagocytes derived
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from the same individual. The rate of reactive oxygen species formation was
analysed at 30 second intervals for 7 minutes before that addition of arachidonic acid
and gamma-linolenic acid and for 13 minutes after.
3.3 Results
(a) Effect of Arachidonic Acid and Gamma-Linolenic Acid on
Phagocyte Reactive Oxygen Species Generation
Preliminary analysis indicated a normal distribution of fluorescence in gates B
(monocytes) and C (neutrophils) but not A (lymphocytes) (Figure 3.1). Mean
fluorescence associated with phagocyte populations B and C was therefore used to
estimate reactive oxygen species generation. Analysis of variance (ANOVA) was
used to compare treatment groups.
The rate of reactive oxygen species generation in peripheral mononuclear and
polymorphonuclear phagocytes was significantly stimulated (P<0.05-P<0.001)
following addition of l-40pM arachidonic acid and gamma-linolenic acid (Figure
3.1). In both patient and control phagocytes, this stimulation was associated with
increased dichlorofluorescein-associated fluorescence and a broadening of the
fluorescence distribution describing reactive oxygen species formation (Figure 3.1).
Cell viability was greater than 58%, and was not significantly different in patients
and control phagocytes.
(b) The Kinetics of Arachidonic Acid and Gamma-Linolenic Acid
Induced Activation of Phagocyte Reactive Oxygen Species
Generation
Arachidonic acid and gamma-linolenic acid increased reactive oxygen species
formation in each peripheral leukocyte category (Figure 3.2). Similar kinetics were
observed in response to arachidonic acid and gamma-linolenic acid, although
arachidonic acid had the greatest stimulatory effect. Essential fatty acid-mediated
stimulation of oxidative activity followed a linear regression curve during the first 10
minutes of analysis, even at the lower concentration of the weaker agonist (6pM
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gamma-linolenic acid). Correlation coefficients for the rate of increase of reactive
oxygen species with time in phagocytes treated with 6uM gamma-linolenic acid were
0.685 in patient monocytes, 0.839 in patient neutrophils, 0.862 in control monocytes
and 0.862 in control neutrophils.
(c) Comparison ofGamma-Linolenic Acid and Arachidonic Acid
Stimulation in Patient and Control Phagocytes
Essential fatty acid-mediated stimulation of phagocyte reactive oxygen species
generation was significantly less in patient groups in comparison with control cells
(p<0.005, n=15), although this difference was more apparent in neutrophils than
monocytes (Figure 3.2). Stimulation of control neutrophils was significantly greater
than patient neutrophils at 15uM (p<0.05, n=15) and 30uM (p<0.05, n=16)
arachidonic acid. The mean increase in reactive oxygen species production over 5.5
minutes ranged from 1.5± 2.7% for patient neutrophils treated with 8pM gamma-
linolenic acid to 50.1±15.0% for control neutrophils stimulated with 15p.M
arachidonic acid.
(d) Generation of Reactive Oxygen Species in Patient Phagocytes
Before and After Surgery
The effect of surgery on reactive oxygen species generation was compared by pairing
pre-operative and post-operative levels of reactive oxygen species production, and
analysing differences between these groups using ANOVA. Significantly greater
reactive oxygen species generation was detected in post-operative patient phagocytes
(p<0.05-p<0.01) (Figure 3.3). Additionally, analysis of the pre-operative group
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Figure 3.1. The effect of 40gM gamma-linolenic acid on granulocyte peroxidation in
a peripharal blood leukocyte preparation from a patient with lung cancer. Diagram 1
indicates the forward and side scatter of (A) lymphocytes, (B) monocytes and (C)
granulocytes in peripharal blood leukocytes previously incubated with 5gM 2'7'-
dichlorofluorescein diacetate. Diagram 2 is a sub-population histogram of the
intensity of dichlorofluorescein associated fluorescence (x-axis) vs. cell number (y-
axis) in granulocytes (region C of the cytogram) in cells incubated with 40[iM
gamma-linolenic acid for 8 minutes at 20°C ( ■) compared with cells from the same
region and individual in the absence of exogenous essential fatty acid stimulus (□).




Figure 3.2. The effects of arachidonic acid and gamma-linolenic acid on
mononuclear and polymorphonuclear reactive oxygen production in lung cancer
patients and healthy controls. The percentage of pre-stimulated reactive oxygen
intermediate production in patient phagocytes loaded with 2',7'-dichlorofluorescein
and paired normal control phagocytes were analysed simultaneously using flow
cytometry ofmean 2',7'-dichlorofluorescein fluorescence in mononuclear (mono)
and polymorphonuclear (poly) cells from the same individual. Results describe mean
± SEM reactive oxygen intermediate production in phagocytes exposed for 5.5
minutes in vitro to either: (A) gamma-linolenic acid, lithium salt 6pM (□) or 30pM (
■ ) or (B) arachidonic acid, sodium salt, 4uM (Q) or 15pM ( ■ ). Mean reactive
oxygen intermediate production in the presence of n-6 essential fatty acids was
expressed as a percentage of unstimulated reactive oxygen intermediate production in
the same individual. *reactive oxygen intermediate production significantly different
from pre-stimulation reactive oxygen intermediate production P<0.05, **P<0.01,
***P< 0.001 using ANOVA to compare stimulated values with pre-stimulated values
in the same individual. In (A), sixteen leukocyte samples from the control group and
16 leukocyte samples from the patient group and sixteen samples from the control
group were incubated with 6pM (Q) and 30pM ( ■ ) respectively. In (B), 16 samples
in the patient and control groups were incubated with 4uM arachidonic acid (Q) and






Figure 3.3. The generation of reactive oxygen intermediate production in patient
phagocytes expressed as a percentage ofmean control phagocyte production before
(group 1) and after (groups 2 and 3) pulmonary resection. Group 2 leukocytes were
taken 48 hours after surgery and group 3 leukocytes 7 days after surgery. Mean
reactive oxygen intermediate production (± SEM) was analysed by monitoring 2',7'-
dichlorofluorescein associated fluorescence in 20 patients and 20 paired controls in
monocytes ( ■ ) and neutrophils (Q) after 5.5 minutes incubation. Post-operative
monocyte and neutrophil reactive oxygen intermediate (groups 2 and 3) were
compared with pre-operative reactive oxygen intermediate in the same patient.
Significant increases in reactive oxygen intermediate after surgery *(P<0.05),
**(P<0.01) are indicated in monocytes and neutrophils in both surgical groups.
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3.4 Discussion
The main purpose of this study was to characterise experimental and dose response
conditions suitable for analysis of human primary glioma. This was achieved using
flow cytometric analysis of the oxidative activity of phagocyte preparations acquired
from lung cancer patients undergoing pulmonary resection. The morphological
properties of these cells were investigated, and were found to correlate well with
previously established forward and side-scatter characteristics (Ormerod, 1990 and
Darzynkiewicz and Crissman, 1990). Dose response characteristics were analysed,
and a significant stimulation of reactive oxygen species formation in patient and
control phagocytes was observed at 1 -40uM arachidonic acid and gamma-linolenic
acid (Figures 3.1 and 3.2).
The kinetics of reactive oxygen species formation following addition of arachidonic
acid and gamma-linolenic acid were similar in monocytes and neutrophils, although
2-3 fold greater concentrations of gamma-linolenic acid were required to produce
equivalent stimulation (Figure 3.2). This suggests that gamma-linolenic acid may act
as a partial agonist at the molecular sites where arachidonic acid induces stimulation
ofphagocyte reactive oxygen species production. It is unlikely that differences in cell
viability accounted for the relatively low sensitivity of patient phagocytes to
exogenous essential fatty acid stimulus, as no significant differences in phagocyte
permeability to ethidium homodimer were detected.
Differences were observed between basal oxidative activity and essential fatty acid
sensitivity in i) patient and control phagocytes, and ii) phagocytes obtained pre and
post-operatively. Reactive oxygen species production was elevated in neutrophils
acquired from lung cancer patients, and when stimulated with exogenous arachidonic
acid and gamma-linolenic acid these cells responded with low reactive oxygen
species formation in comparison with those obtained from healthy donors. Similarly,
monocytes and neutrophils acquired post-surgically were characterised by elevated
basal reactive oxygen species formation. These differences are consistent with partial
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activation of phagocytes by lung cancer and its surgical treatment via arachidonic
acid-dependant pathways.
These results suggest that phagocytes previously activated by lung cancer or surgery
are activated less by exogenous n-6 essential fatty acids. This lack of
hyperstimulation may be important as the antiproliferative properties arachidonic
acid and gamma-linolenic acid may be pertinent to bronchogenic carcinoma.
Although there has been little improvement in long term survival following resection
ofbronchogenic carcinoma over the last 20 years (Shields et al, 1994), recent
evidence suggests that arachidonic acid and gamma-linolenic acid are associated with
inhibition of tumour proliferation and viability in a human lung carcinoma grown in
nude mice(deAntueno et al, 1998). Additionally, there is evidence that phagocytes are
associated with tumour cytotoxic reactions in human lung cancer (Braun et al, 1993),
and that stimulation of peripheral blood monocytes ofhuman lung tumour patients
may be involved in the control ofmetastasis (Braun et al, 1993, Gjomarkaj et al,
1994 and Karmali et al, 1986).
The stimulation of phagocyte reactive oxygen by n-6 essential fatty acids may also be
relevant to malignant glioma therapy. Although it is well established that glioma
patients are immunosupressed, especially in their T-cell function (Roszman et al,
1991 and Tada and Tribolet, 1993), there is often evidence of a rudimentary attempt
of the host to reject the tumour (Jaeckle, 1994). Approximately 30-60% of primary
human gliomas have mononuclear cell infiltrates (Bullard et al, 1986 and Stevens et
al, 1988), and antigen-antibody complexes have been observed in gliomas (Wood
and Morantz, 1979 and Wood et al, 1980). In addition, activated microglia have been
observed surrounding invading tumour cells (Streit, 1994).
The suppression ofT-cell function observed in glioma patients may arise from the
release of immunosuppressive factors such as transforming growth factor-beta
(TGFP) from transformed glial cells (Weller and Fontana, 1995). TGFpi inhibits the
proliferation of certain cancer cells in vitro, and there is evidence that this activity is
56
increased by polyunsaturated fatty acids (Newman, 1990). Similar results have been
obtained with other cytokines including tumour necrosis factor (TNF), and certain
interleukins and growth factors (Puntis and Jiang, 1994). It has been hypothesised
that this action is due to the conversion of essential fatty acids to a common lipid
mediator which acts as a second messenger for these cytokines and their receptors
(Begin and Horrobin, 1985, Peppelenbosch et al, 1993 and Mollerup and Haugen,
1996).
Potentiation of reactive oxygen in CNS leukocytes may therefore induce inhibition of
tumour proliferation through potentiation of the immune response. However,
additional studies are required to evaluate the effect of exogenous essential fatty
acids on oxidative activity in glioma-associated leukocytes, and to characterise the
contribution of phagocyte reactive oxygen species generation to glioma cytotoxicity.
3.5 Conclusions
This study established experimental conditions appropriate for the evaluation of
human glioma oxidative activity. In addition, this analysis provided information on
reactive species generation in phagocytes, its stimulation in response to malignant
transformation and surgery, and its regulation by arachidonic acid.
Elevated reactive oxygen species formation was detected in the neutrophils of lung
cancer patients and in the monocytes and neutrophils of patients after surgery.
Further stimulation of oxidative activity was observed following the addition of
arachidonic acid and gamma-linolenic acid, with gamma-linolenic acid being the
weaker agonist. However, phagocytes activated by malignant transformation were
characterised by low sensitivity to exogenous essential fatty acid stimulation. These
differences are consistent with activation of phagocyte reactive oxygen species




The Stimulation of Cellular Oxidative Activity in Human Glioma by
Arachidonic Acid and Gamma-Linolenic Acid
4.1 Introduction
The purpose of this study was to analyse the oxidative activity of human glioma cell
preparations in the presence and absence of exogenous arachidonic acid and gamma-
linolenic acid. Differences were investigated between i) the basal oxidative activity of
tumour tissue and tumour-associated normal brain, ii) the kinetics of reactive oxygen
species formation in normal and tumour tissue and iii) the essential fatty acid
sensitivity of tumours of different grades.
These studies were undertaken to investigate a potential clinical role for n-6 essential
fatty acids in glioma therapy. The mean adult survival for patients suffering from
malignant glioma is typically less than one year following diagnosis (Thomas and
Graham, 1995, Chapter 1, Berens and Giese, 1999 and Neider et al, 2000), and it is
unlikely that this poor prognosis can be improved through increasing the efficacy of
existing therapeutic procedures (Darling, 1990). The elucidation of novel therapies
with the potential to increase tumour cytotoxicity, either alone or in conjunction with
conventional treatments, would therefore have important clinical implications.
The pro-oxidative activities of essential fatty acids may be pertinent to malignant
glioma therapy. In vitro and ex vivo studies have demonstrated an inverse association
between basal reactive oxygen species formation and malignant progression of glioma
(Levcheko and Demchuk, 1991 and Louwe et al, 1997), supporting the hypothesis
that oxygen-based free radicals are involved in the regulation of tumour proliferation
and death. Oxidative activity in a series of astrocytoma cell lines was inversely
proportional to the grade of tumour from which the cell lines were derived, thus it was
observed that the oxidative activity of human glioma tissue was lower than that of
associated normal brain (Louw et al, 1997). Additionally, the oxidative activity of
human astrocytoma and meningioma cells has been shown to be lower than that of
non-transformed brain tissue (Levcheko and Demchuk, 1991). As it has been
demonstrated that human glioma is deficient in the products of delta-6-desaturation,
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including arachidonic acid, gamma-linolenic acid and docosahexaenoic acid (Martin
et al, 1996), this supports the hypothesis that the low levels of basal oxidation
observed in transformed glial cells are due to deficiency of essential fatty acids
(Bartoli and Galeotti, 1979 and Cheeseman et al, 1984).
These observations suggest that addition of exogenous essential fatty acids may
inhibit glioma proliferation by providing substrate for the production of potentially
cytotoxic oxygen-based free radicals and lipid peroxides (Cornwell and Morisaki,
1984 and Gonzalez, 1992), and evidence supporting this hypothesis has been acquired
from in vitro investigations. Arachidonic acid-mediated inhibition of cell division in a
human glioma cell clone was associated with increased oxidative activity (Liepkalns
et al, 1982), and inhibition of cell proliferation in glioma cell lines by gamma-
linolenic acid was associated with potentiation of free radical activity (Das et al,
1990a).
Although these observations are consistent with a therapeutic role for arachidonic acid
and gamma-linolenic acid in the management ofmalignant glioma, there is limited
information on a number of parameters of clinical importance. A correlation between
tumour grade and essential fatty acid sensitivity has not yet been established, and the
kinetics of reactive oxygen species formation in human glioma tissue in response to
exogenous essential fatty acid stimulation have not been described. The purpose of
this study was to address these issues by investigating the effect of exogenous
arachidonic acid and gamma-linolenic acid on reactive oxygen intermediate
generation in short-term primary cultures of fresh human glioma tissue removed at
biopsy.
However, the kinetics of oxidative activity in human glioma explants were not
described well by existing statistical methods (Ratkowsky, 1989). This was due
predominantly to cellular heterogeneity which is a characteristic of glial tumours,
particularly those ofhigh grade. Consequently, it was necessary to derive novel
statistical parameters which more accurately described the complexity of the reaction
kinetics observed in mixed cell populations.
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Using these novel statistical models, the dynamics of tumour reactive oxygen
intermediate generation in the presence and absence of arachidonic acid and gamma-
linolenic acid was investigated, and the dependence of reactive oxygen intermediate
formation on essential fatty acid type and concentration was determined. To further
characterise the association between cellular oxidative activity, essential fatty acid
sensitivity and malignant progression, reactive oxygen species formation in human
glioma tissue was compared with that of associated normal brain. Additionally, the
kinetics of glioma cell oxidation in the presence of exogenous arachidonic acid and
gamma-linolenic acid was compared with that of tumour-associated normal brain and
areas of focal tumour necrosis. The results from this study provide further information
on the control of reactive oxygen intermediate formation in human primary brain
tumours and the scientific rationale behind putative therapies for brain tumours using
arachidonic acid and gamma-linolenic acid.
4.2 Materials and Methods
(a) Tissue Preparation
Explants of fresh glioma, and, if available, tumour-associated normal and necrotic
tissue, were obtained at the time of surgery. Informed consent and local ethical board
permission was obtained. The tissues were chopped using sterile disposable scalples,
digested with collagenase, washed and resuspended at a density of 106 cells/ml in
Hams F-10 medium. The cells were loaded with 2'7'-dichlorofluorescin diacetate,
the intracellular probe of oxidative activity (Section 2.2b and 2.3b).
(b) Analysis of Cellular Oxidative Activity
The kinetics of2'7'-dichlorofluorescin oxidation were determined in the presence and
absence of exogenous essential fatty acids at 10 second intervals. The pre-stimulated
rate of reactive oxygen intermediate generation was determined for 7 minutes, and the
essential fatty acid-stimulated rate of reactive oxygen intermediate production was
determined in the presence of4-40pM arachidonic acid or gamma-linolenic acid for
up to 3 hours (Section 2.3b). At each time point, 5 000 or 10 000 cells were analysed.
2'7'-dichlorofluorescin was chosen for analysis of oxidative activity because of its
rapid cellular uptake and well characterised metabolism and stochiometry (Cathcart et
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al, 1983 and Leaver et al, 1995). However, use of this probe was associated with a
number of problems: probe leakage following cellular uptake has been reported,
intracellular fluorescin degradation can take place (Makrigiorgos et al, 1996) and the
activity of intracellular esterases, which are responsible for the metabolic conversion
of dichlorofluorescin to dichlorofluorescein, may be low in tumour cells (Watson et
al, 1978). To compensate for this, the rate of endogenous probe leakage and
degradation was corrected by expressing oxidative metabolism in the presence of
exogenous essential fatty acid as a ratio of the unstimulated rate. In unstimulated
cells, the fluorescence of 2'7'-dichlorofluorescein was expressed in terms of the
change in fluorescence of the initial 2',7'-dichlorofluorescin load per cell at the
beginning of the incubation, thus correcting for variations in uptake.
(c) Statistical Analysis of Essential Fatty Acid Induced Stimulation of
Tumour Oxidation
Reactive oxygen intermediate production was analysed using the exponential
function:-
where y=the ratio of the stimulated/unstimulated reactive oxygen intermediate
production, I=the intercept on the y axis when t=0 seconds, P= the range of the
response between to seconds and t°°, and k= the rate at which y changed from its initial
value I at t=0 seconds to its final value as it approached its asymptotic maximum at t=
OO seconds.
(d) Statistical Analysis of Tumour Oxidation in the Absence of
Essential Fatty Acid
Tumour oxidation in the absence of essential fatty acid was analysed using the
equation:-
y = I+P[l-exp(kt)] (Equation 1)
y=olog(-p) + olog (log time + 200 seconds) (Equation 2)
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where y=mean cell fluorescence in unstimulated cells compared with cell
fluorescence immediately after loading cells with 2'7'-dichlorofluorescin. The y
intercept I=olog(-p) indicates probe metabolism per cell at 200 seconds and a is the
rate constant describing the change in cell associated fluorescence per second. The
goodness of fit of this model was estimated using the residual means squared value
(Section 2.4b).
(e) Analysis of Cell Viability
Cell viability was determined in the presence and absence of arachidonic acid or
gamma-linolenic acid at the end of each analysis of oxidative activity. 1ml aliquots of
collagenase-dispersed glioma cells were incubated with lmg/ml propidium iodide.
Propidium iodide-associated fluorescence, which is inversely proportional to cell
viability, was determined using flow cytometry (Section 2.6).
(f) Analysis of Tumour Pathology
The WHO classification and grade of each tumour analysed for peroxidative activity
was determined using standard histopathological techniques (Section 2.10). Where
appropriate, the glial origin of the tumour was investigated using immuno-
histochemical analysis ofGFAP expression.
4.3 Results
(a) The Effects of Arachidonic acid and Gamma-Linolenic Acid on
the Kinetics of Reactive Oxygen Intermediate Generation
The brain tumours analysed in this study were obtained from 30 patients undergoing
surgical resection or biopsy. Median age was 51 years (range 5-74) and 20 of the 30
patients were male. 18 of the 30 tumours received were glioblastomas (grade IV), and
within this group mean patient age was 58.5 years. Three of these GBM patients were
below the age of 35 and 12 were male. 9 of the remaining 12 tumours were
astrocytomas (grades I-II), 3 were anaplastic astrocytomas (grade III), one was an
anaplastic ependymoma (grade III) and one was an anaplastic oligodendroglioma
(grade III). Five samples of peritumoural normal brain and one sample of tumour-
associated necrotic tissue, each derived from biopsy specimens of glioblastoma, were
also available for analysis.
62
Collagenase-dispersed cells derived from these tissues were used to investigate the
effect of arachidonic acid and gamma-linolenic acid on tumour cell peroxidation.
This was achieved by analysing the stimulation ratio, i.e. the ratio of basal reactive
oxygen species formation to reactive oxygen species formation in the presence of
exogenous essential fatty acid, in 5 000 or 10 000 cells at 10 second intervals for up to
three hours. High, intermediate and low doses of arachidonic acid and gamma-
linolenic acid were randomised after the dose response characteristics of essential
fatty acid associated stimulation of reactive oxygen intermediate production were
established. These concentrations were selected to fall within a range known to elicit a
significant (p<0.005) stimulation of reactive oxygen intermediate production within
10 minutes, while having minimal effects on cell membrane integrity (Section 4.3e).
The stimulation ratio was used to derive two kinetic constants: the asymptotic
maximum (3 and a rate constant K. A good estimate of the asymptotic maximum (3,
which indicated the total extent of stimulated oxidation, was obtained when the
stimulation ratio approached the asymptote during the course of the experiment.
However, the estimate of (3 was poor for the four curves whose stimulation ratios
continued to rise at a more uniform rate. When analysing the kinetic constant K, the
inverse of K was plotted, as lower values of K indicated a more rapid rate of increase
of the stimulation ratio with time (Figure 4.1, Table 4.1 and Table 4.2).
A significant correlation between arachidonic acid and gamma-linolenic acid
concentration, asymptotic maximum (3 (p<0.001) and the rate constant k were
detected in the 38 samples analysed using multivariate ANOVA. An effect of fatty
acid type on the maximum stimulation (3 was also detected (p<0.003), with gamma-
linolenic acid being more active than arachidonic acid in stimulating tumour
peroxidation (Tables 4.1 and 4.2). The goodness of fit of this model was estimated
using the residual means squared value was r2=0.977±0.00469, range 0.837-0.998.
The rate of unstimulated 2',7'-dichlorofluorescin oxidation in these samples therefore
showed a good fit to equation 2. A compartmental model using equation 1 for the
initial t=0-200 second stage did not give a better fit to the unstimulated rate curve.
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Basal oxidative metabolism was analysed using equation 2. Dichlorofluorescein-
associated fluorescence was expressed as a proportion of initial cell associated probe
because deficits in tumour cell esterase activity compared with normal cells, which
may result in impaired cell loading of the probe, have been reported (Watson et al,
1978). The y axis intercept I at 200 seconds was used to analyse probe metabolism
and the rate constant a was used to investigate probe leakage from cells. The two
stimulation ratio kinetic constants (3 and k, and the unstimulated kinetic constants a
and I for each of the 38 cell preparations are shown in Tables 4.1 and 4.2. The
goodness of fit of this model was estimated by analysing the y axis intercept and the
residual means squared (r2). The y intercept i.e. the ratio of the
stimulated/unstimulated reactive oxygen intermediate production at t=0 seconds was
close to the predicted value of 1, being 1.019±0.0229 (mean± SEM of 38 data sets,
range 0.783-1.528). The residual means squared was r2=0.9719-0.00476 (mean± SEM
of 38 data sets, range 0.902-0.998).
(b) The Effect of Tumour Grade on Essential Fatty Acid Induced
Stimulation ofCellular Oxidation
A correlation was found betweenWHO tumour grade and the stimulation constant
(3, with high grade tumours generally exhibiting the highest overall level of cellular
oxidation in the presence of exogenous n-6 essential fatty acid (Figures 4.2 and 4.4).
This association was not linear, and was greatest in grade I-13I tumours (Figure 4.4).
The initial rate of essential fatty acid-mediated stimulation of oxidative activity,
which was proportional to 1/k, also tended to be greater in high grade tumours. These
observations suggest that high grade tumours are characterised by high sensitivity to
exogenous essential fatty acid stimulus.
The linear (Pearson) correlation coefficient between tumour grade and log(3 was 0.614
for the 12 grade I-III tumours analysed in this study. This was calculated by dividing
the stimulation constant (3 by essential fatty acid concentration. When the stimulus
concentration was not corrected, the correlation coefficient for tumour grade versus
log[3 was 0.543. The correlation coefficient between tumour grade and the rate
constant k was 0.408. This was also calculated by dividing k by stimulus
64
concentrations, as essential fatty acid concentration has been shown to influence the
kinetic rate constant k.
An increase in the variability of (3 was observed in high grade tumours. This may be
due to cellular heterogeneity, which increases with malignant progression of human
glioma. The oxidative responses measured in this study were those ofmixed cell
populations, and immunohistochemical analysis indicated a greater variability of cell
types present in tumours ofhigh grade. A significant inverse relationship between
tumour grade and propidium iodide permeability was also detected (Figure 4.4A).
This observation is consistent with histological features of these tumours, as areas of
necrosis are most commonly associated with grade IV tumours.
(c) Reactive Oxygen Intermediate Production in Normal and Tumour
Cells
Basal oxidative activity and sensitivity to exogenous arachidonic acid were analysed
in cell preparations obtained from 5 human primary gliomas and associated
peritumoural normal brain (Table 4.3). During each investigation, up to 95
measurements of basal and stimulated oxidative activity were made at 10 second
intervals in samples containing 5 000 or 10 000 cells. Basal oxidative activity was
significantly lower in tumour tissue in comparison with normal brain (Figure 4.3).
Differences were also observed between the responses of normal and tumour tissue to
exogenous essential fatty acid stimulation. The stimulation ratio of 71 paired 10 000
cell samples was significantly greater in tumour tissue following a 0-20 minute
incubation with arachidonic acid or gamma-linolenic acid (p<0.0000017). These
differential responses were detected in the initial phase of the stimulation curve (3-6
minutes), and also at the later phase (10-20 minutes) when most curves were
approaching their asymptotic maximum (3.
(d) Reactive Oxygen Intermediate Production in Necrotic and Viable
Tumour Cells
One glioblastoma sample received for analysis possessed a large visible region of
tumour-associated necrosis. The necrotic region was dissected, and used for analysis
of oxidative activity in the presence and absence of 12pM gamma-linolenic acid. A
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significantly lower rate of basal oxidation was observed for the dissected necrotic
region in comparison with viable tumour cells (pO.OOOl), and the stimulation ratio
was significantly higher in non-necrotic tissue. These differences were observed
throughout the course of the investigation (Figure 4.5).
(e) Cell Viability
Cell viability was determined using flow cytometric analysis ofPI uptake
immediately following analysis of oxidative activity. Mean viability±SEM of the 30
tumour cell preparations was 91.2±1.56% (Tables 4.2 and 4.3). This was not
significantly different from the viability of tumour cells incubated in the presence of
4-40pM arachidonic acid and gamma-linolenic acid (90.3±2.45%). Tissue storage did
not significantly increase cell permeability to propidium iodide. Mean viability of 25
tissue preparations analysed less than 24 hours following resection was 91.0±1.92%
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Figure 4.1. The rate of reactive oxygen intermediate formation in cells derived from
a glioblastoma tumour incubated in the presence (closed circles) or absence (open
circles) of 36pM sodium arachidonate, as measured by 2',7'-dichlorofluorescein
oxidation. The y-axis indicates mean 2',7'-dichlorofluorescein oxidation per cell at
515-545nm. Total cell fluorescence at 488nm was proportional to the mean cellular
















FA type |lM % V Days P K (/ I
AA 4 97.81 0.771 0 1 NA NA
AA 18 96.235 0.781 0.191 1.442 33.07 66.14
AA 18 94.81 3 0.4 0.0058 100 112.48
GLA 40 99.14 3 4.175 0.0071 100 112.74
AA 4 60.09 0.771 0 1 NA NA
AA 18 87.99 2 0.301 0.0049 61.47 90.3
AA 36 84.61 2 0.077 0.0084 98.21 114.18
AA 4 98.31 2.813 0.118 1 168.67 166.74
AA 18 93.27 3 1.198 0.0028 77.18 97.96
AA 18 70.28 0.104 0.583 0.0212 100 124.43
AA 18 86.99 0.781 0.062 0.0529 36.81 73.62
AA 18 96.53 0.781 0.074 0.008 52.82 80.23
GLA 12 91.06 3 0.449 1 40.34 72.41
GLA 27 97.98 1 2.143 0.0023 50.33 81.8
GLA 27 98.77 4 3.676 0.0013 97.45 104.49
GLA 40 95.45 3 5.746 0.0093 79.27 84.56
Table 4.1. Kinetic rate constants of oxidative metabolism in cells derived from
explants ofhuman primary gliomas. Column 1: grade: WHO grade I-III, 0=normal
brain, stimulated with either arachidonic acid or gamma-linolenic acid. Column 2:
fatty acid type. Column 3: fatty acid concentration (pM). Column 4: The overall
viability (%V) of cells acquired from tumour explants. Column 5: the period of
tissue storage in days in Hams F-10 medium. Columns 6 and 7: the kinetic rate
constants (3 and k of stimulated cells (see Figure 4.3). Columns 8 and 9: the kinetic




pM % V Days P K oC I
4 AA 4 84 1 0 0.0941 34.53 69.06
4 AA 18 87.36 0.7604 0.264 0.0178 126.15 135.17
4 AA 18 90.4 0.792 0.8 0.0004 141.97 142.52
4a AA 18 86.76 0.833 0.747 0.0036 100 199.17
4b : AA 18 93.76 0.833 0.838 0.0164 89.93 114.83
4 AA 18 94 0.9375 0.058 1 34.76 69.52
4e AA 18 95 0.8125 0.385 1 56.93 84.46
4f recurr AA 18 79.96 0.8125 0.468 0.0019 44.27 72.7
4 AA 18 98.08 1 0.485 0.0061 125.43 132.95
4c AA 18 98.81 1.03 0.102 1 41.13 82.26
4d stor AA 18 99.11 4.0313 0.436 0.0127 53.75 78.52
4 AA 36 93.86 0.948 0.75 0.0036 50.04 77.22
4a' GLA 12 92.17 1.885 1 0.0014 100 117.11
4b' necr GLA 12 94.65 1.885 1 0.0005 100 119.42
4 GLA 12 98.59 0.917 0.326 0.011 99.1 101.77
4 GLA 12 98.35 0.917 0.11 0.0132 100 115.77
4a GLA 20 83.99 0.125 0.127 0.0028 49.48 77.69
4b GLA 20 94.32 0.125 6.883 0.0001 100 123.83
4 GLA 20 97.69 1 0.622 0.0024 70.21 88.12
4a GLA 20 97.21 1 0.524 0.0095 100 123.12
4b GLA 20 97.72 1 0.556 1 82.88 95.8
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Figure 4.5. Comparison of the stimulation of reactive oxygen intermediate
formation in viable and necrotic regions of an explant ofglioblastoma
multiforme by the addition of 12pM gamma-linolenic acid at 270 seconds. The
rate of 2'7'-dichlorofluorescein formation is shown in black diamonds for the
viable cells and open squares for necrotic cells. Results are expressed as %
stimulation ofmean basal cell fluorescence.
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4.4 Discussion
This study describes oxidative metabolism in the presence and absence of arachidonic
acid and gamma-linolenic acid in 36 collagenase-dispersed explants of human
primary brain tumours. In each of the samples analysed, arachidonic acid and gamma-
linolenic acid rapidly increased intracellular reactive oxygen intermediate production
(Figure 4.1). The initial increase in peroxidation 0-200 seconds after addition of
arachidonic acid or gamma-linolenic acid was greater than any subsequent increase in
peroxidative activity, and in most tumour samples the rate of peroxidation approached
an elevated steady state after 10 minutes incubation (Tables 4.1 and 4.2). All the
tumour cell preparations analysed responded to exogenous arachidonic acid and
gamma-linolenic acid in a grade dependent manner, with high grade tumours tending
to have higher values of the asymptotic maximum P and the rate constant k. The
stimulation of reactive oxygen intermediate generation by arachidonic acid was
significantly greater in tumour tissue in comparison with normal human brain in the
five paired samples for which non-transformed tissue was available (p<0.0000017,
paired t-test, n=71).
In both normal and tumour tissue, the stimulation of reactive oxygen intermediate
formation was proportional to essential fatty acid type and concentration. Although
the kinetics of the reactive oxygen intermediate response to arachidonic acid and its
C18 precursor gamma-linolenic acid were similar, the extent of gamma-linolenic
acid-induced stimulation of reactive oxygen intermediate production was greater at
equimolar concentrations. This suggests that the ability of long chain PUFA to
stimulate reactive oxygen species formation is not proportional to hydrocarbon chain
saturation, and that essential fatty acids may potentiate glioma oxidative activity by
modulating molecular pathways other than lipid peroxidation.
In each of the thirty tumour preparations, the lower rate of reactive oxygen
intermediate production by necrotic cells was confirmed by sub-population analysis.
The laser scatter profile of necrotic cells is characterised by low forward angle and
right angle light scatter. A significantly (p<0.0001) lower response was obtained
when necrotic cells of a mixed tumour population were gated (see also Chapter 5). An
association was also observed between cell membrane permeability and tumour grade
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with grade IV tumours exhibiting greater membrane permeability to vital dyes. This
correlates with histochemical features used in the diagnosis ofmalignant gliomas, as
glioblastoma is characterised by areas of focal necrosis.
Evidence for an anti-proliferative effect of exogenous gamma-linolenic acid at the
concentrations used in this study has been demonstrated in a number of tumour types
(Karmali et al, 1985, Begin et al, 1986, Hyashi et al, 1990 and Pritchard and Mansell,
1990). Although the pathways by which arachidonic acid and gamma-linolenic acid
exert their tumour cell toxicity are poorly characterised, there is evidence that reactive
oxygen intermediates can diffuse rapidly across membranes during lipid peroxidation
(Slater, 1984a and 1984b) and that the metabolic flux of arachidonic acid and gamma-
linolenic acid in membranes is involved in cell signalling and cell death (Merrill and
Schroeder, 1993 and Leaver et al, 1995). This may involve modulation of the activity
of the transcription factors NF-k(3 and bcl2 associated pathways (Abate et al, 1990,
Schreck et al, 1992 and Kane et al, 1993). In addition, arachidonic acid directly
activates c-jun, resulting in cellular apoptosis (Rizzo and Carlo-Stella, 1996), and p53
involvement in reactive oxygen intermediate metabolism has recently been
demonstrated (Polyak et al, 1997). However, additional studies are required to further
characterise the molecular events associated with essential fatty acid-mediated
induction of tumour cytotoxicity.
4.5 Conclusions
The results of this study support the hypotheses that i) reactive oxygen intermediate
generation is impaired in human malignant glioma in comparison with associated
normal brain and that ii) exogenous arachidonic acid and gamma-linolenic acid
stimulate glioma peroxidative activity. Analysis of tumour-associated normal brain
indicated that human glioma tissue was characterised by low basal oxidative activity
and high sensitivity to exogenous essential fatty acid stimulus in comparison with
non-transformed cells. Reactive oxygen species formation in the absence of
arachidonic acid or gamma-linolenic acid was significantly lower in tumour tissue in
each of the 5 samples available for analysis. Although both normal and tumour cells
responded to exogenous essential fatty acid stimulus with increased reactive oxygen
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species formation, this increase was significantly greater in cells derived from
transformed tissue (p<0.0000017).
The magnitude of essential fatty acid-mediated stimulation of glioma oxidative
activity was a function of tumour grade, with more malignant tumours responding
with higher sensitivity to exogenous n-6 essential fatty acids. Both the rate (defined
by the constant k) and extent (defined by the asymptotic maximum (3) of stimulated
oxidative metabolism were greater in high grade tumours, although this association
was not linear for (3. The kinetics of oxidative metabolism observed in response to
exogenous arachidonic acid and gamma-linolenic acid were similar, although gamma-
linolenic acid was the more potent agonist at equimolar concentrations. Neither
arachidonic acid nor gamma-linolenic acid was associated with loss of cell membrane
permeability at the concentrations used in this study.
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Chapter 5:
The Stimulation of Reactive Oxygen Intermediate Production in
Glioma Populations by Arachidonic Acid and Gamma-Linolenic
Acid
5.1 Introduction
The purpose of this study was to provide preliminary information on the flow
cytometric characteristics and oxidative activities of human glioma sub-populations.
Sub-populations were selected on the basis of their forward scatter, which is
proportional to cell size, and side scatter, which is proportional to granularity which
is related to DNA content. These regions were analysed in terms of i) basal oxidative
activity, ii) oxidative activity following stimulation by exogenous arachidonic acid
and iii) propidium iodide permeability. Following this analysis, additional studies
were undertaken to investigate the oxidative activity of cells of glial origin present in
tumour biopsy samples. This was achieved using flow cytometric analysis ofGFAP
distribution.
This sub-population analysis was undertaken because it is known that glial tumours,
particularly those of high grade, are characterised by cellular heterogeneity (Figure
5.1) (Darling, 1990 and Thomas and Graham, 1995, Chapter 1). This heterogeneity
is due in part to pathological processes associated with malignant progression, for
example cellular dedifferentiation, angiogenesis and necrosis (Greaber et al, 1996
and Louis, 1997). Additionally, glial tumours rapidly invade surrounding normal
brain, resulting in diffuse boundaries between neoplastic and non-neoplastic tissue
(Turazzi and Licata, 2000). For these reasons, cell preparations derived from biopsy
specimens contain varying proportions of tumour cells at various stages of
dedifferentiation, normal brain cells, erythrocytes, reactive and non-reactive
leukocytes, blood vessel endothelium and tumour cells characterised by low viability
(Darling, 1990, Thomas and Graham, 1995, Chapter 1 and Berens and Giese, 1999)
(Figure 5.1).
Although the cellular heterogeneity of human glioma is well established, the various
cell types present in primary tumour samples have not been studied extensively
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using flow cytometry. However, these considerations are important as the sensitivity
of individual reactive populations to exogenous n-6 essential fatty acids will
contribute to the overall level of reactive oxygen species formation observed. These
investigations were undertaken to provide further information on the dynamics of
reactive oxygen species formation in human glioma tissue. Analysis of the glioma
sub-population characterised by GFAP-positivity was undertaken to test the
hypothesis that malignant glial cells are characterised by impaired basal reactive
oxygen species formation, but high sensitivity to exogenous arachidonic acid and
gamma-linolenic acid.
Preliminary observations indicated that unlike the phagocyte preparations analysed
in Chapter 3, cells derived from glioma explants were not sorted into discrete sub-
populations. In addition, variability of cellular composition meant that a cell
population which occurred in an individual tumour did not necessarily occur in all
glioma preparations. It was therefore necessary to select tumours whose laser scatter
profiles were similar, so that gates selected for one tumour could readily be applied
to the others being investigated. This selection provided 5 glioblastomas (including 1
which had recurred), and 1 anaplastic oligidendroglioma and 1 pilocytic
astrocytoma. These tumours had all been treated with 18 or 36pM arachidonic acid,
and their oxidative activity had been analysed at similar time intervals.
A total of 6 populations were analysed in each of these tumours, including a region
along the x=y gradient characterised by low to medium forward and side scatter
(Gl), a region of low side scatter which occurred below this main population (G2), a
region of high side scatter and medium forward scatter (G3), a region ofmedium
forward and side scatter (G4) and cells possessing very high forward and side scatter
(G5). In addition, a region close to the origin was selected (G6) (Figure 5.2).
Linear regression models were then used to define the following parameters: i) the
rate constant k, ii) the asymptotic maximum p, iii) basal oxidative activity, iv) %
stimulation of reactive oxygen intermediate generation and v) the rate ofprobe
efflux. The rate ofprobe influx was compared with the influx of the viability probe
propidium iodide. Unlike the analysis of cellular oxidation in ungated glioma
preparations (Chapter 4), it was not necessary to use complex statistical analysis in
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this study. This was due in part to the relatively small population size and the more
heterogeneous nature of the cell populations being investigated.
Analysis of the oxidative activity of cells of glial origin present in tumour biopsy
samples was achieved using flow cytometric analysis ofGFAP distribution. The sub-
population of cells expressing GFAP was identified in ethanol-fixed cell
preparations acquired from 17 tumours grades I-IV by i) the binding of a polyclonal
anti-GFAP antibody and ii) the high forward angle and high side angle laser scatter
characteristic of differentiated cells. This GFAP-positive cell population was gated
and the stimulation of reactive oxygen intermediate generation in response to n-6
essential fatty acid was analysed in fresh cells.
GFAP was used in these studies because it is a well characterised astrocytic marker
(Debus et al, 1983, Miettinen et al, 1984, Coakham et al, 1985 Garson et al, 1985
and Royds et al, 1986) with an established role in the routine diagnosis of the biopsy
samples which were analysed for oxidative activity (Chapter 4). The previously
established record ofGFAP immunoreactivity made it possible to ensure that all the
samples selected for flow cytometric analysis were GFAP-positive. This was
necessary because of an important disadvantage of this marker, namely that it may
not be present in all astrocytic tumours. This is particularly so for those characterised
by a high degree of cellular dedifferentiation (Kurpad et al, 1994).
Other well established astrocytic markers are S-100 protein and vimentin. Vimentin
is an intermediate filament protein found predominantly in immature glia (Yang et
al, 1994). S-100 protein is a highly acidic protein which is also localised primarily in
glial cells, although some may be present in neuronal nuclei or the plasma membrane
(Moore, 1982). Vimentin and S-100 protein possess all the disadvantages associated
with GFAP, and are less commonly used in routine diagnosis. Other tumour
markers, e.g. nuclear proliferation markers (BrdU, PCNA, MIB-I), growth factors
(EGF) and oncogene and tumour suppressor gene products (bcl2 and p53) have
limited value in predicting clinical outcome, and cannot be correlated precisely with
WHO tumour type and grade ofmalignancy (Kurpad et al, 1995, Stemmer-
Rachamimov and Louis, 1997, McKeever, 1998, Grzybicki and Moore, 1999,
Morrison and Prayson, 2000 and Reavey-Cantwell et al, 2001).
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The lack of specific markers for malignant astroglial cells remains an important
problem in neuro-oncology research (Yang et al, 1994, Kurpad et al, 1995, Stemmer-
Rachaminov and Louis, 1997 and Grzybicki and Moore, 1999). Despite recent
advances in the profiling of gene expression and monoclonal antibody technology,
little progress has been made in elucidating molecular markers of glioma diagnosis
and prognosis (Kurpad et al, 1995 and Grzybicki and Moore, 1999). One exception
may be the intermediate-filament-associated protein IFAP-300KDa (Yang et al,
1994). An immunofluorescence study has indicated that IFAP-300KDa is detectable
in all astrocytic tumours, but not normal mature or reactive astrocytes. This protein
may therefore represent a specific marker for transformed astrocytes, and it may
have a role in subsequent characterisation of the tumour sub-population.
Figure 5.1. A histological section of glioblastoma showing regions of cellular
heterogeneity. Apoptotic nuclei are visible in the viable glioblastoma tumour cells
adjacent to an area of necrosis (right). Haematoxylin and eosin x200.
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5.2 Materials and Methods
(a) Characterisation of Typical Laser Scatter Profiles
Tumour sub-population analysis was conducted retrospectively from stored data
which was acquired during investigation of glioma oxidative activity (Chapter 4).
(b) Characterisation of the GFAP-Positive Population
(i) Monoclonal GFAP Staining
Ethanol-preserved glioma cells were washed, resuspended at a density of lxl06
cells/ml and incubated with monoclonal rabbit anti-cow GFAP diluted 1:5, 1:10 and
1:20 in distilled water. The cells were incubated at room temperature for 30 minutes,
centrifuged, resuspended in phycoerythrin diluted 1:10 in distilled water and
incubated at 4°C for 2 hours. GFAP-positive cells were identified using flow
cytometry (Section 2.5a).
(ii) Polyclonal GFAP staining
lml aliquots of ethanol preserved cells were washed and incubated for 2 hours with
anti-GFAP-FITC at dilutions 1:5, 1:10 and 1:20. The cells were centrifuged and
resuspended for flow cytometry at 564-607nm using a Becton Dickinson FACScan
flow cytometer and LYSIS software (Section 2.5b).
(c) Statistical Analysis ofHuman Glioma Sub-Population Oxidation
Basal oxidative activity in human glioma sub-populations was analysed using the
equation:-
ABF(0_2oo) - ABF(20o-4oo) xlOO (Equation 1)
where ABF=the change in mean basal 2',7'-dichlorofluorescein-associated
fluorescence over the time periods shown (in seconds) as subscripts in parentheses.
For each determination ofmean basal fluorescence over a 200 second interval, 6-10
values ofmean 2',7'-dichlorofluorescein-associated fluorescence were used. The
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rate of decrease of 2',7'-dichlorofluorescein-associated cellular oxidation gave an
indication of the rate of probe efflux and hence loss ofmembrane permeability. This
was compared with the extent of influx of the viability probe propidium iodide
(Section 2.4c).
The rate of increase of cellular oxidation in human glioma sub-populations
following the addition of exogenous arachidonic acid was analysed using the
equation:-
AF(o-2oo) -AF(200-400) /AF(0-200) x 100 (Equation 2)
where AF=the mean % increase in 2',7'-dichlorofluorescein-associated fluorescence
over the time periods shown in parentheses. Arachidonic acid was added at t=0.
Further determinations of the increase in reactive oxygen intermediate generation
every 200 seconds for up to 1 200 seconds were made if possible. The SEM of all
determinations was calculated in analysis of both basal and stimulated reactive
oxygen intermediate generation (Sections 2.4c).
5.3 Results
(a) Analysis Tumour Sub-Population Oxidative Activity
The six regions selected for analysis are shown in Figure 5.2 and their fluorescence
distribution profiles in Figure 5.3. Their responses to exogenous essential fatty acid
stimulus are described in Figure 5.4, Table 5.1 and Table 5.2. Sub-population
analysis of cell membrane permeability is shown in Table 5.3, and the rate of probe
efflux is described in Table 5.4. The morphological and oxidative characteristics of
human glioma sub-populations are discussed in Section 5.3b.
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Figure 5.2. Dot plot of cells derived from a collagenase dispersed explant of human
glioblastoma multiforme. Cells are separated on the basis of forward scatter (FCS)
(x-axis), which is proportional to cell size, and side scatter (SSC) (y-axis), which is
proportional to granularity. Similar regions were selected for an additional four
glioblastoma tumours, one anaplastic astrocytoma and one pilocytic astrocytoma.
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Figure 5.3. Fluorescence intensity distributions for the tumour sub-populations
described by gates 1-6 in Figure 5.2. The y-axis indicates 2'7'-dichlorofluorescein-
associated fluorescence, which is proportional to cellular peroxidation, and the x-
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Figure 5.4. Rate curves describing the stimulation ratio of cellular peroxidation by
36pM arachidonic acid in human glioma sub-populations. The stimulation profiles
shown for gates 1 to 6 indicate the oxidative responses of cells gated by the laser
scatter regions illustrated in Figure 5.2. No significant stimulation of cellular



















200 400 600 000
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diaanosis reaion time (s) time <s)
0-200 200-400
mean SEM mean SEM
astro. G1 103.1946 0.023451 103.5295 0.083818
(grade 1) G2 106.4201 1353483 100.1448 2.545388
G3 98.90995 1.241533 99.10099 4.123364
G4 114.7819 2.518534 119.3178 3.198115
G5 101.9837 3.3085 110.5634 3.562616
G6 103.3532 -0.02854 103.8153 1.109435
mean SEM mean SEM
AA G1 100.8479 -1.38526 102.4207 1.217805
(qrade II) G2 1C3.S893 1.428315 109.0909 1.55499
G3 99.93717 1.83443 98.7568 3.900485
G4 105.8254 1.623941 105.1085 2.594544
G5 115.1428 1.587672 113.6377 2.783379
G6
mean SEM mean SEM
GBM G1 118.949 3.055285
(qrade IV) G2 117.8698 3.206817 154.9604 3.85537
G3 122.3102 1.980024 128.289 1.208461
G4 123.2211 16.68486 127.8485 10.33746
G5 98.98336 14.86495 110.2033 8.461848
G6 115.0281 2.941634 137.3116 3.915765
mean SEM mean SEM
GBM G1 100.6305 -0.42859 107.2163 1.610611
(grade IV) G2 107.8161 2.817088 113.6984 3.233605
G3 105.58 1.464795 111.5144 2.86143
G4 103.2048 3.517723 116.0883 4.323675
G5 113.1336 12.34382 113.3629 18.58938
G6 98.3345 -0.51521 106.1528 0.835862
mean SEM mean SEM
GBM G1 120.0262 1.014269 145.4456 2.424145
(grade IV) G2 117.631 5.261634 153.3514 3.985527
G3 120.546 7.747371 134.3915 4.304141
G4 115.4541 7.284966 126.348 6.210505
G5 202.0921 19.33363 219.0529 15.96918
G6 119.9983 1.471631 147.726 1.683237
mean SEM mean SEM
GBM G1 115.0677 3.586096 119.4991 1.874596
(grade IV) G2 115.077 4.151504 123.7289 6.852435
G3 124.2637 10.07214 136.8946 6.0168
G4 147.266 8.521032 149.968 7.652833
G5 107.5625 4.856717 125.5983 1.14844
G6 109.0644 2.008869
mean SEM mean SEM
GBMrecurr G1 110.8598 1.247929 118.3283 -0.02905
(grade IV) G2 123.1584 5.604772 146.3973 5.363785
G3 120.8266 4.294948 149.1854 ! 2.945346
G4 128.5069 0.999287 115.3945) 6.39961
G5 152.8398 22.29511 207.1123 I 21.85634
G6 !
Table 5.1. Sub-population analysis of arachidonic acid-mediated stimulation of
reactive oxygen intermediate generation in the seven samples of human gliomas
grades I-IV using equation 2. Results were calculated as mean percent stimulation of
2'7'-dichlorofluorescein-associated fluorescence over the time periods 0-200
seconds, 200-400 seconds and 400-600 seconds for each sub-population (gates 1-6)




TIME fsl m GATE 1 GATE 2 GATE 3 GATE 4 GATE 5 GATE 6
0-200 mean 0.145822 0.192328 0.04363 0.12358 0.086534 0.168675
SEM 0.035443 0.049153 0.034106 0.052914 0.022709 0.029032
n 5 5 5 5 4
200-400 mean 0.03564 -0.05984 0.082228 -0.04377 0.136332 -0.01149
SEM 0.028736 0.06627 0.043636 0.051911 0.174125 0.030942
n 4 5 5 5 5 4
Table 5.2. Stimulation of reactive oxygen intermediate formation in 4 explants of
human glioblastoma by 18gM arachidonic acid at 0-200 seconds, 200-400 seconds
and 400-600 seconds in the cell sub-populations described by gates 1-6 in Figure
5.2. AF1 indicates the increase in 2'7'-dichlorofluorescein-associated fluorescent
Results are expressed as the mean ±SEM
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diaanosis reaion tlmefs) ! Kiiiiini
0-200 I 200-400
mean SEM mean SEM
astro. G1 0.054576 0.04374 0.065719 -0.46821
(grade 1) G2. 0.097778 107392128 i 0.143753 i-0.39998 |
G3 10.012988 0.14734 i 0.098002 0.078515
G4 0.112528 -0.23839 0.11314 0.477271
G5 0.021569 0.196143 ;0.104159 -0.6624
G6 10.043409 -0.16825 , 0.055064 0.157876
I I
I mean SEM I mean SEM
AA G1 0.00249 0.122073 |-0.00499 -0.66559
(qrade II) G2 -0.0023 0.414722 i0 0.261451
G3 -0.02253 -0.09224 0.015198 0.011119
G4 -0.01675 -0.31143 0.05906 0.407942
G5 0.005209 -0.09411 -0.05246 -1.31981
G6 -0.0075 -0.92154 1-0.00186 0.14001
i
mean SEM I mean SEM
GBM G1 0.196197 -0.55608 I
(qrade IV) G2 0.208433 -0.10157 10.208232 0.17403
G3 0.225658 10.300236 10.134088 0.162519
G4 -0.12626 1-1.25082 10.178815 -0.01972
G5 -0.50092 I-0.33C39 10.127401 0.567403
G6 0.160099 1-0.06181 10.129766 0.54781
I
mean SEM | mean SEM
GBM G1 0.07396 1-0.18457 i 0.058401 -0.03284
(grade IV) G2 0.163628 10.09738 10.1834 0.515198
G3 0.127864 -0.13268 0.101252 0.157431
G4 0.092031 0.25103 0.121343 0.063568
G5 -0.20051 -0.15537 0.188992 0.166304
G6 0.060968 -0.15383 0.07708 0.119766
mean SEM mean SEM
GBM G1 0.090211 0.515517 10.057866 -0.17932
(grade IV) G2 0.010924 0.097557 [0.062514 -0.57457
G3 0.086132 -0.64214 0.01122 -0.56492
G4 -0.00013 0.163884 i 0.001277 0.070949
G5 0.186128 -0.09321 0.186224 0.367297
G6 0.087107 -0.16 0.054903 -0.00803
mean SEM I mean SEM
GBM G1 0.046674 -0.32617 I 0.049572 0.347764
(grade IV) G2 0.043758 0.262472 I -0.04702 0.03893
G3 -0.10337 -0.16746 | 0.088956 0.122716
G4 1-0.16547 0.12696 | 0.08759 -0.01114
G5 10.091355 0.145202 i 0.102549 -0.11102
G6 109.0644 | 2.008869 I
!
mean | SEM i mean SEM
GBMrecurr G1 0.017325 -0.84011 I 0.111042 0.537366
(grade IV) G2 0.17606 0.184007 I 0.181325 0.34312
G3 0.127174 0.240625 I 0.14176 0.453791
G4 0.018799 -0.37522 0.070577 -0.09006
G5 0.089455 0.456672 -0.13163 -0.44659
' ! G6 1 -3.9 -277.03 I 0.815537 0.99635
Table 5.3. Sub-population analysis of cell membrane permeability in the seven
samples ofhuman primary glioma grades I-IV using equation 1. Results were
calculated as the mean decrease in 2'7'-dichlorofluorescein-associated fluorescence
over the time periods 0-200 seconds and 200-400 seconds for each sub-population
(gates 1-6) indicated in Figure 5.2. using equation 1. Results are expressed as the
mean±SEM. astro=astrocytoma, G=gate.
time (5) ae1 gate 1 GATE 2 GATE 3 GATE 4 GATE 5 gate 6,
0-200 mean -0.08478 -0.12056 -0.09269 0.036206 0.066896 0.898
SEM -0.08487 0.034972 0.04841 0.042704 0.113092 0.866794
(n) 5 5 5 5 5 4
200-400 mean -0.06922 -0.11769 -0.09546 -0.09192 -0.09471 -0.26932
SEM 0.012199 0.043239 0.020792 0.026159 0.052772 0.158265
(n)
400-600 mean -0.03885 -0.09922 -0.0266 -0.04971 -0.03306 -0.03906
SEM 0.017225 0.023257 0.028358 0.008944 0.054922 0.003592
(n) 3 4 4 4 4 3
Table 5.4. Rate ofprobe efflux in 4 explants of human glioblastoma multiforme at
0-200 seconds, 200-400 seconds and 400-600 seconds in the cell sub-populations
described by gates 1-6 in Figure 5.2. AF1 indicates the change in 2'7'-
dichlorofluorescein-associated fluorescence in the absence of exogenous essential
fatty acid stimulus. Results are expressed as the mean ±SEM.
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(b) Morphological and Oxidative Characteristics ofHuman Glioma
Sub-Populations
Gate 1: In each of the tumours analysed, the largest sub-population was represented
by region 1. This region lay along the x=y gradient, and was characterised by low to
medium forward and side scatter. Smaller sub-populations gated within G1 were did
not possess normal fluorescence distributions, indicating the overall heterogeneity of
cells within this region. However, it was observed that as individual regions selected
within G1 moved further along the x=y gradient away from the origin, basal
oxidative activity, essential fatty acid sensitivity and sub-population homogeneity
increased.
Gate 2: The cell population defined by G2 was characterised by low forward and
side scatter, and occurred slightly below the largest cell population Gl. Low values
of forward and side scatter are characteristic of small size and low DNA content
respectively. Although it is not possible to accurately identify this population, it is
possible that cells within this region represent red blood cells, as this would be
consistent with the morphological properties described above. Additional evidence
supporting the hypothesis that these cells may represent tumour-associated
erythrocytes was acquired from flow cytometric analysis of high grade tumours.
When the laser scatter profiles of glioblastoma explants possessing macroscopically
visible erythrocyte contamination were compared with those of low grade
astrocytomas free from ertythrocyte contamination, a cell population was observed
in the high grade tumour whose morphological characteristics were similar to those
observed in G2: both these populations were characterised by low forward and side
scatter, and both had low basal oxidative activity and sensitivity to exogenous
essential fatty acid stimulus. Preliminary investigations also suggested that the
occurrence of this population increased with tumour grade. This is consistent with
the observation that malignant progression is associated with the local release of
angiogenic factors which increase vascular proliferation.
Gate 3: The cells in region 3 were characterised by high side scatter and low to
medium forward scatter. Again, it is not possible not possible to accurately identify
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this population, however, it is possible that this region represents polymorphonuclear
leukocytes. These cells are characterised by high granularity, and previous studies
indicated that these cells respond to exogenous n-6 essential fatty acids with
increased reactive oxygen species formation (Chapter 3).
Additionally, it was demonstrated in Chapter 3 that leukocytes are activated by
surgery. Consequently, the relatively high level basal oxidative activity observed in
this sub-population may represent lymphocyte activation following glioma resection.
These changes may also be due to local inflammatory reactions associated with
tumour proliferation. However, further studies are required to confirm the identity of
this population.
Gate 4: Gate 4 was characterised by high side scatter which separated it from the
largest cell population Gl, however, it was more difficult to distinguish this
population from G3 and also from the large cells occurring in G5. Cells in G4 were
characterised by low basal oxidative activity, low membrane permeability and high
sensitivity to exogenous arachidonic acid. At concentrations of arachidonic acid and
gamma-linolenic acid greater than 12p,M, the stimulation profile of this population
tended to follow linear kinetics.
Gate 5: The highest level of basal oxidative activity occurred in the relatively
diffuse gate 5, which was characterised by large cells which possessed high forward
and side scatter. This population also responded with increased reactive oxygen
intermediate production to exogenous n-6 essential fatty acid stimulus. Although the
relatively small number of cells in this population precluded further detailed sub-
population analysis, there was limited evidence that basal oxidation became lower as
side scatter was reduced, and that this was associated with an increase in sensitivity
to exogenous arachidonic acid.
Gate 6: The population closest to the origin had the lowest basal oxidative activity
and essential fatty acid sensitivity of all the populations studied, and analysis of the
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propidium iodide permeability of the cells in this region suggested significant loss of
membrane integrity. As the laser scatter profile ofmacroscopically necrotic tissue
demonstrates that a high proportion of the cells analysed in this preparation were
located towards the origin, it was concluded that this region is likely to represent
non-viable cells and cell debris resulting from mechanical damage during tissue
preparation.
(c) Characterisation of the Oxidative Response of the GFAP
Positive Population
When ethanol-preserved human glioma preparations were labelled with monoclonal
GFAP, the proportion of GFAP-positive cells was typically less than 5% of the total
cell population. A normal distribution of GFAP-associated fluorescence was not
observed, and the kinetics of reactive oxygen species formation in GFAP-positive
cells was characterised by high scatter. In contrast, GFAP positivity was expressed in
up to 15% of cells when polyclonal GFAP was used. These differences may have
been due to higher affinity of the polyclonal antibody for GFAP epitopes, or the
presence of larger numbers ofpolyclonal GFAP binding sites. For these reasons,
polyclonal GFAP staining was used in all subsequent analyses ofGFAP positivity
and oxidative activity.
The sub-population of cells expressing GFAP in ethanol-fixed cell preparations was
characterised by i) the binding of anti-GFAP antibody and ii) high forward and side
scatter which characteristic of differentiated cells (Figure 5.5 and Table 5.5). This
GFAP-positive cell population was gated, and used to identify a similar region in
fresh cells derived from the same tumour. The kinetics of reactive oxygen
intermediate generation in this sub-population was analysed in the presence and
absence of exogenous n-6 essential fatty acid.
The GFAP-positive cells responded with high sensitivity to exogenous essential fatty
acid stimulus, with the mean increase in 2'7'-dichlorofluorescein-associated
fluorescence being greater than that of the ungated population (Figures 5.6).
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However, the kinetics of this increase in oxidative activity were not described well
by linear statistical models. This is a characteristic of heterogeneous cell
populations, and it is possible that the GFAP-positive population represents a
mixture of untransformed glial cells (possibly reactive astrocytes), and tumour cells
with varying GFAP expression. The wide distribution of reactive oxygen
intermediate within this sub-population may also be the result of the relatively small
population size: approximately 125 cells/sample were present in the GFAP positive
population compared with 5 000 cells in the ungated tumour population (Table 5.5).
There was evidence that GFAP expression was a function of tumour grade, however,
this association was not linear (Figure 5.7). Highest GFAP positivity was observed
in grade III tumours and lowest in grade II tumours. The low expression ofGFAP in
glioblastoma tumours may be due to loss ofglial phenotype resulting from cellular
dedifferentiation. Tumours analysed flow cytometrically for GFAP expression were
also analysed using immunohistochemistry, and a correlation was observed between
the GFAP staining intensity characterised by these two methods. However,
numerical analysis of this association was difficult because of cellular heterogeneity
and regional variation characteristic of these tumours.
GFAP positivity was also observed in the very large cells occurring in G5, and
regions ofG3 and G4 with high side scatter and intermediate forward scatter.
Morphologically similar cell types were observed on laser scatter profiles of
macroscopically normal brain, suggesting that these cells may represent
untransformed neurones and glia. Additionally, cells in this region were
characterised by lower granularity than those thought to represent malignant tumour,
suggesting lower DNA content.
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Figure 5.5. Flow cytometric analysis ofpolyclonal GFAP expression in a
collagenase-dispersed explant of human glioblastoma. GFAP positivity is
analysed in the ungated population (page 96) and in the populations expressing
high (Gl) (diagram 1 page 97) and intermediate (G2) (diagram 2 page 98)
GFAP/FITC-associated fluorescence. GFAP positivity was analysed using
FITC-conjugated polyclonal GFAP at dilutions 1:5, 1:10 and 1:20. Control

































































































































































































































































Table 5.5. Summary ofGFAP positivity in populations expressing high (Gl) and
intermediate (G2) GFAP/FITC-associated fluorescence. 5 000 cells were analysed at
each determination ofGFAP expression in the ungated tumour population (WP).
Oligoastro-oligoastrocytoma, gem. astro.-gemistocytic astrocytoma, AO-anaplastic
































Figure 5.6. The stimulation of reactive oxygen intermediate formation in an explant
of collagenase dispersed human ependymoma, WHO grade III, and a GFAP-positive
sub-population. Graph A shows the forward (x-axis) (FSC) and side scatter (y-axis)
(SSC) cytogram of the whole tumour population and G1 represents a cell population
with high GFAP expression. The mean stimulation ratio of reactive oxygen
intermediate formation by 27|aM gamma-linolenic acid (added at 120 seconds) is


































Figure 5.7. Flow cytometric comparison of the cell numbers exhibiting high
GFAP/FITC-associated fluorescence (as indicated by gate 1 in Figure 5.5) in
collagenase dispersed explants ofhuman primary gliomas grades I-IV. Cells were
incubated with polyclonal GFAP at dilutions 1:5 (black diamonds) and 1:10 (black
squares) and analysed on a Becton Dickinson FASCsan flow cytometer. 5 000 cells
were analysed at each determination ofGFAP positivity.
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5.4 Discussion
The characterisation of total glioma reactive oxygen intermediate generation in the
presence and absence of exogenous arachidonic acid and gamma-linolenic acid was
described in Chapter 4. However, the oxidative activity of the tumour cell
preparations observed in vitro were those ofmixed cell populations containing
differing proportions of transformed glial tissue at varying stages dedifferentiation,
erythrocytes, leukocytes, normal brain and vascular endothelium. The purpose of this
study was to carry out preliminary differentiation between various cell types present
in human glioma explants, and to characterise them in terms ofbasal oxidative
activity, essential fatty acid sensitivity and cell membrane permeability.
Preliminary investigations confirmed the heterogeneity of the human glioma
preparations analysed for oxidative activity. The variability of cellular composition
generally increased with tumour grade, and this observation correlates with the
occurrence of known diagnostic indicators (Darling, 1990, Thomas and Graham,
1995, Chapter 1, Berens and Giese, 1999 and Turazzi and Licata, 2000). Rapid cell
division results in high metabolic demand, which may induce necrotic cell death in
areas of the tumour exposed to unfavourable diffusion gradients for oxygen and
nutrients. Consequently, clonal selection may result in the emergence ofhypoxia
resistant, highly malignant cells, facilitating more aggressive tumour growth
(Graeber et al, 1996 and Louis, 1997). In addition, there is evidence that hypoxia is
associated with the release of angiogenic factors, in particular vascular endothelial
growth factor (VEGF), which results in endothelial proliferation (Louis, 1997).
Unlike the flow cytometric analysis of lysed whole blood, where lymphocytes were
distributed in distinct populations of known size and granularity (Chapter 3, Figure
3.1), human glioma cell populations were less discrete. Overlap occurred between
the sub-populations representing the various cell populations present in human
glioma, and individual cell types could not be distinguished easily. Despite these
difficulties however, the regions described by gates 2, 3, 5 and, to a lesser extent 4,
were characterised by normal distributions of fluorescence intensity. This suggested
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that homogeneous cell populations occurred within these regions. In comparison, the
cells which possessed intermediate values of forward and side scatter in gate 1 could
not be completely resolved due to population heterogeneity.
Different rates of basal reactive oxygen species generation were observed in each of
the cell populations investigated, and these differences were consistent with the
hypothesis that reactive oxygen intermediate generation is low and essential fatty
acid sensitivity is high in tumour tissue. Analysis of the laser scatter profiles of
macroscopically normal brain indicated that the cells present in G5 were most likely
to represent non-malignant brain tissue, while the cells present in G4 were thought to
represent malignant glioma cells. This was due to their GFAP-positivity and high
side scatter, which is indicative of elevated DNA content. In comparison with the
cells present in the G5 region, G4 cells possessed lower basal oxidative activity.
However, both G4 and G5 cells responded with increased formation of reactive
oxygen intermediates following the addition of exogenous n-6 essential fatty acids.
The morphological properties of other cell populations were investigated, and
preliminary conclusions were made concerning their possible identity. The laser
scatter profiles of i) a glioblastoma tumour with macroscopically visible erythrocyte
contamination, ii) tumour associated necrotic tissue and iii) peripheral leukocyte
preparations assisted in the identification of red blood cells, non-viable cells and
reactive immune cells. It was concluded that these populations may be represented
by G2, G6 and G3 respectively. The high level ofbasal oxidative activity observed
in G3 may represent lymphocyte activation through surgery or local inflammatory
changes associated with glioma pathogenesis, as similar observations were made in
lymphocyte preparations acquired from patients undergoing pulmonary resection
(Chapter 3). However, additional studies are required to confirm the identity of these
and other tumour-associated cell populations.
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5.5 Conclusions
This study has confirmed that the human glioma explants analysed for oxidative
activity are characterised by cellular heterogeneity. Preliminary analysis indicated
that some of the glioma cell populations indicated by flow cytometric analysis may
represent red blood cells, tumour-associated lymphocytes and necrotic tissue, as the
morphological and oxidative characteristics of these populations correlated with
those acquired from analysis of known tissue samples.
This study also identified a group of cells which may represent malignant glioma.
These cells were characterised by high side scatter, which suggests abnormal DNA
content, and GFAP positivity, which is indicative of a glial phenotype. These cells
were present in regions G4, G5 and, to a lesser extent G3. The cells in these regions
responded with increased reactive oxygen species generation following stimulation
by exogenous essential fatty acids, suggesting that at least one GFAP-positive sub-
population is characterised by essential fatty acid sensitivity. Additional studies are
required to confirm the identity of this and other reactive cell populations, and to




The Stimulation of Apoptotic Activity in Human Glioma and the
Rat C6 Glioma Cell Line by Arachidonic Acid and Gamma-
Linolenic Acid
6.1 Introduction
The purpose of this study was to provide evidence supporting the hypothesis that the
stimulation of reactive oxygen species formation in human glioma tissue (which was
demonstrated in Chapter 4) has biological significance. This was undertaken by
analysing human glioma cell death following administration of arachidonic acid and
gamma-linolenic acid at concentrations previously shown to stimulate glioma
oxidative activity. Specifically, this investigation i) characterised the pro-apoptotic
activities of arachidonic acid and gamma-linolenic acid in collagenase-dispersed
human glioma tissue, ii) examined the kinetics of this pro-apoptotic activity, iii)
investigated differences in sensitivity to the pro-apoptotic activities of n-6 essential
fatty acids between tumours ofdifferent grades, and tumour-associated normal brain
where available and iv) correlated endogenous endonuclease activity with cell
membrane permeability.
The stimulation of apoptotic activity by arachidonic acid and gamma-linolenic acid in
human glioma tissue was undertaken to provide further information on the poorly
characterised mechanisms underlying essential fatty acid-mediated potentiation of
glioma cell death. The study of tumour cell death is of clinical importance because
although traditional cancer therapy was developed largely on attempts to limit the
rate of cell proliferation, more recent evidence suggests that tumours may also have
deficits in the control of cell death (Graeber et al, 1996, Malcomson et al, 1996 and
Novelli et al, 1996). In particular, recent interest has been focused on the study of
apoptotic cell death which is an energy requiring genetically determined process
which is under the control ofboth environmental and autocrine regulators (Wyllie et
al, 1980, Arends et al, 1990 and Bellamy et al, 1995). It has characteristic features
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such as chromatin condensation and DNA cleavage which differentiate it from
necrosis. The final stage of apoptosis involves segmenting cellular fragments into
membrane bound apoptotic bodies which are readily engulfed by phagocytes without
associated tissue inflammation (Wyllie et al, 1980 and Arends et al, 1990). Apoptosis
is therefore biochemically and morphologically distinct from a pathological form of
cell death termed necrosis, which may result from inflamatory or ischaemic tissue
insults.
Treatments which increase apoptosis may represent a novel approach to the
management ofmalignant glioma, and there is evidence that tumour cytotoxicity
induced by essential fatty acids may be attributable to stimulation of this mode of cell
death. Eicosaepentaenoic acid induced cell cycle arrest and apoptosis in pancreatic
cancer cells in vitro (Lai et al, 19969, arachidonic acid induced a concentration and
time dependant toxicity to HepG2-MV2El-9 cells (Chen et al, 1998), arachidonic
acid, gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid induced
apoptosis in Hep2 human larynx tumour cells (Colquhoun et al, 1998) and
arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid stimulated
apoptosis in various leukaemia cell lines (Finstad et al, 1998).
In vivo studies have also indicated that essential fatty acids stimulate apoptosis. Oils
rich in n-3 and n-6 essential fatty acids inhibited the formation of skin papilloma
induced by croton oil (Ramesh and Das, 1996 and Ramesh and Das, 1998a),
hepatoma induced by diethylnitrosamine (Ramesh and Das, 1995) and ascitic tumour
growth (Ramesh and Das, 1998b) and eicosapentaenoic acid and docosahexaenoic
acid inhibited the growth ofMorris hepatocarcinoma transplanted into ACI/T rats
(Calviello et al, 1998). Additionally, immunohistochemical analysis of a series of
high grade malignant gliomas suggested that apoptotic cells surround the tumour
central necrotic cores (Iwaki et al, 1994). This is consistent with the stimulation of
apoptosis by locally released inflammatory mediators including arachidonic acid
(Iwaki et al, 1994).
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Although there is evidence that essential fatty acids are associated with the
stimulation of apoptotic cell death, the kinetics essential fatty acid-mediated
stimulation of apoptosis are difficult to interpret. This may be due to inter-
experimental variations in cellular susceptibility to pro-apoptotic stimuli. There is
evidence that cells exist in at least two different states with regard to their
predisposition to apoptosis (Bellamy et al, 1995). In the primed state, cells are
endowed with the necessary effector proteins to enter into apoptosis if appropriately
triggered. In the unprimed state, the effector mechanisms associated with apoptosis
need to be synthesised before apoptosis can proceed. This susceptibility depends
upon environmental considerations such as local availability of growth and survival
factors, and also the activity of tumour suppressor genes and oncogenes, both of
which can be upregulated prior to the initiation of programmed cell death (Collins et
al, 1994). As this study was undertaken on fresh human glioma tissue obtained at
biopsy, it was predicted that the phenotype of these cells, and hence inherent
sensitivity to pro-apoptotic stimuli, would be more representative ofmalignant
glioma occurring in situ than established cell lines and experimentally induced
tumours.
During these investigations, human glioma cell apoptosis was determined in the
presence and absence of 30pM arachidonic acid at 0, 15, 30 and 45 minutes, and then
at hourly intervals for up to 36 hours. This concentration was selected as it is known
to stimulate tumour cell peroxidation, but is not associated with changes in plasma
membrane permeability. The sampling frequency of this study was designed
primarily to analyse apoptotic activity over time periods when increased reactive
oxygen species formation had been detected in human glioma preparations (Williams
et al, 1997) (Chapter 4).
Apoptotic activity was analysed using TUNEL flow cytometry in collagenase-
dispersed tumour cells. Stimulation of endogenous endonuclease was investigated
following the addition of exogenous arachidonic acid and gamma-linolenic acid, and
differences in the rate and extent of tumour cell apoptosis were determined in
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gliomas of various grades and tumour-associated normal brain where available. Flow
cytometry was also used to investigate basal apoptosis in high and low grade glioma,
and results were compared with histological features ofprogrammed cell death
observed in paraffin-fixed sections of the same tumour. The effect of arachidonic
acid and gamma-linolenic acid on glioma cell necrosis was determined by analysing
membrane permeability to vital dyes.
Radiation-induced programmed cell death in the rat C6 cell line was used to establish
experimental conditions, and to characterise the response of a single cell type
undergoing early, intermediate and late apoptosis. C6 cells were also used to
investigate the previously uncharacterised effect of gamma-linolenic acid on
apoptotic activity in long term culture, and to determine the effect of gamma-
linolenic acid on glioma cell proliferation.
6.2 Materials and Methods
(a) Standardisation of the Apoptotic Response using Radiation
Confluent C6 cells were harvested using trypsin digestion (Section 2.2c),
resuspended at a density of 106 cells/ml in Hams F-10 medium containing 10% FCS
and irradiated at 2Gy (Section 2.9b). At intervals of 0 andl5 minutes and 6, 8 and 9
hours post-irradiation, 1ml aliquots were fixed in 100% ethanol.
Ethanol preserved glioma cells were used for TUNEL analysis of apoptotic activity.
The cells were washed with phosphate buffered saline, incubated for 10 minutes at
room temperature with cacodylate buffer and centrifuged and incubated with reaction
buffer containing terminal deoxynucleotide transferase and fluorescein-12-2'-dUTP
for 2 hours. The cells were resuspended in phosphate buffered saline for 15 minutes
and analysed by flow cytometery. This identified apoptotic cells on the basis of
fluorescein-12-dUTP-associated fluorescence (Section 2.7).
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(b) Analysis of Apoptotic Activity in Human Glioma Tissue
(i) Cell preparation
Single cell suspensions of fresh human glioma tissue and, if available, tumour-
associated normal brain were obtained using collagenase digestion (Section 2.2b).
Cell suspensions were washed, resuspended at 1x10s cells/ml in collagenase free
Hams F-10 medium and incubated in the presence or absence of 30pM arachidonic
acid or gamma-linolenic acid. At 0, 15, 30 and 45 minutes, and hourly intervals for
periods ofup to 36 hours, 1ml aliquots were fixed in 100% ethanol for TUNEL
analysis of apoptotic activity (Section 2.7).
(ii) Analysis of Tumour Cell Viability
Tumour cell viability was measured immediately after ethanol fixation. 1 OOpl aliquots
of collagenase-dispersed cells were incubated with 50pl trypan blue for 2 minutes at
room temperature. Stained nuclei were counted in a microscopic field containing
100-200 cells at magnification x40, and expressed as a percentage of viable non-
staining cells (Section 2.6).
(iii) Pathology
The pathology of each tumour analysed for apoptotic activity was determined using
standard histopathological techniques (Section 2.10).
(c) Analysis of Apoptotic Activity in the Rat C6 Glioma Cell Line
Pre-confluent C6 cells were incubated with Hams F-10 medium containing 10% FCS
and gamma-linolenic acid at concentrations OpM, lpM, 5pM, lOpM, 20pM and
40pM. Medium bathing the cells was harvested and centrifuged every 6 hours, and
cell pellets were stored in 100% ethanol for TUNEL analysis of apoptotic activity.
After 7 days, adherent C6 cells were harvested using trypsin digestion, and cell
viability was determined by measuring propidium iodide uptake. Remaining adherent
cells were stored in 100% ethanol for TUNEL analysis (Sections 2.7).
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(d) Analysis of Proliferative Activity in the Rat C6 Glioma Cell Line
Proliferative activity was determined in the rat C6 glioma cell line in the presence
and absence of exogenous gamma-linolenic acid using the MTT assay as a measure
of the activity of intracellular dehydrogenases (Section 2.8).
6.3 Results
(a) Flow cytometric characterisation of apoptosis in the rat C6
glioma cell line
Flow cytometric analysis of irradiated cells indicated the presence of a group of cells
which were distinct from those constituting the highest proportion of the total
population. These cells were characterised by high dUTP/FITC-associated
fluorescence, which indicated high endogenous endonuclease activity and hence the
occurrence of apoptosis. In the absence of radiation, 0.038% of cells assayed for
apoptotic activity exhibited high dUTP-associated fluorescence (Figure 6.1), and this
increased to 0.14% at 15 minutes post-irradiation. After 6 hours a large increase in
endogenous endonuclease activity was observed, and this was associated with the
emergence of a population which had not been identified previously. In comparison
to the population previously associated with stimulation of apoptotic activity, cells
present in this new region were characterised by lower side scatter and lower dUTP-
associated-fluorescence. These morphological changes are consistent with small cell
size and increased membrane permeability. This is suggestive of the development of
apoptotic bodies which are formed during the latter phases of apoptosis. At 8 hours
the formation of these apoptotic bodies had increased by approximately 50%,
although there was continued evidence ofTUNEL positivity in the population
thought to represent cells undergoing early apoptotic events. At 9 hours both early
and late apoptotic populations were indistinguishable from the non-apoptotic
population.
As a result of their high fluorescence intensity, cells undergoing early and
intermediate apoptotic events could be defined by a single gate termed Fl-1. This
method was used in preference to gating individual sub-populations because cells
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undergoing apoptosis exhibited changes in morphology and fluorescence intensity,
and consequently passed rapidly through smaller fixed gates. However, if these bit
maps were reset during the course of an experiment, it would not have been possible
to compare individual time points on a quantitative basis.
The Fl-1 gate was used to estimate apoptotic index, which is defined as the ratio of
cells present in the Fl-1 gate to the number of cells in the whole population. The
single gate gave lower estimates of arachidonic acid induced stimulation of apoptosis
than more restricted bit maps defining individual sub-populations. This was because
sub-populations in late apoptosis with intermediate to low dUTP-associated
fluorescence were not included in the Fl-1 gate.
Having established the apoptotic activity ofC6 cells in response to radiation, the
single Fl-1 gate was used to analyse apoptotic activity in human glioma cells in the
presence and absence of arachidonic acid and gamma-linolenic acid. Patterns of
patterns of dUTP/FITC associated-fluorescence were similar to those observed in
Figure 6.1 (Figure 6.2 and 6.3). However, in two human tumour samples (one
oligoastrocytoma and one glioblastoma multiforme), it was necessary to use a
horizontal gate to differentiate between populations of differing side scatters in
addition to the vertical Fl-1 gate. This was because changes in endonuclease activity
were detected predominantly in the small cell fraction of these tumours. Another
glioblastoma multiforme showed evidence of a small cell population which was
incompletely gated by the single Fl-1 gate, and was therefore underestimated.
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Figure 6.1. The stimulation of apoptosis in the rat C6 glioma cell line by 2Gy
irradiation. Cells were selected for TUNEL positivity using a single high
fluorescence gate (Fl-1). The early apoptotic population is shown in red and the late













Figure 6.2. Apoptosis in cell preparations acquired from explants ofhuman glioma
using TUNEL flow cytometry. Collagenase dispersed samples of anaplastic
oligodendroglioma incubated in the presence (B) or absence (A) of 30pM
arachidonic acid for 15 minutes were labelled with FITC conjugated dUTP. This
identified apoptotic cells (indicated by black arrow) on the basis ofFITC associated
fluorescence (FL-1), x axis and side scatter, y axis on a Becton Dickinson FACScan
flow cytometer using LYSIS software. In each sample 5 000-10 000 cells were
analysed and cells with FL-1>80 were gated. The proportion ofTUNEL-positive
cells in was 20.53% and 6.57% in the presence and absence of arachidonic acid




Figure 6.3. The effect of arachidonic acid on apoptosis in tumour cells prepared from
a sample of cerebellar oligoastrocytoma. Isolated cells were incubated in the presence
(B) or absence (A) of 30pM arachidonic acid for 15 minutes. Apoptotic activity was
assessed using TUNEL flow cytometry on a Becton Dickinson FACSscan flow
cytometer using LYSIS software. In each sample 10 000 cells were analysed and cells
with FL-1>80 were gated. The proportion ofTUNEL-positive cells was 0.76% and
6.62% in the absence and presence of arachidonic acid respectively. The basal
apoptotic rate of cells derived from this tumour is shown in Table 6.1.
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(b) Analysis of Basal Apoptosis in Human Glioma Cells
The basal apoptotic index of the human tumour preparations analysed was
determined at each time point. Mean apoptotic index was 3.04±0.81% over the initial
incubation period of 0-2 hours, and 1.64%±0.45% over the later period of 3-24 hours
(Table 6.1). Although basal apoptosis varied with time and tumour type, a significant
proportion of cells acquired from human tumours had a basal apoptotic index of less
than 1%. This supports the finding that glial tumours have lower rates of endogenous
apoptotic activity than normal brain tissue (Schiffer et al, 1995 and Kordek et al,
1996). However, a relatively high mean apoptotic rate (5.2±3.1%) was observed in
one oligodendroglial tumour. Morphological features of apoptosis were also observed
in a paraffin-fixed section of this tumour stained with haematoxylin and eosin.
Similarities in the basal rate of apoptosis within certain classes of tumours were
noted (Figure 6.4). Early (0-2 hour) peaks of apoptotic activity followed by later
peaks between 9 and 12 hours were detected in three glioblastoma multiforme
tumours (Figure 6.4). However, individual variations were detected in the amplitude
and duration of these periodic increases in apoptotic activity. In addition, differences
between individual tumours of the same class occurred with respect to the timing and
duration of these changes. As a result of this observation, the basal rate of apoptosis
at each incubation time was used to determine the apoptotic index, rather than the

























































Table 6.1. basal apoptosis in 16 human gliomas analysed at 0-12 hours. TUNEL-
positive cells are indicated as a percentage total of cells analysed ±SEM of (n) 2 000-
10 000 determinations from each tumour. Cells were selected for high endonuclease
activity using a single high fluorescence (Fl-1) gate. This tends to underestimate cells
in early apoptosis (moderate Fl-1, high side scatter), and also in late apoptosis (low to
moderate Fl-1, low side scatter).
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Figure 6.4. The basal rate of tumour cell apoptosis in vitro. Basal apoptosis was
determined in three glioblastomamultiforme tumours using TUNEL flow cytometry.
The mean fraction of cells exhibiting TUNEL-positivity was analysed in 45
5 000-10 000 cell samples from three different tumours. Results from individual
tumours are identified using different symbols.
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(c) The Effect of Arachidonic Acid on Glioma Cell Apoptosis
A statistically significant increase in human glioma cell apoptosis was detected in the
presence of exogenous arachidonic acid. Increases in arachidonic acid stimulated
endonuclease activity were transient, with each peak lasting for 2-3 hours. However,
more than one peak in apoptotic activity was detected in most tumour preparations
(Figure 6.5). Overall, 12 peaks were detected in the 7 tumour cell preparations where
the proportion of essential fatty acid treated cells in the apoptotic gate was
significantly greater than that of control cells (p<0.006, paired t-test).
Differences in the kinetics of arachidonic acid-induced stimulation of endogenous
endonuclease activity were detected in tumours of different grades, with low grade
tumours, particularly oligodendrogliomas, tending to respond more rapidly to the
pro-apoptotic stimuli. In a collagenase dispersed explant of anaplastic
oligodendroglioma, the proportion of cells characterised by high endonuclease
activity increased from 6.6% to 20.53% after a 15 minutes incubation with
arachidonic acid (Figure 6.2). Cells derived from an explant of anaplastic
oligoastrocytoma had lower basal apoptosis before arachidonic acid stimulation, but
responded with a statistically significant increase in endonuclease following a 15
minute incubation with 30pM arachidonic acid (Figure 6.3).
The stimulation of apoptosis by exogenous essential fatty acids in both high and low
grade tumours was not associated with significant changes in membrane permeability
during in vitro incubations. This suggests the induction of a cytotoxic mechanism
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Figure 6.5. The effect of arachidonic acid on glioma apoptosis. The apoptosis ratio
was determined in seven tumour preparations treated with 30mM arachidonic acid.
The proportion ofTUNEL-positive cells in 132 2 000-10 000 cell samples obtained
from arachidonic acid treated/untreated cells between 0-12 hours is shown in 1
oligodendroglioma (black bars), three astrocytomas (white bars) and three
glioblastoma multiforme tumours (red bars).
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VIABILITY OF HUMAN GLIOMA CELLS:
EFFECT OF ARACHIDONIC ACID
TIME %VIABILITY % VIABILITY (n)
(hours) CONTROL ARACHIDONIC
ACID
0 91.8±3.21 92i2.9 (5)
0.5 89±4.19 89.7i4.01 (3)
0.75 84±7.07 87±3.54 (2)
1 90.8±3.55 89.4i4.53 (5)
2 84±6.36 80.5i6.01 (2)
3 88.5±3.72 82.75il.43 (4)
4 89.25±2.63 89.5il.87 (4)
5 88.5±3.13 84.75i2.7 (4)
6 86±3.24 83.8i3.65 (5)
8 85.4±3.31 84.2i3.1 (5)
9 78.3±3.6 78i3.68 (3)
10 77.3±4.48 74i3.68 (3)
12 78.7i2.76 85.7i4.38 (3)
Table 6.2. Viability of human glioma cells following a 0-12 hour incubation with
30pM arachidonic acid. Human glioma cell membrane integrity was measured by
monitoring trypan blue permeability throughout the experiments. Results are shown
as the percentage of viable cells at each time point ±SEM. The number of
determinations of cell viability is shown in parentheses.
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(d) The effect of Arachidonic Acid on Normal and Tumour Tissue
Apoptosis
Apoptotic activity in human glioma tissue and tumour-associated normal brain was
investigated over 0-12 hours in the presence and absence of exogenous arachidonic
acid (Figure 6.6). In normal brain preparations, mean basal apoptotic index over the
incubation period was 1.75±0.172%. In the presence of arachidonic acid, normal
cells exhibited a modest increase in mean apoptotic activity. Similarly, an increase in
apoptosis in the presence of arachidonic acid was detected in tumour cells, but this
effect was greater, with peaks of apoptotic activity of 3.22%, 3.07% and 4.29% being
detected at 5, 8 and 12 hours respectively. These increases in tumour cell apoptosis in
the presence of arachidonic acid resembled those of the two other glioblastoma
tumours in which possessed a similar rate of basal apoptosis. The apoptotic indices of
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Figure 6.6. The effect of arachidonic acid on apoptosis in cells derived from normal
and tumour tissue. The apoptosis ratio was determined in cell preparations acquired
from an explant of glioblastoma multiforme and associated normal brain over a
period of 12 hours. Cell preparations were incubated in the presence or absence of
30|iM arachidonic acid. The proportion ofTUNEL positive cells is shown in white
bars for normal tissue and black bars for glioblastoma multiforme tissue.
123
(e) The effect of exogenous gamma-linolenic acid on apoptosis and
proliferation in the rat C6 glioma cell line
Gamma-linolenic acid induced a concentration-dependant stimulation of apoptotic
activity in rat C6 glioma cells over a period of seven days (Figure 6.7). Maximum
stimulation of apoptotic activity occurred at seven days with the highest
concentration (40pM) of gamma-linolenic acid. The stimulation of apoptotic activity
fluctuated with time with the first peaks in endogenous endonuclease activity
occurring at 1 and 3 days after the addition of gamma-linolenic acid (Figure 6.8). In
the adherent C6 monolayer, gamma-linolenic acid had little effect on apoptosis in the
concentration range l-40pM. At higher concentrations of gamma-linolenic acid
(50jiM-lmM) no cells were available as an adherent monolayer. Stimulation of
apoptosis in the rat C6 cell line by gamma-linolenic acid in the concentration range
20-40pM was associated with inhibition of cell proliferation, as measured by the
MTT assay. Lower concentrations of gamma-linolenic acid (0-5fiM) had little effect
on apoptosis but increased cell proliferation (Figure 6.8).
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Figure 6.7. Estimation of apoptosis using the TUNEL assay in non-adherent glioma
cells collected from C6 cultures incubated in the presence and absence of 0-40uM
gamma-linolenic acid. Detached cells were removed every six hours for analysis.
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6.4 Discussion
This study has indicated that arachidonic acid and gamma-linolenic acid stimulated
apoptosis in glioma cells derived from human brain tumours and the rat C6 glioma
cell line, as measured by TUNEL analysis of endogenous endonuclease activity. In
human tumour preparations, the apoptotic activity of cell preparations acquired from
tumours of different grades responded with different kinetics to exogenous
arachidonic acid and gamma-linolenic acid. High grade tumours generally responded
less rapidly, with maximum stimulation of endogenous endonuclease activity
occurring between 10-12 hours. Low grade tumours typically responded within two
hours. Low grade tumours may respond more rapidly to exogenous arachidonic acid
and gamma-linolenic acid because constitutively expressed pro-apoptotic effector
pathways sensitive to essential fatty acids and their metabolites are primed and
rapidly initiate apoptosis if appropriately triggered. The relatively slow response of
high grade tumours may be due to the requirement for activation of gene transcription
ofpro-apoptotic mediators. Development of grade IV glioblastoma multiforme
involves gene mutations which can result in loss of sensitivity to pro-apoptotic
stimuli (Louis, 1997). This insensitivity may be exacerbated by structural and
morphological conditions. High metabolic demands resulting from rapid proliferation
and competition for oxygen and nutrients can lead to selective pressures which may
favour the survival of cell populations least resistant to necrosis and other forms of
cell death (Louis, 1997).
A primary contribution of inflammatory processes to the initiation of apoptosis in
human tumour preparations was not obvious. Morphological and histological
evidence indicated limited leukocyte infiltration and astrocyte activation at the sites
of apoptosis. In addition, flow cytometric analysis of tumour cell preparations
sensitive to the pro-apoptotic actions of arachidonic acid did not show a
predominance ofhigh side scatter, small to medium sized cells typical of phagocyte
populations. It is possible however that changes detected in tumour cells were
secondary to stimulated peroxidation in adjacent cells.
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The stimulation of apoptotic activity in human glioma and the rat C6 cell line
fluctuated with time. In human glioma tissue there was evidence of an initial increase
in endonuclease activity during the first two hours of incubation, which was followed
by further peaks in the stimulation of apoptotic activity between three and 36 hours.
Similarly, in the rat C6 glioma cell line there was evidence of time dependant
variations in apoptotic activity, with peaks occurring at 1, 3 and 7 days. Similar
kinetics have been observed in human colon carcinoma cell lines (Wyllie et al, 1992).
The molecular pathways which mediate these time-dependant episodes of increased
apoptotic activity have not been well characterised. However, the initial stimulation
of apoptosis may involve induction ofmetabolic pathways associated with pro-
apoptotic activity in cells endowed with the necessary effector proteins (Bellamy,
1995). Further peaks may occur when the effector proteins associated with apoptosis
have been synthesised de novo. There is evidence that dopamine is capable of
inducing apoptosis in post-mitotic sympathetic neurones via its oxidative
metabolites, which correlates with two peaks of cyclin B and proliferating cell
nuclear antigen expression (Shirvan et al, 1997). The essential fatty acid-sensitive
inositol trisphosphate/Ca2+ signalling pathway may also be involved in generating
fluctuations in apoptotic activity (Berridge, 1997), and it has been reported that up-
regulation of apoptosis during embryogenesis involves several time dependant
changes in gene expression (Furlow et al, 1997).
This study indicated that individual human tumours exhibited variable basal rates of
apoptosis. This finding concurs with that of Schiffer et al (1995) and Kordeck et al
(1996), who described varying levels of apoptosis in different brain tumour types.
Despite these variations, high grade tumours were generally characterised by low
basal rates of apoptosis in this study. An inverse association between tumour
proliferative activity and apoptosis has also been established in glial tumours of
embryonal orogin, where a trend towards low apoptotic activity was observed in
tumours with high mitotic indices (Schiffer et al, 1995).
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6.5 Conclusions
This study has demonstrated that arachidonic acid and gamma-linolenic acid
stimulate apoptotic activity in human glioma tissue and the rat C6 glioma cell line.
This stimulation fluctuated with time, with peaks of apoptotic activity generally
being followed by a reduction in dUTP-associated fluorescence one hour later. The
kinetics of n-6 essential fatty acid-mediated stimulation of apopotosis were grade
dependant. Tumour tissue responded with high sensitivity to exogenous arachidonic
acid in comparison with tumour-associated normal brain, and high grade GBM
tumours generally took longer to respond to the pro-apoptotic stimulus than low
grade astrocytomas. It was also observed that high grade tumours were characterised
by low basal apoptotic activity. At the concentrations of arachidonic acid and
gamma-linolenic acid used, there was no evidence of statistically significant changes
in cell membrane integrity, further supporting the hypothesis that the induction of
apoptosis is the principal cause of essential fatty acid-mediated cytotoxicity. These
observations provide additional evidence supporting a clinical role for n-6 essential
fatty acids in the treatment ofmalignant glioma.
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Chapter 7:
The Interaction of Irradiation with Arachidonic Acid and Gamma-
Linolenic Acid
7.1 Introduction
The purpose of this study was to investigate the potentiation of tumour reactive
oxygen species formation and apoptosis in rat C6 glioma cells in the presence and
absence of arachidonic acid, gamma-linolenic acid and radiation. These activities
were investigated at concentrations of arachidonic acid and gamma-linolenic acid
previously shown to stimulate glioma oxidative activity and programmed cell death,
and over time periods where peaks in apoptotic activity had been observed.
These investigations were undertaken to investigate a potential clinical role for n-6
essential fatty acids as a therapeutic adjuvant in glioma radiotherapy. These
considerations are important because of the poor clinical response of malignant
glioma to standard fractionated radiotherapy. Despite the recent introduction of
stereotactic radiosurgery and gamma knife radiotherapy, which increase the
precision of positioning of small treatment beams, the prognosis for patients
suffering from malignant glioma is not significantly better now than it was thirty
years ago (Taphoorn et al, 1994, Forsyth and Cairncross, 1995 and Sichez, 1996). In
addition, ultra high dose rates (Cygler et al, 1994), intraoperative radiotherapy
(Shimbamoto et al, 1994 and Hara et al, 1995), accelerated hyperfractionation
(Glinski, 1993, Sugawara et al, 1994 and Freeman et al, 1996) and concurrent
radiotherapy and standard and multiagent chemotherapy (Eyre et al, 1993, Heideman
et al, 1993, Jeremic et al, 1994, Dillman et al, 1995, Hui et al, 1995 and Buchsbaum
and Robertson, 1996) have not been associated with significant clinical benefit.
It has been proposed that essential fatty acid-mediated potentiation of cellular
oxidative activity may increase the sensitivity ofmalignant glioma to radiotherapy
because of the pivotal role of reactive oxygen intermediates in radiation induced
cytotoxicity is well established (Halliwell and Gutteridge, 1985 and Hagen, 1989).
Radiation-induced stimulation of reactive oxygen intermediate production may,
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under appropriate conditions, result in self-propagating chain reactions leading to
DNA double strand breaks and locally denatured regions (Halliwell and Gutteridge,
1985, Hagen, 1989 and Wardman and Ross, 1990). This induces p53 dependant G,
phase cell cycle arrest which allows time for DNA repair or elimination of lethally
damaged cells by apoptosis (Gupta et al, 1996).
Results presented in this thesis and elsewhere indicate that human glioma cells are
characterised by low basal reactive oxygen species formation (Levchenko and
Demchik, 1991 and Williams et al, 1997). This may be partially due to deficiency of
n-6 essential fatty acids including arachidonic acid and gamma-linolenic acid
(Martin et al, 1996). These observations suggest that addition of exogenous essential
fatty acids may be associated with potentiation of radiation-induced cytotoxicity by
providing pro-oxidative substrate upon which radiation can act.
In these investigations, the kinetics of cellular peroxidation, apoptotic activity and
cell membrane integrity were investigated in rat C6 glioma cells in the presence and
absence of radiation and exogenous n-6 essential fatty acid. The cells were irradiated
at 2Gy because this is a therapeutically relevant dose (Chang et al, 1995) associated
with tumour cytotoxicity in human glioma cell lines (Ross et al, 1994). In addition,
2Gy is close to the mid-point used in irradiation experiments using the C6 cell line
and sensitising agents (Zhang et al, 1993, Stapper et al, 1995 and Bergenheim et al,
1995).
In addition, the interaction of arachidonic acid and sodium nitroprusside was
investigated. Sodium nitroprusside is a NO donor which may have a role as a
therapeutic adjuvant in the management ofhuman glioma due to its action as a
vasodilator (Whittle 1996). This may increase the delivery of cytotoxic drugs to
tumour tissue. In addition, there is evidence that NO donors potentiate free radical
activity (Ioannidis and deGroot, 1993 and Hata et al, 1996), which may contribute to
tumour cell cytotoxicity in vivo (Krinsky et al, 1992). Essential fatty acid-mediated
potentiation of this action may be associated with increased glioma cell death.
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7.2 Materials and Methods
(a) Cell Preparation
(i) Cell Irradiation
Rat C6 glioma cells were harvested and resuspended at a density of 106 cells/ml in
Hams-FlO medium. This cell suspension was used to completely fill 50ml cell
culture flasks, taking care to exclude all air gaps. The flasks were irradiated at 2Gy
with a 6MV X-ray beam in the presence and absence of20pM arachidonic acid or
gamma-linolenic acid (Section 2.9b). At intervals of 1, 2, 3, 4, 6, 8 and 10 hours
post-irradiation, 1ml aliquots were analysed for peroxidative and apoptotic activity,
and cell membrane integrity (Sections 2.3, 2.6 and 2.7).
(ii) The Interaction of n-6 Essential Fatty Acids with Sodium
Nitroprusside
C6 cells were harvested, resuspended at a density of 106 cells/ml in Hams F-10
medium and incubated in the presence and absence of 0.1mM sodium nitroprusside
and/or 20pM arachidonic acid (Section 2.9a). Glioma cell peroxidation, viability and
apoptosis was analysed as described previously (Section 7.2ai).
(b) Analysis of Peroxidative Activity
C6 cells were centrifuged and incubated with 5pM 2',7'-dichlorofluorescin diacetate
for 10 minutes at 37°C. The cells were washed and resuspended in Hams F-10
medium containing 10% FCS. The rate of reactive oxygen intermediate production
was determined using flow cytometric quantitation of2',7'-dichlorofluorescein
production (Section 2.3).
(c) Analysis ofApoptotic Activity
C6 cells were fixed by exposure to 100% ethanol and stored at -4°C for 1-3 weeks.
Apoptotic activity was determined using TUNEL flow cytometery (Section 2.7).
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(d) Analysis of Cell Viability
Cell viability was determined immediately after analysis ofperoxidative activity
using flow cytometric analysis ofpropidium iodide permeability (Section 2.6).
7.3 Results
(a) Effect of Irradiation. Arachidonic Acid and Gamma-Linolenic
Acid on Oxidative Activity in the Rat C6 Glioma Cell Line
Oxidative activity in the rat C6 glioma cell line was increased in response to
irradiation and exogenous n-6 essential fatty acid stimulus (Figure 7.1). Potentiation
of glioma cell reactive oxygen species formation following addition of arachidonic
acid and gamma-linolenic acid typically occurred within 3 hours of stimulation, with
peaks ofup to 700% of the untreated control being observed after 2 hours.
Subsequent smaller increases of up to 200% occurred within the next 7 hours. The
maximum stimulation of oxidative activity in response to radiation was less than that
observed in response to arachidonic acid or gamma-linolenic acid, with peaks ofup
to 400% of the untreated control occurring. This stimulation occurred throughout the
incubation period with fewer fluctuations in reactive oxygen intermediate generation
with time. In one experiment the maximum stimulation of oxidative activity
occurred between 4 and 8 hours. These results suggest different kinetic mechanisms
for the stimulation of reactive oxygen intermediate production by essential fatty
acids and radiation. No statistically significant differences were observed between






















Figure 7.1. The stimulation of cellular peroxidation in 6 single cell suspensions of
the rat C6 glioma cell line by (A) 20pM exogenous arachidonic acid or gamma-
linolenic acid and (B) 2Gy irradiation. The y-axis indicates reactive oxygen
intermediate formation which is expressed as percent stimulation of the untreated
control and the x-axis indicates time in hours.
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(b) Analysis of Apoptotic Activity in the Rat C6 Glioma Ceil Line
Irradiation and exogenous n-6 essential fatty acid stimulus potentiated apoptotic
activity in the rat C6 glioma cells (Figure 7.2 and Figure 7.3). There was evidence of
an early stimulation of endogenous endonuclease activity, although in certain cases
additional peaks of smaller magnitude were observed after 4 and 6 hours. The
kinetics of the stimulation of apoptotic activity were complex, and peaks in
apoptotic activity were often followed by a reduction in TUNEL positivity one hour
later. The kinetics of these episodic increases in apoptotic activity were similar to
those observed in human astrocytoma (Chapter 6).
Radiation induced stimulation of endogenous endonuclease activity also occurred
within one hour, although the magnitude of this early response was generally less
than that observed in response to exogenous arachidonic acid and gamma-linolenic
acid (Figure 7.2b). This stimulation was maintained for up to 10 hours post-
irradiation. In certain cases, peaks of apoptotic activity occurred at 5 and 6 hours
post-irradiation, with maximum stimulation being approximately 600%. In general
however, fewer episodic fluctuations of endogenous endonuclease activity occurring
with time in comparison with the effect of 20pM exogenous arachidonic acid or
gamma-linolenic acid alone.
The maximum stimulation of apoptotic activity induced by exogenous essential fatty
acid stimulus occurred within the first two hours of incubation. This is in contrast to
the later response observed following exposure to radiation. However, the magnitude
of the maximum stimulation was similar in both cases, with increases ofup to 600%
of the unstimulated control being observed. These results suggest the induction of
different kinetic mechanisms for the stimulation of apoptosis by radiation and
arachidonic acid and gamma-linolenic acid.
Simultaneous exposure to radiation and exogenous n-6 essential fatty acids was
associated with greater than additive potentiation of apoptotic activity. In most cases
this synergistic stimulation was maintained over the 10 hour incubation period,
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however maximum peaks were observed at 4, 7 and 8 hours post-irradiation. Again,
the kinetics of this stimulation were complex and there was evidence that peaks in
apoptotic activity were followed by a reduction in endogenous endonuclease activity
1 hour later. The maximum stimulation of apoptosis was approximately 4 000% of
the untreated control. No statistically significant differences were observed between
the stimulation of apoptosis by arachidonic acid or gamma-linolenic acid.
During the analysis of apoptotic activity, contemporary sampling was used to
calculate changes in endogenous endonuclease activity. This was due to the
observation that the apoptotic index (AI) in untreated tumour samples changed with
time. There was evidence of variable basal apoptotic indices in human tumours
(Chapter 6). There is also evidence that variation ofAI occurred with time in single
cell suspensions of the rat C6 cell line. This may be partly related to cell damage
caused by trypsinisation and resuspension, and subsequent recovery from mechanical
damage sustained during cell preparation. In addition, membrane damage due to
essential fatty acid effects was studied. Pre-stimulation analysis of apoptotic activity
was also carried out initially but this was not routinely calculated. This was due
principally to subsequent negative values in certain tumour preparations which were
difficult to analyse statistically and the initial low viability of cell preparations
following trypsinisation and resuspension.
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Figure 7.3. The stimulation of apoptosis in rat C6 glioma cells irradiated at 2Gy in
the presence (B) and absence (A) of 20pM exogenous arachidonic acid or gamma-
linolenic acid. Cells were selected for TUNEL positivity by using a high
fluorescence (Fl-1) gate.
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(c) The Effect of Sodium Nitroprusside on Oxidative Activity in the
Rat C6 Glioma Cell Line
Sodium nitroprusside stimulated reactive oxygen intermediate formation in rat C6
glioma cells (Figure 7.4). This stimulation occurred within one hour and was
maintained throughout the 10 hour duration of the investigation. The magnitude and
kinetics of sodium nitroprusside-mediated potentiation of glioma reactive oxygen
species formation was similar to that observed in response to addition of exogenous
arachidonic acid, and although the stimulation of reactive oxygen intermediate
generation was generally higher in response to sodium nitroprusside, this difference
was not statistically significant.
Simultaneous exposure to arachidonic acid and sodium nitroprusside resulted in
potentiation of oxidative activity. This potentiation was maximal during the first





























Figure 7.4. The stimulation of reactive oxygen intermediate formation in rat C6
glioma cells by the nitric oxide donor sodium nitroprusside. Results are expressed as
mean reactive oxygen intermediate formation in cells incubated with 20(iM
arachidonic acid (closed diamonds), O.lmM sodium nitroprusside (closed squares),
20|iM arachidonic acid and sodium nitroprussude combined (open diamonds) and
vehicle alone (open squares).
7.4 Discussion
This study has provided preliminary evidence that arachidonic acid, gamma-
linolenic acid and radiation stimulated apoptotic and peroxidative activity in single
cell suspensions of the rat C6 glioma cell line. However, differences were observed
between the kinetic profiles of these stimulatory effects. Arachidonic acid and
gamma-linolenic acid stimulated apoptosis and reactive oxygen intermediate
formation within the first three hours of exposure. This early oxidative response
observed in glioma cells following arachidonic acid and gamma-linolenic acid
exposure was similar to that described for the short term stimulation of peroxidative
activity in Chapter 4. In contrast, radiation induced stimulation of oxidative activity
occurred throughout the duration of the experiment, although the maximum
stimulation was lower. These results suggest different kinetic mechanisms for the
stimulation of reactive oxygen intermediate production by radiation and essential
fatty acids.
Preliminary investigations also indicated that sodium nitroprusside potentiated
peroxidative activity in the rat C6 glioma cell line. The kinetics of this stimulation
were similar to those induced by arachidonic acid. There was also evidence that
reactive oxygen intermediate generation was potentiated when C6 cells were
simultaneously exposed to both sodium nitroprusside and arachidonic acid. This
potentiation was greatest during the first two hours of exposure.
The stimulation of apoptosis in response to exogenous n-6 essential fatty acids also
occurred relatively rapidly, with maximum increases in endogenous endonuclease
activity typically occurring within the first three hours of incubation. Although
radiation-induced stimulation of apoptosis also occurred within one hour, maximum
stimulation was typically observed towards the end of the incubation period. The
stimulation of apoptosis induced by exogenous arachidonic acid or gamma-linolenic
acid was generally greater than that induced by radiation.
141
There was evidence of potentiation of apoptotic activity following simultaneous
exposure to arachidonic acid or gamma-linolenic acid and radiation. This stimulation
occurred throughout the ten hour incubation period, but was typically maximised at
6-8 hours post-irradiation. In one case, dUTP-associated fluorescence in C6 cells
exposed to gamma-linolenic acid and radiation was up to 4 000% of the non-
irradiated control.
These results are consistent with the hypothesis that essential fatty acids potentiate
glioma cell response to radiotherapy. Although the molecular pathways responsible
for this activity have not been well characterised, it has been proposed that essential
fatty acids may reduce radioresistance by modulating PIP3 activity (Woloschak et al,
1990 and Uckun et al, 1993). Inhibition of protein kinase C is associated with
sensitisation of human tumours to ionising radiation (Hallahan et al, 1992), and there
is evidence that essential fatty acids reduce the activity of activated protein kinase C
(Chen and Murakami, 1992, Hilian and Nelson, 1992 and may et al, 1993). This
inhibition may be associated with reduced expression of activated ras, an oncogene
which confers radiation resistance and is associated with protein kinase C activity
(Sklar, 1988 and Borner and Weinstein, 1990). There is also evidence that pre¬
exposure of glioma cell lines to the cytokines IFNy and TNFa, whose activity and/or
secretion can be modified by linoleic acid, arachidonic acid, and gamma-linolenic
acid (Ku et al, 1991 and Baldie et al, 1993), can inhibit bcl2 mediated rescue from
apoptosis following irradiation by sensitising for FAS/APO-1 dependent killing
(Weller et al, 1995).
In addition to increasing efficacy, essential fatty acids may reduce the occurrence of
pathological side effects associated with radiotherapy (Hopewell et al, 1993). It has
been proposed that damage to peri-tumoural tissue which occurs following exposure
to radiation may result from loss of essential fatty acids rather than the accumulation
of toxic metabolites. This implies that increasing the availability of essential fatty
acids will limit and/or reverse radiation-induced damage to normal tissue (Horrobin,
1990). These radio-protective actions may result, in part at least, from modification
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of eicosanoid metabolism. Radiation causes an imbalance in the ratio of
mono:dienoic eicosanoids (Schneidkraut et al, 1984, Weshler et al, 1987 and Ward,
1990) however gamma-linolenic acid increases the production ofmonoenoic PGE,
rather than dienoic prostaglandins such as PGE2 and TXA2 (Hopewell et al, 1993). In
addition, gamma-linolenic acid inhibits leukotriene formation (Horrobin and Manku,
1990).
7.5 Conclusions
This study has provided evidence that arachidonic acid and gamma-linolenic acid
interact with radiation to potentiate oxidative and apoptotic activity in vitro. The
increase in reactive oxygen intermediate formation occurred within the first three
hours of exposure to exogenous essential fatty acid stimulus post-irradiation,
suggesting that stimulation of reactive oxygen intermediate production is an early
event. This result concurs with the observation that oxidative activity increased
within 10 seconds of exogenous essential fatty acid stimulation in collagenase
dispersed explants of human malignant glioma, and that this increase can be
maintained for up to 3 hours (Chapter 4).
In conclusion, this study has provided evidence that exogenous arachidonic acid,
gamma-linolenic acid and therapeutically relevant doses of irradiation stimulated
reactive oxygen intermediate generation and apoptotic activity in the rat C6 glioma
cell line. There was also preliminary evidence that arachidonic acid interacted with
the nitric oxide donor sodium nitroprusside to potentiate reactive oxygen
intermediate formation. These results are consistent with a possible role for





8.1 Aims and Hypotheses
Despite the considerable progress which has been made in understanding the
molecular biology ofmalignant gliomas, the prognosis for patients suffering from
these tumours has not improved substantially in recent years (Roth and Weller,
1999). Furthermore, cytoreductive surgery and radiotherapy remain the preferred
treatments for malignant glioma, although it is thought that novel cytotoxic drugs
may represent the most promising therapeutic strategies for the future (Darling, 1990
and Roth and Weller, 1999). The evaluation of alternative anti-tumour agents is
therefore an important aim of neurooncology research.
One promising strategy may be modulation of the oxidative activity of these tumours
through administration of essential fatty acids. These highly unsaturated lipids act as
substrates for the production of lipid peroxides, which may be implicated in glioma
cytotoxicity and radiosensitisation (Cornwell and Morisaki, 1984 and Gonzalez,
1992). C/s-unsaturated fatty acids inhibited the growth of glioma cell lines in vivo
and in vitro (Das et al, 1990a), PUFA administration was associated with the
rejection of transformed microglial tumour cells in vivo (Frei et al, 1994),
peroxidised low density lipoprotein was cytotoxic to human glioma cell lines
(Kikuvhi et al, 1997) and gamma-linolenic acid, eicosapentaenoic acid and
docosahexaenoic acid were cytotoxic to 36B10 rat astrocytoma cell lines in vitro
(Vartak et al, 1997 and 1998). Additionally, oral administration of gamma-linolenic
acid induced tumour regression and improved patient survival in a small clinical trial
(Das, 1995). However, only fifteen patients were assessed in this study, and adequate
control groups were not included.
Although these previous studies provided evidence supporting a clinical role for n-6
essential fatty acids in malignant glioma therapy, limited information was available
on the activity of essential fatty acids in fresh human glioma tissue. Most
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investigations had been carried out on established cell lines, and the limitations of
these experiments were concerned predominantly with loss of tumour phenotype
associated with cell culture, and the lack of comparative analysis of the oxidative
activities of tumours of different grades. Additionally, the mode of cell death
resulting from essential fatty acid administration had not been well characterised.
There was also limited information on the interactive effects of essential fatty acids
and radiation in malignant glioma cells, particularly with respect to the kinetics of
reactive oxygen species formation and the mode of cell death induced. The purpose
of this study was to provide additional information on the role of essential fatty acid
metabolism in glioma cytotoxicity and radiosensitisation by investigating the
hypotheses that:-
1) Oxidative activity is impaired in human glioma tissue in comparison with
tumour-associated normal brain
2) Addition of exogenous essential fatty acids stimulates tumour reactive oxygen
species generation
3) Potentiation of tumour reactive oxygen species generation is associated with
tumour cytotoxicity, in part at least through stimulation of apoptosis
4) Stimulation of tumour oxidative and apoptotic activity by arachidonic acid and
gamma-linolenic acid is potentiated by simultaneous exposure to therapeutic
doses of radiation
8.2 Investigations Undertaken
(a) General practical considerations
Investigation of these hypotheses lead to a number of important practical
considerations. These related predominantly to tissue availability, and the
complexity of experimental and data analysis which arose from the cellular
heterogeneity which is characteristic of this tumour type. Preliminary investigation
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of the initial hypotheses suggested that analysis of essential fatty acid-mediated
stimulation of glioma oxidative and apoptotic activity was likely to be complex. This
was due to variations in basal oxidative activity, cell composition, viability and
tumour grade between tumours acquired from different patients, and also the cellular
heterogeneity of tumour preparations derived from individual tumours. As a result of
these confounding factors, it was initially necessary to use relatively homogeneous
cell preparations to characterise the experimental conditions required to analyse the
both the pro-oxidative and the pro-apoptotic activities of arachidonic acid and
gamma-linolenic acid in vitro.
These preliminary investigations were undertaken using fresh leukocyte
preparations, which were used to define the conditions most appropriate for analysis
of tumour oxidative activity. In addition to characterising experimental conditions,
analysis of the oxidative response of these cells may be relevant to the overall
cytotoxic activities of essential fatty acids, as infiltrating lymphocytes are sometimes
present in human gliomas (Roszman et al, 1991 and Tada and Tribolet, 1993).
Results of this study also assisted the identification of the characteristics a human
tumour sub-population thought to represent infiltrating phagocytes.
Cellular heterogeneity was also responsible for the complexity of analysis of
apoptotic activity in human glioma. Consequently, the terminal desoxynucleotidyl
transferase binding characteristics of the rat C6 cell line stimulated into apoptosis by
a therapeutically relevant dose of radiation was used to identify human tumour cell
populations undergoing programmed cell death. As insufficient quantities of human
glioma tissue were available for analysis, and cellular heterogeneity would have
made tumour-specific responses difficult to delineate, the rat C6 cell line was also
used for investigation of essential fatty acid-mediated radiosensitisation. Although
further investigations are required to analyse essential fatty acid-mediated
radiosensitisation in human glioma tissue, the results of this study provided
preliminary information on the previously uncharacterised association between the
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kinetics of reactive oxygen species formation and apoptotic cell death in glioma
cells.
(b) Human glioma oxidation
It has been postulated that impaired reactive oxygen species generation is associated
with increased proliferative activity (Barber and Wilbur, 1959, Bernheim, 1963,
Mead and Fulco, 1976 and Masotti et al, 1988, Cheeseman et al, 1984, Levchenko
and Demchik, 1991 Bartoli and Galeotti, 1979, Barber and Wilbur, 1959, Bernheim,
1963, Mead and Fulco, 1976 and Masotti et al, 1988), and that tissues with low basal
oxidative activity respond to exogenous essential fatty acid stimulus with increased
production of potentially cytotoxic lipid peroxides. This study demonstrated for the
first time that these hypotheses are pertinent to human malignant glioma. Reactive
oxygen intermediate formation was an inverse function ofproliferative activity in
collagenase-dispersed glioma tissue, the basal rate of tumour oxidation being
significantly lower than that of associated normal brain (p<0.0000017). Additionally,
the kinetics of essential fatty acid-mediated stimulation of glioma oxidative activity
were grade dependent. Although the kinetics of essential fatty acid-stimulated
reactive oxygen intermediate formation followed an exponential function in both
normal and tumour cell preparations, tumour cells showed significantly higher
sensitivity than normal tissue (p<0.0000017).
Sub-population analysis also provided preliminary evidence supporting the
hypothesis that tumour cells have low basal oxidative activity and high sensitivity to
exogenous essential fatty acid stimulation. Preliminary investigations revealed a
GFAP-positive population which was characterised by high side scatter (which is
indicative ofhigh granularity and hence DNA content). These morphological and
immunohistochemical features are characteristic of the known properties of human
glioma cells. The cell population identified in this way possessed low basal
oxidative activity and reacted with high sensitivity to exogenous arachidonic acid
and gamma-linolenic acid.
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(c) Glioma apoptosis and proliferation
The biological significance of arachidonic acid and gamma-linolenic acid-mediated
stimulation of cellular oxidation was investigated through analysis of glioma cell
proliferation and apoptosis. It was confirmed that at concentrations previously
shown to stimulate glioma reactive oxygen species formation, arachidonic acid and
gamma-linolenic acid inhibited cell proliferation and stimulated apoptosis. The
effects of gamma-linolenic acid on C6 glioma cell proliferation were investigated
using the MTT assay, and preliminary results indicated that gamma-linolenic acid
inhibited tumour cell proliferation over 7 days. These results concur with previous
investigations which demonstrated that gamma-linolenic acid inhibited cell
proliferation in glioma cell lines (Das, 1990), and that inhibition of cell proliferation
in the GHP-212 neuroblastoma cell line was associated with stimulation of cellular
oxidative activity (Hrelia et al, 1996).
The stimulation of apoptotic activity by arachidonic acid and gamma-linolenic acid
was investigated in collagenase-dispersed explants of fresh human primary glioma
obtained at biopsy. Both arachidonic acid and gamma-linolenic acid stimulated
apoptosis for up to 36 hours, with arachidonic acid being more active. The
stimulation of apoptotic activity by exogenous arachidonic acid and gamma-
linolenic acid varied with time: episodes of increased apoptotic activity were
generally followed by lower levels of apoptosis one hour later.
The apoptotic activity of cell preparations acquired from tumours of different grades
responded with different kinetics to exogenous arachidonic acid and gamma-
linolenic acid. High grade tumours generally responded less rapidly, with maximum
stimulation of endogenous endonuclease activity occurring between 10-12 hours.
Low grade tumours typically responded within two hours. Low grade tumours may
respond more rapidly to exogenous arachidonic acid and gamma-linolenic acid
because constitutively expressed pro-apoptotic effector pathways sensitive to
essential fatty acids and their metabolites are primed and rapidly initiate apoptosis if
appropriately triggered. The relatively slow response of high grade tumours may be
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due to the requirement for activation of gene transcription ofpro-apoptotic
mediators. Development of grade IV glioblastoma multiforme involves gene
mutations which can result in loss of sensitivity to pro-apoptotic stimuli (Louis,
1997). This insensitivity may be exacerbated by structural and morphological
conditions. High metabolic demands resulting from rapid proliferation and
competition for oxygen and nutrients can lead to selective pressures which may
favour the survival of cell populations least resistant to necrosis and other forms of
cell death (Louis, 1997).
Although the down-stream pro-apoptotic targets of reactive oxygen intermediates
have not been fully characterised, a number of candidate molecular pathways have
been proposed. There is evidence that hydrogen peroxide induces apoptosis in
hepatoma cells by modulating intracellular Ca2+ and Mg2+, resulting in DNA
fragmentation and activation of the pro-apoptotic enzyme poly(ADP-ribose)
polymerase (Li et al, 2000). Other putative targets include Bcl2, cytochrome P450
and intracellular anti-oxidants. Recent studies indicate that essential fatty acid-
mediated stimulation of apoptosis is associated with depletion of glutathione and
inhibition of carnitine palmitoyl transferase I in cells over expressing cytochrome
P450 (Das, 1999). These studies also suggested that essential fatty acids reduce
expression of anti-apoptotic bcl2, possibly through P450 phosphorylation. Each of
these activities was associated with increased lipid peroxidation (Das, 1999).
Additionally, there is evidence that modification of the activities of certain growth
factors sensitive to essential fatty acids and their metabolites may be implicated in
the initiation of programmed cell death. Deprivation ofPDGF initiates apoptosis in
human glioma cells (Collins et al, 1994 and Westermark et al, 1995) possibly by
modulating the Ras.Raf pathway (Westermark et al, 1995). PDGF is secreted by
transformed glial cells and has been identified in neurones and their processes where
it stimulates astrocyte migration and proliferation (Westermark et al, 1995,
Engebraaten et al, 1993, Whelan et al, 1993 and Pedersen et al, 1994). PDGF and
PDGF receptors are frequently over-expressed in human glioma and specific and
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non-specific PDGF antagonists block the growth of some glioma cell lines in vivo
and in vitro (Kuratsu et al, 1995, Kurimoto et al, 1994, Kurimoto et al, 1995, and
Westermark et al, 1995). Additionally, it is known that the v-sis oncogene of simian
sarcoma virus, which is a retroviral homologue of the B-chain ofPDGF, induces
malignant glioma in experimental animals (Westermark et al, 1995). It is known that
eicosapentaenoic acid inhibits certain well characterised actions of PDGF including
inhibition of PDGF-mediated elevation of intracellular calcium (Locher et al, 1991).
There is also evidence that NGF inhibits growth and stimulates apoptosis in a human
anaplastic glioma cell line (Marushige et al, 1992), possibly by reducing the
expression of bcl2 (Kamada et al, 1996) and augmenting FAS-mediated killing
(Kamada et al, 1996 and Yashima et al, 1996). Arachidonic acid lipoxygenation may
stimulate nerve growth factor secretion in astroglial cultures (Carman-Krzan and
Wise, 1993). NGF may also inhibit tumour growth by stimulating lipid peroxidation
by stimulating the production of hydrogen peroxide (Weese et al, 1993). NGF-
mediated stimulation ofhydrogen peroxide may further increase NGF synthesis
(Pechan et al, 1992).
Additional research is also required to characterise which oxidative products of lipid
metabolism mediate tumour cytotoxicity, either directly or through modulation of
downstream molecular pathways. Although the stimulation of apoptosis in glioma
cell lines following addition of selenium has been attributed to increased reactive
oxygen intermediate generation (Nakatsu et al, 1996 and Zhu et al, 1996), relatively
little is known about the identity of the individual oxygen based free radicals which
are implicated in cell death pathways. Preliminary evidence suggests that increased
formation of conjugated dienes and/or hydroperoxyl groups in polyunsaturated fatty
acid molecules is pertinent to gamma-linolenic acid-induced cytotoxicity (Takeda et
al, 1993). Studies on human arterial smooth muscle cells indicated that moderately
oxidised low density lipoprotein, which contained the highest concentration of lipid
hydroperoxides, induced smooth muscle cell apoptosis within six hours, whereas
other forms of low density lipoprotein had no effect (Siow et al, 1999). It has been
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proposed that lipid hydroperoxides may stimulate cell death by inhibiting bcl2-
mediated rescue from apoptosis (Sandstrom, 1995 and Siow et al, 1999).
(d) Glioma radiosensitisation
The inherent radioresistance of human malignant glioma is a barrier to cure (Mansur
et al, 2000). Research is therefore required to characterise therapeutic interventions
which selectively increase the radiosensitivity of tumour cells while minimising
toxicity to surrounding normal brain. A number of studies have suggested that
essential fatty acids may fill both these criteria. Both radiation and essential fatty
acids stimulate tumour reactive oxygen intermediate generation (Barber and Wilbur,
1959, Dennis and Shimbamoto, 1990 and Yamaguchi et al, 1994), and it has been
demonstrated that potentiation of tumour oxidative activity is associated with tumour
cytotoxicity (Karmali et al, 1984, Das et al, 1987 and Begin et al, 1988). The
relevance of these studies to glioma radiosensitisation has been demonstrated in
vitro. Gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid
decreased the clonogenic capacity of the 36B10 rat astrocytoma cell line following
exposure to therapeutically relevant (0-1 OGy) doses of radiation (Vartak et al, 1997),
and a later study demonstrated that gamma-linolenic acid-mediated potentiation of
radiosensitivity was associated with tumour reactive oxygen species formation
(Vartak et al, 1998). However, these investigations did not evaluate the mode of cell
death resulting from combined essential fatty acid and radiation exposure, and the
kinetics of reactive oxygen species formation in these cells was not reported.
This study addressed these issues by demonstrating that arachidonic acid and
gamma-linolenic acid synergistically stimulated oxidative and apoptotic activity in
rat C6 glioma cells in conjunction with a therapeutically relevant dose of radiation
(Chapter 7). Initially, the individual effects of n-6 essential fatty acids and radiation
on glioma reactive oxygen species generation and apoptosis were investigated.
Arachidonic acid and gamma-linolenic acid administration was associated with an
early potentiation of oxidative activity (typically within the first three hours of the
investigation). Conversely, radiation-induced stimulation of tumour reactive oxygen
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species production typically occurred 6-10 hours post-irradiation. This suggested
that radiation stimulated the induction of a reactive oxygen intermediate producing
mechanism different from that induced by arachidonic acid and gamma-linolenic
acid.
An early apoptotic response was also observed in C6 glioma cells exposed to
arachidonic acid or gamma-linolenic acid alone. In comparison, radiation-induced
stimulation of apoptosis occurred over a period of 12 hours and was maximal
between 6 and 8 hours post-irradiation. This increase was observed when the
stimulation of apoptosis induced by arachidonic acid or gamma-linolenic acid alone
was low. These preliminary experiments suggested that arachidonic acid and
gamma-linolenic acid and radiation may interact to potentiate reactive oxygen
intermediate generation and apoptotic events sensitive to lipid peroxides and their
products.
These results provide additional information on the controversy concerning the
physiological and pathological roles of oxidative metabolism. A pathological role for
oxygen based free radicals has been proposed following exposure to ionising
radiation and cytotoxic drugs (Halliwell and Gutteridge, 1985). Ultraviolet light, X-
rays and gamma-radiation stimulate the formation of reactive oxygen intermediates
including the hydroxyl radical, which has been implicated in the formation ofDNA
lesions known to increase genomic instability (Boon et al, 1984 and Drecher and
Junod, 1996). It has also been proposed that free radicals formed in vivo attack
biological molecules such as lipids, carbohydrates, proteins and DNA to induce
membrane damage, denaturation of protein, inactivation of enzymes, DNA strand
breakage and modification ofDNA bases, which may eventually cause a variety of
pathological events including cancer and ageing (Niki et al, 1991, Davies, 1991,
Sies, 1991 and Halliwell and Gutteridge, 1989).
The hypothesis that reactive oxygen intermediates are implicated in the initiation of
malignant transformation would predict that provision of essential fatty acids would
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potentiate cell damage and tumour proliferation by increasing the availability of
substrate upon which free radicals can act. However, in vivo and in vitro evidence
has indicated that essential fatty acids decrease tumour proliferation (Gonzalez,
1992) and stimulate apoptosis (Lai et al, 1996 and deKock et al, 1996). Additionally,
it has been shown that gamma-linolenic acid reduced radiation-induced damage to
porcine epidermis (Hopewell et al, 1993). An alternative hypothesis has been
proposed which states that while reactive oxygen intermediates may mediate some
degree of cell damage, in many situations it is free radical-induced loss ofmembrane
essential fatty acids which produces much of the pathology (Horrobin, 1991).
The present study supports the hypothesis which suggests a therapeutic role for
essential fatty acid-mediated stimulation ofglioma oxidative activity. However,
additional studies are required to evaluate the combined effects of radiation and
essential fatty acid administration in untransformed human brain tissue. Although an
in vitro study has indicated that the radiosensitising properties of gamma-linolenic
acid are not associated with normal cell toxicity (Vartak et al, 1997), and results
presented in this thesis indicate that tumour-associated normal brain reacts to
essential fatty acid stimulation with lower reactive oxygen species production in
comparison with human glioma tissue (Williams et al, 1997), additional research is
required to further clarify the role of oxidative metabolism in human brain in vivo.
153
8.4 Summary
The following findings and conclusions have been made:-
1) Analysis of the peroxidative activity of cell preparations derived from fresh
human glioma samples and tumour-associated normal brain indicated that basal
cellular oxidation was significantly lower in tumour cells (p<0.0004-0.00001),
2) Arachidonic acid and gamma-linolenic acid stimulated glioma oxidation.
Statistical analysis of the kinetics of the essential fatty acid induced response
suggested that more aggressive tumours, for example glioblastoma multiforme,
responded in a more rapid and sustained manner than less malignant tumours e.g.
astrocytomas.
3) Preliminary immunohistochemical and flow cytometric analysis indicated a group
of cells which was identified as the tumour sub-population. These cells were
characterised by low oxidative activity but high sensitivity to exogenous
arachidonic acid and gamma-linolenic acid.
4) Arachidonic acid and gamma-linolenic acid were not associated with significant
loss of cell membrane integrity, as measured by the uptake of vital dyes,
suggesting that forms of cell death other than necrosis are responsible for
mediating the cytotoxic activities of arachidonic acid and gamma-linolenic acid.
5) FlowTUNEL analysis of human primary brain tumour preparations indicated that
arachidonic acid and gamma-linolenic acid stimulated apoptosis over 24 hours.
Long term cell culture experiments with the rat C6 glioma cell line demonstrated
dose-dependent episodes of increased apoptotic activity over a period of 7 days.
6) There was evidence of a synergistic stimulation cellular oxidation and apoptotic
activity by radiation and exogenous arachidonic acid and gamma-linolenic acid.
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Peaks in oxidative activity may correlate with transient reductions in cell
viability, as measured by the uptake ofvital dyes.
8.3 Conclusions
This study has provided evidence that glioma tissue has low basal oxidative activity
in comparison with tumour-associated normal brain. These observations support the
findings of Cheeseman et al (1984) and Bartoli and Galeotti (1979) who described
low levels of basal oxidative activity in breast and hepatic tumour tissue. Exogenous
arachidonic acid and gamma-linolenic acid stimulated peroxidative activity and
apoptosis in a grade dependant manner (Chapter 4). This finding is in agreement
with previous reports that essential fatty acids stimulate cellular oxidative activity
(Yamamoto, 1985, Porter, 1986, Esterbauer et al, 1987 and Meydani et al, 1990).
Studies on the cellular heterogeneity of human glioma samples have indicated that
the stimulation of reactive oxygen intermediate by exogenous arachidonic acid and
gamma-linolenic acid occurred in GFAP-positive cells (Chapter 5). This finding
provided further evidence supporting the hypothesis that human glioma cells possess
high sensitivity to exogenous arachidonic acid and gamma-linolenic acid.
Additionally, cells possessing high side angle scatter, which was indicative ofGFAP
positivity, rapidly underwent apoptosis when stimulated with exogenous arachidonic
acid and gamma-linolenic acid. These findings are consistent with the hypothesis
that sensitivity to exogenous essential fatty acids is inversely related to cellular
proliferative activity (Horrobin, 1990).
Phagocyte populations from lung cancer and malignant glioma patients have also
been analysed, and there is evidence that they responded with increased reactive
oxygen intermediate production to arachidonic acid and gamma-linolenic acid
(Chapter 3). The magnitude of this increase was generally less than that observed for
human glioma tissue (Chapter 5).
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Concentrations of arachidonic acid and gamma-linolenic acid shown to stimulate
oxidative activity induced apoptosis in human glioma tissue and the rat C6 cell line.
This finding concurs with the observation that gamma-linolenic acid induced
apoptosis in human cervical carcinoma (deKock et al, 1984). Preliminary evidence
suggested that this activity was also associated with inhibition of glioma
proliferation (Chapter 6). Gamma-linolenic acid had previously been shown to
inhibit the proliferation of a glioma cell line in vitro (Das et al, 1990). In addition,
potentiation of the oxidative and apoptotic response of the rat C6 cell line to
exogenous arachidonic acid and gamma-linolenic acid has been demonstrated in the
presence of a therapeutically relevant dose of radiation (Chapter 7). Analysis of the
kinetics of this stimulation indicated that radiation and exogenous arachidonic acid
and gamma-linolenic acid stimulated oxidation and apoptosis at different phases of
the 12 hour incubation period. However, radiation and arachidonic acid and gamma-
linolenic acid may interact to potentiate the stimulation of peroxidative and
apoptotic activity. These results concur with those ofVartak et al (1997 and 1998)
who demonstrated that gamma-linolenic acid inhibited the clonogenic capacity of a
rat astrocytoma cell line in conjunction with radiation.
These results are consistent with a potential therapeutic role for arachidonic acid and
gamma-linolenic acid in the management ofmalignant glioma. Additional research
is necessary to further characterise the pathways which mediate these cytotoxic
activities. Additionally, the response ofmalignant glioma to exogenous essential
fatty acid administration in vivo is not well characterised. Additional research is
necessary to investigate behavioural and toxic side effects of essential fatty acid
administration in vivo, in addition to biochemical and neuropathological responses.
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